carbamazepine has been researched along with Affective Psychosis, Bipolar in 688 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Topiramate, a structurally novel anticonvulsant, is being evaluated for other neurological conditions such as migraine, neuropathic pain, and essential tremor, and also for psychiatric conditions such as bipolar disorder, bulimia, post-traumatic stress disorder, and schizoaffective disorder, in addition to obesity." | 10.19 | The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. ( Chengappa, KN; Gershon, S; Levine, J, 2001) |
| "Lithium carbonate is the drug of choice for the management of bipolar disorder, but 20% to 40% of patients do not exhibit adequate response to this agent." | 10.16 | Non-lithium treatment for bipolar disorder. ( Post, RM, 1990) |
| "The effects of long-term consequences of lithium, valproic acid, carbamazepine and antipsychotic agents on the development of dementia or cognitive impairments in patients with bipolar disorder were investigated." | 9.41 | [Effects of lithium, valproic acid, carbamazepine and antipsychotic agents on cognition in bipolar disorders-A systematic review]. ( Leopold, S; Quante, A, 2023) |
| "The aim of this study was to evaluate the safety and efficacy of extended release carbamazepine (CBZ-ER) monotherapy in the treatment of pediatric bipolar disorder (BD)." | 9.14 | A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. ( Aleardi, M; Biederman, J; Doyle, R; Georgiopoulos, A; Hammerness, P; Joshi, G; Kotarski, M; Mick, E; Walls, S; Williams, C; Wozniak, J, 2010) |
| "This multicenter trial examined the efficacy and safety of oxcarbazepine in the treatment of bipolar disorder in children and adolescents." | 9.12 | A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. ( Berv, D; D'Souza, J; Emslie, GJ; Findling, RL; Kowatch, RA; Lehman, RB; Linden, D; McCague, K; Wagner, KD; Wamil, A; Wilens, TE, 2006) |
| "Carbamazepine is frequently used for treating bipolar disorder, but few large trials have assessed its efficacy in preventing relapse." | 9.11 | A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. ( Kalali, AH; Ketter, TA; Weisler, RH, 2004) |
| "Divalproex maintenance treatment for bipolar disorder resulted in comparable medical costs, clinical and QOL outcomes compared with lithium." | 9.11 | Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial. ( Ahearn, EP; Hirschfeld, RM; Keck, PE; Palmer, C; Revicki, DA; Weisler, RH, 2005) |
| "In a randomized clinical trial (MAP study), the prophylactic efficacy of lithium and carbamazepine was compared in a subgroup of patients (n = 57) who presented either a bipolar II disorder or a bipolar disorder not otherwise specified (DSM-IV)." | 9.09 | Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. ( Greil, W; Kleindienst, N, 1999) |
| "In a randomised multicentre study, the prophylactic efficacy of lithium and carbamazepine was compared in 144 patients with bipolar disorder (74 vs." | 9.08 | Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study. ( Czernik, A; Engel, RR; Erazo, N; Giedke, H; Greil, W; Ludwig-Mayerhofer, W; Müller-Oerlinghausen, B; Osterheider, M; Rudolf, GA; Sauer, H; Schmidt, S; Schöchlin, C; Tegeler, J; Wetterling, T, 1997) |
| "5 years, the differential prophylactic efficacy of lithium versus carbamazepine was compared in 171 patients fulfilling DSM-IV criteria for bipolar disorder." | 9.08 | Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. ( Erazo, N; Greil, W; Kleindienst, N; Müller-Oerlinghausen, B, 1998) |
| "It has been demonstrated in open trials as well as double-blind controlled trials that carbamazepine has therapeutic as well as prophylactic efficacy on bipolar disorders." | 9.05 | Therapeutic and prophylactic effects of carbamazepine in bipolar disorders. ( Okuma, T, 1983) |
| " We review the clinical literature which suggests that tolerance can develop to most treatment approaches in bipolar illness and present an animal model of tolerance development to anticonvulsant effects of carbamazepine or lamotrigine on amgydala-kindled seizures." | 8.87 | Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders. ( Post, RM; Weiss, SR, 2011) |
| "Oxcarbazepine, a keto derivative of the 'mood stabiliser' carbamazepine, may have efficacy in the treatment of acute episodes of bipolar disorder." | 8.87 | Oxcarbazepine for acute affective episodes in bipolar disorder. ( Geddes, J; Macritchie, K; Vasudev, A; Vasudev, K; Watson, S; Young, AH, 2011) |
| "To review data from randomized controlled trials (RCTs) assessing the comparative efficacy of carbamazepine and lithium in treatment of acute manic and maintenance phase of bipolar disorder (BD)." | 8.85 | Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials. ( Ceron-Litvoc, D; de Lima, MS; Geddes, J; Litvoc, J; Soares, BG, 2009) |
| " Controlled trials in elderly patients with epilepsy demonstrate efficacy and tolerability comparable to gabapentin." | 8.84 | Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. ( Nanry, K; Ramsay, E; Sajatovic, M; Thompson, T, 2007) |
| "This paper briefly reviews and comments on the development of lamotrigine as a treatment for bipolar disorder." | 8.84 | Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. ( Ascher, JA; Bowden, CL; Calabrese, JR; DeVeaugh-Geiss, J; Evoniuk, G; Weisler, RH, 2008) |
| "There is an insufficient methodologically rigorous evidence base to provide guidance on the use of oxcarbazepine in the maintenance treatment of bipolar disorder." | 8.84 | Oxcarbazepine in the maintenance treatment of bipolar disorder. ( Geddes, JR; Macritchie, K; Vasudev, A; Watson, S; Young, AH, 2008) |
| "To review the data on the efficacy of oxcarbazepine (OXC) in bipolar disorder (BD) and to provide recommendations for clinicians on the use of this medication in treating BD." | 8.83 | Oxcarbazepine in the treatment of bipolar disorder: a review. ( Bond, DJ; Lam, RW; Pratoomsri, W; Sohn, CH; Yatham, LN, 2006) |
| "Two recently completed large, randomised, double-blind, placebo-controlled trials supporting the efficacy of carbamazepine (CBZ) extended-release capsules (ERC) for the treatment of acute manic and mixed episodes have resulted in US FDA approval of CBZ-ERC, and have reinvigorated the importance of understanding the role of CBZ in bipolar disorder (BD) pharmacotherapy." | 8.82 | Clinical use of carbamazepine for bipolar disorders. ( Ketter, TA; Wang, PW, 2005) |
| "Carbamazepine and valproate are used in the treatment of acute bipolar mania and as maintenance treatments for bipolar disorder." | 8.81 | Carbamazepine and valproate in the maintenance treatment of bipolar disorder. ( Keck, PE; McElroy, SL, 2002) |
| "This meta-analysis assessed the equipotency of carbamazepine and lithium prophylaxis in bipolar disorder." | 8.79 | Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis. ( Bange, F; Dardennes, R; Even, C; Heim, A, 1995) |
| "As clinical experience with lithium treatment of bipolar disorders accumulates, factors predictive of nonresponse are emerging." | 8.79 | Lithium therapy: limitations and alternatives in the treatment of bipolar disorders. ( Calabrese, JR; Woyshville, MJ, 1995) |
| "The research literature on alternative drug treatments to lithium therapy for the prevention of recurrences in bipolar disorders is discussed." | 8.78 | Alternative prophylactic treatments to lithium in bipolar disorders. ( Altamura, AC; Mauri, MC; Percudani, M; Regazzetti, MG, 1990) |
| "The authors review the research literature on drug treatment for the prevention of recurrences in bipolar disorder, emphasizing the available alternatives to lithium therapy." | 8.77 | Alternatives to lithium for preventive treatment of bipolar disorder. ( Gelenberg, AJ; Prien, RF, 1989) |
| "Carbamazepine is a medication used to treat a variety of neurological and psychiatric conditions including seizure disorders, neuropathic pain syndromes, and bipolar disorder." | 8.12 | Neurologic toxicity of carbamazepine in treatment of trigeminal neuralgia. ( Birdsong, S; Bridwell, RE; Brown, S; Clerkin, S; Long, B, 2022) |
| "A 48-year-old man who is a known case of bipolar disorder was maintaining well on a combination of carbamazepine and quetiapine for 3 years until he developed fever, severe leucopenia and lymphadenopathy, along with significant loss of weight and appetite." | 8.02 | Carbamazepine-induced delayed-onset agranulocytosis in a case of bipolar disorder with Kikuchi's disease. ( Innamuri, R; Irudayaraj, C; Kattula, D, 2021) |
| "This preliminary study investigated the neurofunctional effects of carbamazepine-extended release (XR) treatment in 11 manic youth with bipolar disorder during performance of a sustained attention task, the Continuous Performance Task - Identical Pairs version (CPT-IP), during functional magnetic resonance imaging (fMRI)." | 7.80 | The effects of carbamazepine on prefrontal activation in manic youth with bipolar disorder. ( Adler, CM; Bitter, SM; DelBello, MP; Elliott, KB; Klein, CC; Schneider, MR; Strakowski, SM; Weber, W, 2014) |
| "Lithium (LiCl) and carbamazepine (CBZ), the common mood stabilizers, are thought to be effective treatments for bipolar disorder." | 7.79 | Effects of lithium and carbamazepine on spatial learning and depressive behavior in a rat model of bipolar disorder induced by ouabain. ( Huang, AC; Huang, CL; Wang, CC; Wang, EN; Wang, YC, 2013) |
| "We report the case of a 70-year-old female patient with granulomatous interstitial nephritis (GIN) induced by carbamazepine (CBZ)." | 7.78 | Granulomatous interstitial nephritis associated with atypical drug-induced hypersensitivity syndrome induced by carbamazepine. ( Eguchi, E; Kuwahara, T; Nishiguchi, K; Shimazu, K; Tanaka, A; Yorifuji, S, 2012) |
| "Carbamazepine (CBZ) has been used in the treatment of bipolar disorder, both in acute mania and maintenance therapy, since the early 1970s." | 7.78 | Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes. ( Chen, CH; Lin, SK, 2012) |
| "A 26-year-old man with bipolar disorder, seizures, and mild mental retardation secondary to a traumatic brain injury began treatment with carbamazepine for aggression and seizure control." | 7.75 | Carbamazepine-induced hyperammonemia. ( Adams, EN; Lizer, MH; Marks, A, 2009) |
| "This study investigated the association between 2 mood stabilizers (carbamazepine and valproate) and other medications (including other anticonvulsants) and the risks of erythema multiforme (EM), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) among patients with bipolar disorder." | 7.74 | The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study. ( Chang, CJ; Chao, PF; Gau, CS; Gau, SS; Lin, YJ, 2008) |
| "To report two cases of mouth ulcers in lamotrigine patients after oxcarbazepine withdrawal." | 7.74 | Two case reports of oral ulcers with lamotrigine several weeks after oxcarbazepine withdrawal. ( de Leon, J; O'Neill, A, 2007) |
| "An extended-release formulation of carbamazepine, available since 1997 for treatment of epilepsy, has now been approved under a new name, Equetro, for acute mania and mixed episodes of bipolar disorder." | 7.73 | Extended-release carbamazepine (Equetro) for bipolar disorder. ( , 2005) |
| "This monograph summarizes the proceedings of a roundtable meeting convened to discuss the role of carbamazepine in the treatment of bipolar disorder, in light of new data and the recent indication of carbamazepine extended-release capsules (CBZ ERC) for use in the treatment of acute manic and mixed episodes." | 7.73 | Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new data. ( Akiskal, HS; Fuller, MA; Hirschfeld, RM; Keck, PE; Ketter, TA; Weisler, RH, 2005) |
| "The basis for carbamazepine's efficacy in treating bipolar disorder is not agreed on." | 7.73 | Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. ( Bazinet, RP; Chang, L; Lee, HJ; Rao, JS; Rapoport, SI, 2006) |
| "To assess the effectiveness and safety of oxcarbazepine (OXC) in bipolar disorder (BD) and related conditions." | 7.73 | Oxcarbazepine add-on in the treatment of refractory bipolar disorder. ( Lam, RW; Pratoomsri, W; Sohn, CH; Solomons, K; Yatham, LN, 2005) |
| "Carbamazepine extended-release capsules appear safe and efficacious for the treatment of bipolar disorder." | 7.73 | Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients. ( Ginsberg, LD, 2006) |
| "This analysis was a retrospective chart review evaluating the relationship between outcomes and length of treatment with carbamazepine extended-release capsules (CBZ-ERC) (Shire, Wayne, PA, USA) in bipolar disorder." | 7.73 | Outcomes and length of treatment with carbamazepine extended-release capsules in bipolar disorder. ( Ginsberg, LD, 2006) |
| "This analysis is a retrospective chart review evaluating the safety of carbamazepine (CBZ) extended-release capsules (CBZ-ERC) (Shire, Wayne, PA, USA) when used in combination with other agents as part of a polypharmacy regimen in the treatment of patients with bipolar disorder." | 7.73 | Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy. ( Ginsberg, LD, 2006) |
| " Here we used linear regression analysis to identify treatment-specific predictors of response to therapy with beaded extended-release carbamazepine capsules (CBZ-ERC) (Shire, Wayne, PA, USA) in 600 outpatients with bipolar disorder." | 7.73 | Predictors of response to carbamazepine extended-release capsules treatment in bipolar disorder. ( Ginsberg, LD, 2006) |
| " This report presents results from a retrospective assessment of the charts of 23 patients who received once-daily (qd) carbamazepine extended-release capsules (CBZ-ERC) (Shire, Wayne, PA, USA) for the treatment of bipolar disorder." | 7.73 | Safety and efficacy of carbamazepine extended-release capsules in patients with bipolar disorder: QD vs BID. ( Ginsberg, LD, 2006) |
| "An autopsy case of carbamazepine overdose with focal myocarditis is reported." | 7.73 | A case of carbamazepine overdose with focal myocarditis. ( Aoki, Y; Niitsu, H; Saigusa, K; Takamiya, M, 2006) |
| "Divalproex (DVP) and oxcarbazepine (OXC) are used to treat pediatric bipolar disorder (PBPD) with severe aggression but these agents have not been compared in head to head trials." | 7.73 | A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder. ( Fleisher, CA; Gonzalez-Heydrich, J; Korndörfer, SR; MacMillan, CM; Mezzacappa, E; Rao, S, 2006) |
| "To assess the effectiveness and safety of oxcarbazepine in bipolar disorder." | 7.72 | Oxcarbazepine treatment of bipolar disorder. ( Berv, DA; Ghaemi, SN; Hsu, DJ; Klugman, J; Rosenquist, KJ, 2003) |
| "A 38-year-old white woman with PTSD and bipolar disorder who had partially responded to carbamazepine was treated with oxcarbazepine." | 7.72 | Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder. ( Hanretta, AT; Malek-Ahmadi, P, 2004) |
| "A potential model for bipolar disorder, quinpirole-induced biphasic locomotion, was used for a preliminary evaluation of behavioral effects of oral anticonvulsant treatment." | 7.71 | Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder. ( Belmaker, RH; Einat, H; Shaldubina, A; Shimon, H; Szechtman, H, 2002) |
| "We describe a typical case of eosinophilic ulcer of the oral mucosa (EUOM) after an adverse reaction to carbamazepine, in a manic-depressive patient." | 7.70 | [Eosinophilic ulcers of the tongue as an adverse reaction to carbamazepine]. ( Hellín Meseguer, D; Melgarejo Moreno, PJ; Ruiz Macía, JA, 1998) |
| " A metastatic neuroblastoma was detected immediately after birth in a boy born to a 26 year old woman with bipolar disorder, who received carbamazepine (400 mg/day) all through her pregnancy." | 7.70 | Congenital neuroblastoma in a boy born to a woman with bipolar disorder treated with carbamazepine during pregnancy. ( Araujo, H; Baptista, T; Hernández, L; Rada, P, 1998) |
| "Lithium, carbamazepine and sodium valproate are mood stabilizers used in the treatment of bipolar disorder, and although their mechanisms of action remain unknown, signal transduction systems and the associated modulation of gene expression may constitute significant actions." | 7.70 | Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells. ( Jope, RS; Pacheco, MA, 1999) |
| "Inositol uptake was measured at concentrations of 25, 40 and 50 microM in human astrocytoma cell cultures treated for 1-3 weeks with pharmacologically relevant concentrations of LiCl, valproic acid or carbamazepine as well as in control cultures that had not been treated with any drug." | 7.70 | Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations. ( Belmaker, RH; Bersudsky, Y; Hertz, L; Simkin, M; Wolfson, M; Zinger, E, 2000) |
| "Two patients with psychotic disorders who developed Stevens-Johnson Syndrome while on treatment with carbamazepine is reported due to its rarity." | 7.70 | Stevens-Johnson syndrome due to carbamazepine. ( Chaudhury, S; John, TR; Ramadasan, P; Vaishampayne, S, 2000) |
| "To test the hypothesis that, although typical neuroleptics are commonly used in the treatment of bipolar disorder, newer atypical antipsychotic agents, like risperidone, may be more effective and better-tolerated." | 7.69 | Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. ( Baldassano, CF; Ghaemi, SN; Sachs, GS; Truman, CJ, 1997) |
| "This retrospective single-case study demonstrates the development of tolerance and reresponse to carbamazepine in a patient with coexisting trigeminal neuralgia and manic-depressive illness." | 7.68 | Contingent tolerance and reresponse to carbamazepine: a case study in a patient with trigeminal neuralgia and bipolar disorder. ( Pazzaglia, PJ; Post, RM, 1992) |
| "Carbamazepine is increasingly being used in the acute and maintenance treatment of patients with bipolar disorder." | 7.68 | Thrombocytopenia associated with carbamazepine: a case series. ( Castillo, J; Cole, JO; de los Heros, R; Farrer, RJ; Miller, MG; Tohen, M, 1991) |
| "Exacerbation of psoriasis was observed in a 28-year-old patient following the addition of lithium carbonate to a treatment regimen of carbamazepine and other drugs for manic-depressive psychosis." | 7.67 | Exacerbation of psoriasis during lithium treatment. ( Aihara, M; Ikezawa, Z; Ohsawa, J; Saito, S; Sasaki, T, 1989) |
| "Twenty-four patients suffering from affective disorders, who were being regularly treated with carbamazepine, were studied to determine the course of plasma levels of carbamazepine before (trough levels) and two and four hours after morning intake (peak levels)." | 7.67 | Measuring plasma levels of carbamazepine. A pharmacokinetic study in patients with affective disorders. ( Broekman, M; Jansen, GS; Nolen, WA, 1988) |
| "The authors assessed 20 carbamazepine-treated patients for the development of hyponatremia." | 7.67 | Carbamazepine and hyponatremia in patients with affective disorder. ( Camille, Y; Iskandar, H; Nastase, C; Yassa, R, 1988) |
| "A 37-year-old woman with cerebral palsy and a rapid cycling bipolar affective disorder developed drowsiness and slurred speech when being treated with a combination of haloperidol and a low dose of carbamazepine." | 7.67 | An interaction between haloperidol and carbamazepine in a patient with cerebral palsy. ( Brayley, J; Yellowlees, P, 1987) |
| "The effect of carbamazepine on body weight was studied in 24 patients with affective illness." | 7.67 | Effect of carbamazepine on body weight in affectively ill patients. ( Joffe, RT; Post, RM; Uhde, TW, 1986) |
| "The effects on serum electrolytes of carbamazepine, an acute and prophylactic treatment for manic-depressive illness, were assessed in subjects with primary affective disorder." | 7.67 | Effects of carbamazepine on serum electrolytes in affectively ill patients. ( Joffe, RT; Post, RM; Uhde, TW, 1986) |
| "Carbamazepine is gaining recognition as a valuable drug in the treatment of patients with bipolar disorders who fail to respond to lithium." | 7.67 | The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants. ( Fawcett, J; Kravitz, HM, 1985) |
| "A lithium and carbamazepine combination was reported in five patients with bipolar disorder (DSM-III), who had not received benefits from conventional treatments." | 7.66 | A lithium and carbamazepine combination in the treatment of bipolar disorder--a preliminary report. ( Arima, S; Fukui, Y; Inoue, K; Kato, N; Tanaka, K, 1981) |
| "The effect of carbamazepine in bipolar disorder has been studied by several groups." | 7.66 | Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder. ( Nolen, WA, 1983) |
| "Carbamazepine has been used to treat mania for over 2 decades." | 6.71 | A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. ( Kalali, AH; Ketter, TA; Weisler, RH, 2004) |
| " In the present paper, I review studies in unanaesthetized rats using a neuropharmacological approach, combined with kinetic, biochemical and molecular biology techniques, demonstrating that chronic administration of three commonly used mood stabilizers (lithium, valproic acid and carbamazepine), at therapeutically relevant doses, selectively target the brain arachidonic acid cascade." | 6.45 | Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder? ( Bazinet, RP, 2009) |
| "Oxcarbazepine (OXC) is a keto-congener of carbamazepine, which has fewer side effects and drug interactions." | 6.44 | Oxcarbazepine in bipolar disorder: a critical review of the literature. ( Bria, P; Conte, G; Di Nicola, M; Janiri, L; Martinotti, G; Mazza, M; Mazza, S; Pozzi, G; Taranto, C, 2007) |
| "Carbamazepine (CBZ) has a long history of successful use in epilepsy and, therefore, has a safety profile that is well characterised." | 6.43 | Practical considerations for carbamazepine use in bipolar disorder. ( Dostrow, V; Fuller, MA; Gazda, TD; Gupta, S, 2006) |
| "Topiramate, a structurally novel anticonvulsant, is being evaluated for other neurological conditions such as migraine, neuropathic pain, and essential tremor, and also for psychiatric conditions such as bipolar disorder, bulimia, post-traumatic stress disorder, and schizoaffective disorder, in addition to obesity." | 6.19 | The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. ( Chengappa, KN; Gershon, S; Levine, J, 2001) |
| "Lithium carbonate is the drug of choice for the management of bipolar disorder, but 20% to 40% of patients do not exhibit adequate response to this agent." | 6.16 | Non-lithium treatment for bipolar disorder. ( Post, RM, 1990) |
| "Hypothermia is a rare but serious condition that has been associated with various psychiatric medications." | 5.46 | Severe recurrent hypothermia in an elderly patient with refractory mania associated with atypical antipsychotic, valproic acid and oxcarbazepine therapy. ( Ajayi, OO; Holroyd, S, 2017) |
| "The effects of long-term consequences of lithium, valproic acid, carbamazepine and antipsychotic agents on the development of dementia or cognitive impairments in patients with bipolar disorder were investigated." | 5.41 | [Effects of lithium, valproic acid, carbamazepine and antipsychotic agents on cognition in bipolar disorders-A systematic review]. ( Leopold, S; Quante, A, 2023) |
| " Adjusting the maintenance dosage of H(2)-histamine antagonists has been recommended in elderly patients since age-related reduction in renal plasma flow, glomerular filtration rate and renal tubular function may be present, which can in turn elevate histamine levels in plasma and cerebrospinal fluid." | 5.31 | H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures. ( Bergemann, N; Diebold, K; Mundt, C; Roesch-Ely, D; Sartor, K; von Einsiedel, RW, 2002) |
| "The aim of this study was to evaluate the safety and efficacy of extended release carbamazepine (CBZ-ER) monotherapy in the treatment of pediatric bipolar disorder (BD)." | 5.14 | A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. ( Aleardi, M; Biederman, J; Doyle, R; Georgiopoulos, A; Hammerness, P; Joshi, G; Kotarski, M; Mick, E; Walls, S; Williams, C; Wozniak, J, 2010) |
| "Despite the increasing use of lamotrigine (LTG) in bipolar disorder, little is known about its impact on cognition in bipolar patients." | 5.12 | Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results. ( Benabarre, A; Colom, F; Comes, M; Daban, C; Goikolea, JM; Martínez-Arán, A; Sánchez-Moreno, J; Torrent, C; Vieta, E, 2006) |
| "This multicenter trial examined the efficacy and safety of oxcarbazepine in the treatment of bipolar disorder in children and adolescents." | 5.12 | A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. ( Berv, D; D'Souza, J; Emslie, GJ; Findling, RL; Kowatch, RA; Lehman, RB; Linden, D; McCague, K; Wagner, KD; Wamil, A; Wilens, TE, 2006) |
| "Our previous study has shown the beneficial effects of the herbal medicine called Free and Easy Wanderer Plus (FEWP) as adjunctive therapy with carbamazepine (CBZ) in the 12-week treatment of bipolar disorders (Zhang ZJ, Kang WH, Tan QR, Li Q, Gao CG, Zhang FG, et al." | 5.12 | The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies. ( Kang, WH; Li, Q; Tan, QR; Zhang, ZJ, 2007) |
| "Thirty patients with bipolar disorder, currently hypomanic, were randomized to receive oxcarbazepine or divalproex as add-on or monotherapy for 8 weeks." | 5.12 | Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder. ( Curley, E; Foster, B; Hynan, LS; Kelly, DI; Snow, DE; Suppes, T; Sureddi, S, 2007) |
| "The aim of this preliminary open-label trial was to evaluate the efficacy and safety of oxcarbazepine (OXC) as adjunctive therapy in 18 patients with bipolar disorder who did not respond satisfactorily to lithium." | 5.11 | Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode. ( Benedetti, A; Cassano, GB; Dell'Osso, L; Lattanzi, L; Musetti, L; Pini, S, 2004) |
| "Carbamazepine is frequently used for treating bipolar disorder, but few large trials have assessed its efficacy in preventing relapse." | 5.11 | A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. ( Kalali, AH; Ketter, TA; Weisler, RH, 2004) |
| "As trust in drug treatment and trust in the treating physician had a clear impact on adherence to prophylactic lithium, patients' illness concepts and treatment expectations might be promising targets for psychoeducation and psychotherapy in the treatment of bipolar disorder." | 5.11 | Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder? ( Greil, W; Kleindienst, N, 2004) |
| "Divalproex maintenance treatment for bipolar disorder resulted in comparable medical costs, clinical and QOL outcomes compared with lithium." | 5.11 | Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial. ( Ahearn, EP; Hirschfeld, RM; Keck, PE; Palmer, C; Revicki, DA; Weisler, RH, 2005) |
| " 2) Four groups (T1-T4) of remitted patients with bipolar disorders (20 in each group) were successfully maintained on mood stabilizers (lithium or carbamazepine) and classified by the duration of their episode-free period." | 5.10 | The influence of successful prophylactic drug treatment on cognitive dysfunction in bipolar disorders. ( Müller-Oerlinghausen, B; Wolf, T, 2002) |
| " The aim of this study is to determine the effectiveness and safety of olanzapine as an add-on therapy in patients with bipolar disorder with a rapid cycling course during a dysphoric mania episode." | 5.10 | Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine. ( Fernandez-Corres, B; Gonzalez-Pinto, A; Gutierrez, M; Lalaguna, B; Micó, JA; Pérez-Heredia, JL; Tohen, M, 2002) |
| "Omega3 fatty acids may inhibit neuronal signal transduction pathways in a manner similar to that of lithium carbonate and valproate, 2 effective treatments for bipolar disorder." | 5.09 | Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. ( Cress, KK; Diamond, E; Freeman, MP; Marangell, LB; Rueter, S; Severus, WE; Stoll, AL; Zboyan, HA, 1999) |
| "In a randomized clinical trial (MAP study), the prophylactic efficacy of lithium and carbamazepine was compared in a subgroup of patients (n = 57) who presented either a bipolar II disorder or a bipolar disorder not otherwise specified (DSM-IV)." | 5.09 | Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. ( Greil, W; Kleindienst, N, 1999) |
| "This investigation evaluated the relationship between changes in thyroid indices and mood stability during lithium and carbamazepine prophylaxis for bipolar disorder." | 5.09 | Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients. ( Ali, SO; Bryan, AL; Denicoff, KD; Frye, MA; Leverich, GS; Luckenbaugh, D; Post, RM; Smith-Jackson, EE, 1999) |
| "Anticonvulsant agents such as carbamazepine and valproate are alternatives to lithium in treating subjects with bipolar disorder." | 5.09 | Topiramate as add-on treatment for patients with bipolar mania. ( Atzert, R; Brar, JS; Chengappa, KN; Delaney, J; Levin, H; Levine, J; Moffa, N; Parepally, H; Rathore, D; Solai, L, 1999) |
| "In a double-blind, placebo-controlled study, 117 outpatients with DSM-III-R bipolar disorder, depressive phase, were randomly assigned to treatment with paroxetine (N=35), imipramine (N=39), or placebo (N=43) for 10 weeks." | 5.09 | Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. ( Bowden, CL; Evans, DL; Gergel, IP; Gyulai, L; Nemeroff, CB; Oakes, R; Pitts, CD; Sachs, GS, 2001) |
| "Bupropion (BUP) may be less likely than other antidepressants to cause switches into mania and rapid cycling, suggesting utility in bipolar disorder." | 5.08 | Carbamazepine but not valproate induces bupropion metabolism. ( Callahan, AM; Chao, J; George, MS; Hinton, ML; Jenkins, JB; Ketter, TA; Marangell, LB; Pazzaglia, PJ; Post, RM; Schroeder, DH, 1995) |
| "In a randomised multicentre study, the prophylactic efficacy of lithium and carbamazepine was compared in 144 patients with bipolar disorder (74 vs." | 5.08 | Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study. ( Czernik, A; Engel, RR; Erazo, N; Giedke, H; Greil, W; Ludwig-Mayerhofer, W; Müller-Oerlinghausen, B; Osterheider, M; Rudolf, GA; Sauer, H; Schmidt, S; Schöchlin, C; Tegeler, J; Wetterling, T, 1997) |
| "Some outpatients with bipolar disorder refractory to lithium and carbamazepine received clinically relevant prophylactic benefit from valproate when used with lithium or in triple therapy." | 5.08 | Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder. ( Ali, SO; Bryan, AL; Denicoff, KD; Post, RM; Smith-Jackson, EE, 1997) |
| "5 years, the differential prophylactic efficacy of lithium versus carbamazepine was compared in 171 patients fulfilling DSM-IV criteria for bipolar disorder." | 5.08 | Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. ( Erazo, N; Greil, W; Kleindienst, N; Müller-Oerlinghausen, B, 1998) |
| "A multi-institutional study comparing the antimanic effect of carbamazepine (CBZ) and lithium carbonate (Li) was performed using a double-blind group comparison design in a series of 105 patients with bipolar disorders." | 5.06 | Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. ( Hazama, H; Inanaga, K; Itoh, H; Okuma, T; Otsuki, S; Sarai, K; Takahashi, R; Watanabe, S; Yamashita, I, 1990) |
| "It has been demonstrated in open trials as well as double-blind controlled trials that carbamazepine has therapeutic as well as prophylactic efficacy on bipolar disorders." | 5.05 | Therapeutic and prophylactic effects of carbamazepine in bipolar disorders. ( Okuma, T, 1983) |
| " We review the clinical literature which suggests that tolerance can develop to most treatment approaches in bipolar illness and present an animal model of tolerance development to anticonvulsant effects of carbamazepine or lamotrigine on amgydala-kindled seizures." | 4.87 | Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders. ( Post, RM; Weiss, SR, 2011) |
| "Oxcarbazepine, a keto derivative of the 'mood stabiliser' carbamazepine, may have efficacy in the treatment of acute episodes of bipolar disorder." | 4.87 | Oxcarbazepine for acute affective episodes in bipolar disorder. ( Geddes, J; Macritchie, K; Vasudev, A; Vasudev, K; Watson, S; Young, AH, 2011) |
| "A systematic search was carried out of electronic databases, reference books and other sources for original research studies which examined the effects of commonly used mood stabilizers (sodium valproate, carbamazepine, lamotrigine and lithium carbonate) on pregnancy outcomes." | 4.86 | Mood stabilizers in pregnancy: a systematic review. ( Buist, A; Galbally, M; Roberts, M, 2010) |
| "To review data from randomized controlled trials (RCTs) assessing the comparative efficacy of carbamazepine and lithium in treatment of acute manic and maintenance phase of bipolar disorder (BD)." | 4.85 | Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials. ( Ceron-Litvoc, D; de Lima, MS; Geddes, J; Litvoc, J; Soares, BG, 2009) |
| "Carbamazepine began to be studied in a systematic fashion in the 1970s and became more widely used in the treatment of bipolar disorder in the 1980s." | 4.84 | Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice. ( Ballenger, JC; Ketter, TA; Post, RM; Uhde, T, 2007) |
| " Controlled trials in elderly patients with epilepsy demonstrate efficacy and tolerability comparable to gabapentin." | 4.84 | Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. ( Nanry, K; Ramsay, E; Sajatovic, M; Thompson, T, 2007) |
| "Starting with carbamazepine and valproate in the eighties, several anticonvulsant have been established as a treatment option in bipolar disorder." | 4.84 | [Anticonvulsants in the treatment of bipolar disorder]. ( Grunze, H, 2007) |
| "Lithium, valproate, lamotrigine and olanzapine are effective as maintenance therapy for the prevention of relapse in bipolar disorder." | 4.84 | A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. ( Barbieri, M; Beynon, S; Bravo Vergel, Y; Duffy, S; Dunn, G; Geddes, J; Gilbody, S; Palmer, S; Soares-Weiser, K; Woolacott, N, 2007) |
| "This paper briefly reviews and comments on the development of lamotrigine as a treatment for bipolar disorder." | 4.84 | Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. ( Ascher, JA; Bowden, CL; Calabrese, JR; DeVeaugh-Geiss, J; Evoniuk, G; Weisler, RH, 2008) |
| "There is an insufficient methodologically rigorous evidence base to provide guidance on the use of oxcarbazepine in the maintenance treatment of bipolar disorder." | 4.84 | Oxcarbazepine in the maintenance treatment of bipolar disorder. ( Geddes, JR; Macritchie, K; Vasudev, A; Watson, S; Young, AH, 2008) |
| "Valproate, lamotrigine and carbamazepine have a valuable place in the management of bipolar disorder." | 4.83 | Anticonvulsants in bipolar disorder. ( Bowden, CL; Karren, NU, 2006) |
| "Randomised trials comparing haloperidol with placebo or other active treatment in the treatment of acute manic or mixed episodes in patients with bipolar disorder or schizoaffective disorder." | 4.83 | Haloperidol alone or in combination for acute mania. ( Cipriani, A; Geddes, JR; Rendell, JM, 2006) |
| "To review the data on the efficacy of oxcarbazepine (OXC) in bipolar disorder (BD) and to provide recommendations for clinicians on the use of this medication in treating BD." | 4.83 | Oxcarbazepine in the treatment of bipolar disorder: a review. ( Bond, DJ; Lam, RW; Pratoomsri, W; Sohn, CH; Yatham, LN, 2006) |
| "The role of lithium carbonate in the maintenance treatment of bipolar disorder is well established." | 4.82 | Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder. ( Freeman, MP; Gelenberg, AJ; Gnanadesikan, M, 2003) |
| "Two recently completed large, randomised, double-blind, placebo-controlled trials supporting the efficacy of carbamazepine (CBZ) extended-release capsules (ERC) for the treatment of acute manic and mixed episodes have resulted in US FDA approval of CBZ-ERC, and have reinvigorated the importance of understanding the role of CBZ in bipolar disorder (BD) pharmacotherapy." | 4.82 | Clinical use of carbamazepine for bipolar disorders. ( Ketter, TA; Wang, PW, 2005) |
| "Carbamazepine and valproate are used in the treatment of acute bipolar mania and as maintenance treatments for bipolar disorder." | 4.81 | Carbamazepine and valproate in the maintenance treatment of bipolar disorder. ( Keck, PE; McElroy, SL, 2002) |
| " Alternative and adjunctive treatments to lithium in bipolar disorder have been sought and the anticonvulsants carbamazepine and valproate show promise." | 4.81 | Developments in mood stabilisers. ( Ferrier, IN, 2001) |
| "In an attempt to find the key to reducing the excessive morbidity and mortality seen with mood disorders, our laboratory has been extensively investigating lithium's mechanisms of action in an integrated series of clinical and preclinical studies." | 4.80 | Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. ( Bebchuk, JM; Chen, G; Glitz, D; Hasanat, KA; Manji, HK; Moore, GJ, 1999) |
| "Mood-stabilizing drugs including lithium, anticonvulsants, and antipsychotics have established effects in the management of bipolar disorder, especially in mania." | 4.80 | Mood-stabilizing drugs in depression. ( Shelton, RC, 1999) |
| "Three man, aged 66, 60 and 26 years with bipolar disorder and long periods (20-5 years) of effective lithium prophylaxis had relapses on lithium discontinuation." | 4.80 | [Risk of inducing resistance upon stopping and restarting lithium after long-term usage]. ( Hoenderboom, AC; Kupka, RW; Nolen, WA; Oostervink, F, 2000) |
| "This meta-analysis assessed the equipotency of carbamazepine and lithium prophylaxis in bipolar disorder." | 4.79 | Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis. ( Bange, F; Dardennes, R; Even, C; Heim, A, 1995) |
| "As clinical experience with lithium treatment of bipolar disorders accumulates, factors predictive of nonresponse are emerging." | 4.79 | Lithium therapy: limitations and alternatives in the treatment of bipolar disorders. ( Calabrese, JR; Woyshville, MJ, 1995) |
| "Outcome studies of bipolar disorder, the majority of which were conducted before the use of lithium, divalproex, and carbamazepine, generally found that only 50 to 60% of patients achieved good recovery 6 to 12 months after a manic episode." | 4.79 | Outcome in the pharmacologic treatment of bipolar disorder. ( Keck, PE; McElroy, SL, 1996) |
| "Although lithium remains the preferred treatment of bipolar disorder, only 60 to 80% of patients with the classic presentation have an adequate response to this drug." | 4.79 | Predictors of response to mood stabilizers. ( Calabrese, JR; Fatemi, SH; Kujawa, M; Woyshville, MJ, 1996) |
| " We describe the phenomenon of amygdala-kindled seizures episodically breaking through effective daily pharmacotherapy with carbamazepine and valproate, suggesting that these observations could reflect the balance of pathological vs compensatory illness-induced changes in gene expression." | 4.79 | A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. ( Post, RM; Weiss, SR, 1996) |
| "Published reports regarding the time course of onset, clinical factors associated with response, and health-economic impact of the treatment of acute mania with lithium, valproate, and carbamazepine were reviewed (PAPERCHASE data base, 1966 to present, terms: bipolar disorder, drug treatment, lithium, valproate, and carbamazepine)." | 4.79 | Health-economic implications of the onset of action of antimanic agents. ( Bennett, JA; Keck, PE; McElroy, SL, 1996) |
| "The acute and chronic pharmacotherapy of bipolar disorder requires an understanding of the pharmacology of very dissimilar compounds--the mood stabilizers (lithium, carbamazepine and valproate) and several classes of antidepressants." | 4.78 | Pharmacological issues in the treatment of bipolar disorder: focus on mood-stabilizing compounds. ( Ketter, TA; Potter, WZ, 1993) |
| ", carbamazepine, valproate, clonazepam, oxcarbazepine, and electroconvulsive therapy (ECT), for patients with bipolar disorder." | 4.78 | Anticonvulsants in the treatment of bipolar disorder. ( Keck, PE; McElroy, SL; Nemeroff, CB, 1992) |
| "The research literature on alternative drug treatments to lithium therapy for the prevention of recurrences in bipolar disorders is discussed." | 4.78 | Alternative prophylactic treatments to lithium in bipolar disorders. ( Altamura, AC; Mauri, MC; Percudani, M; Regazzetti, MG, 1990) |
| "The anticonvulsants, especially carbamazepine and valproate, offer new clinical and theoretical perspectives in the treatment of lithium-refractory bipolar disorders." | 4.77 | Emerging perspectives on valproate in affective disorders. ( Post, RM, 1989) |
| "The authors review the research literature on drug treatment for the prevention of recurrences in bipolar disorder, emphasizing the available alternatives to lithium therapy." | 4.77 | Alternatives to lithium for preventive treatment of bipolar disorder. ( Gelenberg, AJ; Prien, RF, 1989) |
| "Carbamazepine is a medication used to treat a variety of neurological and psychiatric conditions including seizure disorders, neuropathic pain syndromes, and bipolar disorder." | 4.12 | Neurologic toxicity of carbamazepine in treatment of trigeminal neuralgia. ( Birdsong, S; Bridwell, RE; Brown, S; Clerkin, S; Long, B, 2022) |
| "A 48-year-old man who is a known case of bipolar disorder was maintaining well on a combination of carbamazepine and quetiapine for 3 years until he developed fever, severe leucopenia and lymphadenopathy, along with significant loss of weight and appetite." | 4.02 | Carbamazepine-induced delayed-onset agranulocytosis in a case of bipolar disorder with Kikuchi's disease. ( Innamuri, R; Irudayaraj, C; Kattula, D, 2021) |
| "Use of carbamazepine and valproic acid, but not lithium and lamotrigine, is associated with increased risk of stroke in patients with bipolar disorder." | 3.91 | Mood stabilisers and risk of stroke in bipolar disorder. ( Chang, CK; Chen, CC; Chen, PH; Kuo, CJ; Pan, CH; Su, SS; Tsai, SY, 2019) |
| "We found increased risks of cataract development in long-term users of lithium, lithium combined with other MS and valproic acid combined with other MS for more than two years among patients with BD and schizophrenia." | 3.88 | Associations between use of mood stabilizers and risk of cataract: A population-based nested case-control study. ( Chou, PH; Chu, CS; Lan, TH; Lin, CH, 2018) |
| " This limitation and high risks of neural tube and other major teratogenic effects, especially of valproate, indicate the need for great caution in the use of valproate and carbamazepine to treat bipolar disorder in women of child-bearing age." | 3.88 | Mood-Stabilizing Anticonvulsants, Spina Bifida, and Folate Supplementation: Commentary. ( Baldessarini, RJ; Patel, N; Viguera, AC, 2018) |
| "Two hundred and thirty-four outpatients with bipolar disorders receiving prophylactic treatment with lithium, valproate, carbamazepine, or their combination were followed up for at least 18 months in two Italian psychiatric centers specialized in mood disorders." | 3.88 | Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study. ( Benedetti, A; Cambiali, E; Del Grande, C; Dell'Osso, L; Massimetti, G; Musetti, L; Pergentini, I; Tundo, A, 2018) |
| "Carbamazepine and quetiapine are drugs that are used as mood stabilizers in the treatment of bipolar disorders." | 3.85 | How long does the pharmacokinetic interaction between carbamazepine and quetiapine last after carbamazepine withdrawal? ( Kopecek, M; Potmesil, P, 2017) |
| "We presented a case of a 50 years old woman with bipolar disorder who is treated with lithium and oxcarbazepine, she presented a manic episode and a confusional syndrome after she stopped taking the medication." | 3.85 | Manic espisode, confusional syndrome and reversible splenial lesion after abrupt withdrawal of oxcarbazepine. ( Domínguez, A; González, MF; Livianos, L; Martínez, JC; Merizalde, M; Navalón, P, 2017) |
| "This preliminary study investigated the neurofunctional effects of carbamazepine-extended release (XR) treatment in 11 manic youth with bipolar disorder during performance of a sustained attention task, the Continuous Performance Task - Identical Pairs version (CPT-IP), during functional magnetic resonance imaging (fMRI)." | 3.80 | The effects of carbamazepine on prefrontal activation in manic youth with bipolar disorder. ( Adler, CM; Bitter, SM; DelBello, MP; Elliott, KB; Klein, CC; Schneider, MR; Strakowski, SM; Weber, W, 2014) |
| "These results demonstrate a behaviourally effective oral and chronic regimen for carbamazepine with mood stabilising-like activity in a standard model for mania-like behaviour and two standard models for depression-like behaviour." | 3.80 | Chronic oral carbamazepine treatment elicits mood-stabilising effects in mice. ( Agam, G; Belmaker, RH; Einat, H; Kara, NZ; Karpel, O; Toker, L, 2014) |
| "Given the potential concomitant use of carbamazepine and paliperidone extended-release (ER) in the treatment of schizophrenia or schizoaffective disorder, this open-label, two-treatment sequential study investigated the effect of repeated administration of carbamazepine on the steady-state pharmacokinetics of paliperidone." | 3.80 | Effect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-state. ( Berwaerts, J; Cleton, A; Kerbusch-Herben, V; Remmerie, B; Vandebosch, A, 2014) |
| "Lithium (LiCl) and carbamazepine (CBZ), the common mood stabilizers, are thought to be effective treatments for bipolar disorder." | 3.79 | Effects of lithium and carbamazepine on spatial learning and depressive behavior in a rat model of bipolar disorder induced by ouabain. ( Huang, AC; Huang, CL; Wang, CC; Wang, EN; Wang, YC, 2013) |
| "Evidence accumulating during almost 50 years suggests Na(+), K(+)-ATPase dysfunction in bipolar disorder, a disease treatable with chronic administration of lithium salts, carbamazepine or valproic acid." | 3.79 | Cell-specific mRNA alterations in Na+, K+-ATPase α and β isoforms and FXYD in mice treated chronically with carbamazepine, an anti-bipolar drug. ( Hertz, L; Li, B; Peng, L, 2013) |
| "Patients with major affective disorders are more likely to complete suicide than patients in any other medical group." | 3.79 | Anticonvulsant therapy and suicide risk in affective disorders. ( Goodwin, FK, 1999) |
| "We report the case of a 70-year-old female patient with granulomatous interstitial nephritis (GIN) induced by carbamazepine (CBZ)." | 3.78 | Granulomatous interstitial nephritis associated with atypical drug-induced hypersensitivity syndrome induced by carbamazepine. ( Eguchi, E; Kuwahara, T; Nishiguchi, K; Shimazu, K; Tanaka, A; Yorifuji, S, 2012) |
| " The present study examines the hypothesis that the three antiepileptics approved for bipolar disorder (carbamazepine, lamotrigine, and valproate) are associated with an elevated risk of suicide attempts and suicides." | 3.78 | Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: a 30-year observational study. ( Coryell, WH; Endicott, J; Fiedorowicz, JG; Keller, MB; Leon, AC; Li, C; Solomon, DA, 2012) |
| "Carbamazepine (CBZ) has been used in the treatment of bipolar disorder, both in acute mania and maintenance therapy, since the early 1970s." | 3.78 | Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes. ( Chen, CH; Lin, SK, 2012) |
| "This study investigated the effects of three AEDs (carbamazepine, oxcarbazepine, and valproic acid) on nicotine and nicotine metabolite levels in 149 smokers with schizophrenia and bipolar disorder who participated in an afternoon blood draw for nicotine, cotinine, and 3'-hydroxycotinine (3HC)." | 3.76 | Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness. ( Benowitz, NL; Gandhi, KK; Williams, JM, 2010) |
| "A 26-year-old man with bipolar disorder, seizures, and mild mental retardation secondary to a traumatic brain injury began treatment with carbamazepine for aggression and seizure control." | 3.75 | Carbamazepine-induced hyperammonemia. ( Adams, EN; Lizer, MH; Marks, A, 2009) |
| "This study investigated the association between 2 mood stabilizers (carbamazepine and valproate) and other medications (including other anticonvulsants) and the risks of erythema multiforme (EM), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) among patients with bipolar disorder." | 3.74 | The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study. ( Chang, CJ; Chao, PF; Gau, CS; Gau, SS; Lin, YJ, 2008) |
| "To report two cases of mouth ulcers in lamotrigine patients after oxcarbazepine withdrawal." | 3.74 | Two case reports of oral ulcers with lamotrigine several weeks after oxcarbazepine withdrawal. ( de Leon, J; O'Neill, A, 2007) |
| "This article reports detoxication treatments of a case of combined overdose of carbamazepine and lithium in a 38-year-old female with bipolar disorder." | 3.74 | Detoxication treatment for carbamazepine and lithium overdose. ( Ikeda, H; Kihira, K; Murakami, T; Tanigawa, K; Unei, H, 2008) |
| " Lower doses of valproate and carbamazepine were required to prevent hyperactivity compared to doses required to block tonic-clonic seizures induced by pentylenetetrazole." | 3.73 | Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania. ( Arban, R; Brackenborough, K; Gerrard, P; Large, C; Maraia, G; Wilson, A; Winyard, L, 2005) |
| "An extended-release formulation of carbamazepine, available since 1997 for treatment of epilepsy, has now been approved under a new name, Equetro, for acute mania and mixed episodes of bipolar disorder." | 3.73 | Extended-release carbamazepine (Equetro) for bipolar disorder. ( , 2005) |
| "This monograph summarizes the proceedings of a roundtable meeting convened to discuss the role of carbamazepine in the treatment of bipolar disorder, in light of new data and the recent indication of carbamazepine extended-release capsules (CBZ ERC) for use in the treatment of acute manic and mixed episodes." | 3.73 | Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new data. ( Akiskal, HS; Fuller, MA; Hirschfeld, RM; Keck, PE; Ketter, TA; Weisler, RH, 2005) |
| "The basis for carbamazepine's efficacy in treating bipolar disorder is not agreed on." | 3.73 | Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. ( Bazinet, RP; Chang, L; Lee, HJ; Rao, JS; Rapoport, SI, 2006) |
| "To assess the effectiveness and safety of oxcarbazepine (OXC) in bipolar disorder (BD) and related conditions." | 3.73 | Oxcarbazepine add-on in the treatment of refractory bipolar disorder. ( Lam, RW; Pratoomsri, W; Sohn, CH; Solomons, K; Yatham, LN, 2005) |
| "Carbamazepine extended-release capsules appear safe and efficacious for the treatment of bipolar disorders in children and adolescent patients." | 3.73 | Carbamazepine extended-release capsules: a retrospective review of its use in children and adolescents. ( Ginsberg, LD, 2006) |
| "Carbamazepine extended-release capsules appear safe and efficacious for the treatment of bipolar disorder." | 3.73 | Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients. ( Ginsberg, LD, 2006) |
| "This analysis was a retrospective chart review evaluating the relationship between outcomes and length of treatment with carbamazepine extended-release capsules (CBZ-ERC) (Shire, Wayne, PA, USA) in bipolar disorder." | 3.73 | Outcomes and length of treatment with carbamazepine extended-release capsules in bipolar disorder. ( Ginsberg, LD, 2006) |
| "This analysis is a retrospective chart review evaluating the safety of carbamazepine (CBZ) extended-release capsules (CBZ-ERC) (Shire, Wayne, PA, USA) when used in combination with other agents as part of a polypharmacy regimen in the treatment of patients with bipolar disorder." | 3.73 | Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy. ( Ginsberg, LD, 2006) |
| " Here we used linear regression analysis to identify treatment-specific predictors of response to therapy with beaded extended-release carbamazepine capsules (CBZ-ERC) (Shire, Wayne, PA, USA) in 600 outpatients with bipolar disorder." | 3.73 | Predictors of response to carbamazepine extended-release capsules treatment in bipolar disorder. ( Ginsberg, LD, 2006) |
| " This report presents results from a retrospective assessment of the charts of 23 patients who received once-daily (qd) carbamazepine extended-release capsules (CBZ-ERC) (Shire, Wayne, PA, USA) for the treatment of bipolar disorder." | 3.73 | Safety and efficacy of carbamazepine extended-release capsules in patients with bipolar disorder: QD vs BID. ( Ginsberg, LD, 2006) |
| "An autopsy case of carbamazepine overdose with focal myocarditis is reported." | 3.73 | A case of carbamazepine overdose with focal myocarditis. ( Aoki, Y; Niitsu, H; Saigusa, K; Takamiya, M, 2006) |
| "Divalproex (DVP) and oxcarbazepine (OXC) are used to treat pediatric bipolar disorder (PBPD) with severe aggression but these agents have not been compared in head to head trials." | 3.73 | A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder. ( Fleisher, CA; Gonzalez-Heydrich, J; Korndörfer, SR; MacMillan, CM; Mezzacappa, E; Rao, S, 2006) |
| "To assess the effectiveness and safety of oxcarbazepine in bipolar disorder." | 3.72 | Oxcarbazepine treatment of bipolar disorder. ( Berv, DA; Ghaemi, SN; Hsu, DJ; Klugman, J; Rosenquist, KJ, 2003) |
| "Population-based sample of 20 638 health plan members aged 14 years or older who had at least 1 outpatient diagnosis of bipolar disorder and at least 1 filled prescription for lithium, divalproex, or carbamazepine between January 1, 1994, and December 31, 2001." | 3.72 | Suicide risk in bipolar disorder during treatment with lithium and divalproex. ( Fireman, B; Goodwin, FK; Hunkeler, EM; Lee, J; Revicki, D; Simon, GE, 2003) |
| "A 38-year-old white woman with PTSD and bipolar disorder who had partially responded to carbamazepine was treated with oxcarbazepine." | 3.72 | Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder. ( Hanretta, AT; Malek-Ahmadi, P, 2004) |
| "A potential model for bipolar disorder, quinpirole-induced biphasic locomotion, was used for a preliminary evaluation of behavioral effects of oral anticonvulsant treatment." | 3.71 | Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder. ( Belmaker, RH; Einat, H; Shaldubina, A; Shimon, H; Szechtman, H, 2002) |
| "Valproate may have greater acceptability than lithium among patients with bipolar disorder and substance use disorder." | 3.70 | Medication compliance among patients with bipolar disorder and substance use disorder. ( Greenfield, SF; Griffin, ML; Najavits, LM; Soto, JA; Tohen, M; Weiss, RD; Wyner, D, 1998) |
| "We describe a typical case of eosinophilic ulcer of the oral mucosa (EUOM) after an adverse reaction to carbamazepine, in a manic-depressive patient." | 3.70 | [Eosinophilic ulcers of the tongue as an adverse reaction to carbamazepine]. ( Hellín Meseguer, D; Melgarejo Moreno, PJ; Ruiz Macía, JA, 1998) |
| " A metastatic neuroblastoma was detected immediately after birth in a boy born to a 26 year old woman with bipolar disorder, who received carbamazepine (400 mg/day) all through her pregnancy." | 3.70 | Congenital neuroblastoma in a boy born to a woman with bipolar disorder treated with carbamazepine during pregnancy. ( Araujo, H; Baptista, T; Hernández, L; Rada, P, 1998) |
| "We report two cases of concomitant rashes and blood dyscrasias in geriatric psychiatry patients receiving carbamazepine therapy for bipolar disorder." | 3.70 | Concomitant rash and blood dyscrasias in geriatric psychiatry patients treated with carbamazepine. ( Cates, M; Powers, R, 1998) |
| "Lithium, carbamazepine and sodium valproate are mood stabilizers used in the treatment of bipolar disorder, and although their mechanisms of action remain unknown, signal transduction systems and the associated modulation of gene expression may constitute significant actions." | 3.70 | Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells. ( Jope, RS; Pacheco, MA, 1999) |
| "Inositol uptake was measured at concentrations of 25, 40 and 50 microM in human astrocytoma cell cultures treated for 1-3 weeks with pharmacologically relevant concentrations of LiCl, valproic acid or carbamazepine as well as in control cultures that had not been treated with any drug." | 3.70 | Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations. ( Belmaker, RH; Bersudsky, Y; Hertz, L; Simkin, M; Wolfson, M; Zinger, E, 2000) |
| "Two patients with psychotic disorders who developed Stevens-Johnson Syndrome while on treatment with carbamazepine is reported due to its rarity." | 3.70 | Stevens-Johnson syndrome due to carbamazepine. ( Chaudhury, S; John, TR; Ramadasan, P; Vaishampayne, S, 2000) |
| " Carbamazepine was reported to be moderately to markedly effective in the following percentage of patients: partial complex seizures, 85." | 3.69 | Efficacy of carbamazepine compared with other agents: a clinical practice survey. ( Denicoff, KD; Meglathery, SB; Post, RM; Tandeciarz, SI, 1994) |
| " The anticonvulsant drugs valproate and carbamazepine are emerging as efficacious alternative and adjunctive treatments for bipolar disorder." | 3.69 | Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? ( Lenox, RH; McNamara, RK; Watson, DG; Watterson, JM, 1996) |
| "To test the hypothesis that, although typical neuroleptics are commonly used in the treatment of bipolar disorder, newer atypical antipsychotic agents, like risperidone, may be more effective and better-tolerated." | 3.69 | Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. ( Baldassano, CF; Ghaemi, SN; Sachs, GS; Truman, CJ, 1997) |
| "Seven psychiatric inpatients receiving carbamazepine 600 mg/day were coadministered clarithromycin 400 mg/day for 5 days to treat atypical pneumonia." | 3.69 | Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients. ( Kaneko, S; Ohkubo, T; Otani, K; Shimoyama, R; Sugawara, K; Yasui, N, 1997) |
| "Characteristics of the responders and nonresponders to prophylactic treatment with carbamazepine (CBZ) or lithium (Li) were investigated in a retrospective study of 215 bipolar disorder patients who had received more than 2 years of CBZ or Li treatment in Japan." | 3.68 | Effects of carbamazepine and lithium on affective disorders. ( Okuma, T, 1993) |
| "Lithium remains the mainstay of pharmacologic therapy for the majority of patients with bipolar disorder; however, significant numbers of patients with both classical bipolar disorder and syndromal variants fail to respond to lithium therapy." | 3.68 | Algorithm for patient management of acute manic states: lithium, valproate, or carbamazepine? ( Gerner, RH; Stanton, A, 1992) |
| "Toxic epidermal necrolysis (Lyell syndrome) developed in a 43-year woman treated with carbamazepine, perazine, and sulpiride for recurrent manic bipolar disorder." | 3.68 | [Electroconvulsive therapy in treatment of acute life threatening catatonia in toxic epidermal necrolysis (Lyell syndrome)]. ( Beckmann, H; Kornhuber, J; Weller, M, 1992) |
| "This retrospective single-case study demonstrates the development of tolerance and reresponse to carbamazepine in a patient with coexisting trigeminal neuralgia and manic-depressive illness." | 3.68 | Contingent tolerance and reresponse to carbamazepine: a case study in a patient with trigeminal neuralgia and bipolar disorder. ( Pazzaglia, PJ; Post, RM, 1992) |
| "Carbamazepine is increasingly being used in the acute and maintenance treatment of patients with bipolar disorder." | 3.68 | Thrombocytopenia associated with carbamazepine: a case series. ( Castillo, J; Cole, JO; de los Heros, R; Farrer, RJ; Miller, MG; Tohen, M, 1991) |
| "To break continuous psychoses, the ECT (5 to 10 sessions daily or every other day) was given to 20 patients with affective and schizoaffective psychoses, who suffered not less than 3 affective cycles a year and were resistant to the preventive therapy with lithium carbonate or carbamazepine++ on condition they were used continuously for a year." | 3.68 | [Use of electroconvulsive therapy for breaking the continual course of drug-resistant affective and schizoaffective psychoses]. ( Moshchevitin, SIu; Mosolov, SN, 1990) |
| "A 52-year-old woman with bipolar disorder, rapid-cycling type, developed delirium while taking therapeutic doses of carbamazepine and neuroleptics." | 3.67 | Case report of a possible interaction between neuroleptics and carbamazepine. ( Ciccone, JR; Kanter, GL; Yerevanian, BI, 1984) |
| "A thyrotropin (thyroid-stimulating hormone; TSH) stimulation test with thyroid-releasing hormone (TRH) was performed on six patients with a DSM-III diagnosis of major depressive disorder, both before and during a trial of carbamazepine." | 3.67 | The effects of carbamazepine on the thyrotropin response to thyrotropin-releasing hormone. ( Gold, PW; Joffe, RT; Post, RM; Uhde, TW, 1984) |
| "The prolonged (up to two years) use of finlepsin in manic-depressive and schizoaffective psychoses in 35 patients has shown this drug to possess a prophylactic effect comparable with the prophylactic action of lithium." | 3.67 | [Preventive treatment of affective psychoses with finlepsin]. ( Digilov, AG; Skorik, AI; Vovin, RIa, 1984) |
| "Exacerbation of psoriasis was observed in a 28-year-old patient following the addition of lithium carbonate to a treatment regimen of carbamazepine and other drugs for manic-depressive psychosis." | 3.67 | Exacerbation of psoriasis during lithium treatment. ( Aihara, M; Ikezawa, Z; Ohsawa, J; Saito, S; Sasaki, T, 1989) |
| "Hematological indices were measured in 8 patients with bipolar disorder during carbamazepine and carbamazepine-lithium combination treatment." | 3.67 | Hematological effects of lithium potentiation of carbamazepine in patients with affective illness. ( Joffe, RT, 1988) |
| "A patient with atypical bipolar disorder and panic attacks treated with alprazolam 7." | 3.67 | Carbamazepine-induced reduction of plasma alprazolam concentrations: a clinical case report. ( Arana, GW; Epstein, S; Greenblatt, DJ; Molloy, M, 1988) |
| "Twenty-four patients suffering from affective disorders, who were being regularly treated with carbamazepine, were studied to determine the course of plasma levels of carbamazepine before (trough levels) and two and four hours after morning intake (peak levels)." | 3.67 | Measuring plasma levels of carbamazepine. A pharmacokinetic study in patients with affective disorders. ( Broekman, M; Jansen, GS; Nolen, WA, 1988) |
| "The authors assessed 20 carbamazepine-treated patients for the development of hyponatremia." | 3.67 | Carbamazepine and hyponatremia in patients with affective disorder. ( Camille, Y; Iskandar, H; Nastase, C; Yassa, R, 1988) |
| "Carbamazepine is now used by many clinicians in the treatment of bipolar disorder (BD) refractory to standard treatments, including lithium and neuroleptics." | 3.67 | Long-term response to carbamazepine: a retrospective study. ( Cohen, BM; Frankenburg, FR; Lipinski, JF; Tohen, M, 1988) |
| "A 37-year-old woman with cerebral palsy and a rapid cycling bipolar affective disorder developed drowsiness and slurred speech when being treated with a combination of haloperidol and a low dose of carbamazepine." | 3.67 | An interaction between haloperidol and carbamazepine in a patient with cerebral palsy. ( Brayley, J; Yellowlees, P, 1987) |
| "A bipolar patient is described in whom erythema multiforme major, or Stevens-Johnson syndrome, developed after treatment with carbamazepine." | 3.67 | Erythema multiforme major in a patient treated with carbamazepine. ( Fawcett, RG, 1987) |
| "The effect of carbamazepine on body weight was studied in 24 patients with affective illness." | 3.67 | Effect of carbamazepine on body weight in affectively ill patients. ( Joffe, RT; Post, RM; Uhde, TW, 1986) |
| "The effects on serum electrolytes of carbamazepine, an acute and prophylactic treatment for manic-depressive illness, were assessed in subjects with primary affective disorder." | 3.67 | Effects of carbamazepine on serum electrolytes in affectively ill patients. ( Joffe, RT; Post, RM; Uhde, TW, 1986) |
| "Carbamazepine is gaining recognition as a valuable drug in the treatment of patients with bipolar disorders who fail to respond to lithium." | 3.67 | The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants. ( Fawcett, J; Kravitz, HM, 1985) |
| " In view of increasing interest in the therapeutic potential of carbamazepine (CBZ) in bipolar disorder, we examined the effect of CBZ pretreatment on methylphenidate-induced behavioral activation and euphoria." | 3.67 | Methylphenidate infusion in euthymic bipolars: effect of carbamazepine pretreatment. ( Bow, J; Gershon, S; Lerer, B; Meyendorff, E; Moore, NC, 1985) |
| "Of six bulimic outpatients who completed a double-blind crossover trial with carbamazepine, one patient, who had a history suggestive of bipolar disorder, responded dramatically with cessation of binge eating." | 3.66 | Carbamazepine in the treatment of bulimia. ( Darby, PL; Garfinkel, PE; Garner, DM; Kaplan, AS, 1983) |
| "A lithium and carbamazepine combination was reported in five patients with bipolar disorder (DSM-III), who had not received benefits from conventional treatments." | 3.66 | A lithium and carbamazepine combination in the treatment of bipolar disorder--a preliminary report. ( Arima, S; Fukui, Y; Inoue, K; Kato, N; Tanaka, K, 1981) |
| "The authors present the case of a woman with bipolar disorder who developed reticulocytosis after two trials of carbamazepine." | 3.66 | Case report of carbamazepine-induced reticulocytes. ( Steinbook, RM; Warren, JA, 1983) |
| "The effect of carbamazepine in bipolar disorder has been studied by several groups." | 3.66 | Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder. ( Nolen, WA, 1983) |
| " Safety was assessed by treatment-emergent adverse events (TEAEs), vital signs, weight, and extrapyramidal symptoms (EPSs)." | 2.77 | Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder. ( Higuchi, T; Kanba, S; Katagiri, H; Takahashi, M; Takita, Y; Tohen, M, 2012) |
| " Adverse events were systematically recorded throughout the study." | 2.74 | Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study. ( Chopra, D; Gupta, NK; Kakkar, AK; Kataria, D; Rehan, HS; Unni, KE, 2009) |
| "In epilepsy, slow-release formulations of carbamazepine (CBZ) have fewer adverse events (AEs) compared with immediate-release (IR) formulations." | 2.74 | Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study. ( Chopra, AS; El-Mallakh, RS; Mickus, GJ; Penagaluri, P; Salem, MR, 2009) |
| "Topiramate was generally well tolerated." | 2.71 | Adjunctive topiramate in bipolar II disorder. ( Benabarre, A; Colom, F; Comes, M; Corbella, B; Goikolea, JM; Martínez-Arán, A; Reinares, M; Sánchez-Moreno, J; Torrent, C; Vieta, E, 2003) |
| "Carbamazepine has been used to treat mania for over 2 decades." | 2.71 | A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. ( Kalali, AH; Ketter, TA; Weisler, RH, 2004) |
| "Carbamazepine has shown reasonable antimanic properties, but its use has been limited because of enzyme-inducing effects." | 2.70 | Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design. ( Amann, B; Dittmann, S; Frye, MA; Grunze, H; Hummel, B; Schaefer, M; Stampfer, R; Sterr, A; Walden, J, 2002) |
| "Past substance abuse was evident in 34% of the bipolar sample and comprised most often alcoholism (82%), followed by cocaine (30%), marijuana (29%), sedative-hypnotic or amphetamine (21%), and opiate (13%) abuse." | 2.69 | A history of substance abuse complicates remission from acute mania in bipolar disorder. ( Garno, JL; Goldberg, JF; Kocsis, JH; Leon, AC; Portera, L, 1999) |
| " Further increment in dose was carried out at weekly intervals, guided by clinical improvement, serum levels and treatment emergent adverse events." | 2.69 | Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. ( Goswami, U; Kohli, K; Vasudev, K, 2000) |
| "Inositol is a constituent of the intracellular phosphatidyl inositol (PI) second messenger system, which is linked to various neurotransmitter receptors." | 2.69 | Inositol as an add-on treatment for bipolar depression. ( Buttenfield, J; Chengappa, KN; Gershon, S; Hardan, A; Kupfer, DJ; Levine, J; Luther, J; Mallinger, AG; Pollock, B; Vagnucci, A; Verfaille, S, 2000) |
| "All 10 patients tolerated the addition of an MAOI well, and mean self-rated side effect scores did not change significantly." | 2.68 | Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. ( Ketter, TA; Parekh, PI; Post, RM; Worthington, K, 1995) |
| "Although mania defines bipolar I disorder, depressive episodes and symptoms dominate the longitudinal course of, and disproportionately account for morbidity and mortality in, bipolar disorders." | 2.66 | Bipolar disorders. ( Berk, M; Brietzke, E; Goldstein, BI; Kessing, LV; López-Jaramillo, C; Majeed, A; Malhi, GS; Mansur, RB; McIntyre, RS; Nierenberg, AA; Rosenblat, JD; Vieta, E; Vinberg, M; Young, AH, 2020) |
| "Carbamazepine has a unique spectrum of clinical efficacy in paroxysmal pain syndromes and epilepsy, as well as in affective illness." | 2.65 | Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness. ( Ballenger, JC; Gold, PW; Post, RM; Rubinow, DR; Uhde, TW, 1983) |
| "Carbamazepine has recently been reported to have therapeutic potential in mania." | 2.65 | Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study. ( Belmaker, RH; Bental, E; Klein, E; Lerer, B, 1984) |
| " Carbamazepine in the dosage of 200-600 mg was administered for 1 year." | 2.65 | A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. ( Hazama, H; Inanaga, K; Mori, A; Okuma, T; Otsuki, S; Sarai, K; Takahashi, R; Watanabe, S, 1981) |
| "Carbamazepine may prove to be a useful additional treatment for affective illness." | 2.65 | Carbamazepine in manic-depressive illness: a new treatment. ( Ballenger, JC; Post, RM, 1980) |
| " This systematic review aimed to assess the prevalence of their adverse effects (AEs) and to provide recommendations on their clinical management." | 2.52 | Management of adverse effects of mood stabilizers. ( Hidalgo, D; León-Caballero, J; Murru, A; Pacchiarotti, I; Popovic, D; Vieta, E, 2015) |
| " In the present paper, I review studies in unanaesthetized rats using a neuropharmacological approach, combined with kinetic, biochemical and molecular biology techniques, demonstrating that chronic administration of three commonly used mood stabilizers (lithium, valproic acid and carbamazepine), at therapeutically relevant doses, selectively target the brain arachidonic acid cascade." | 2.45 | Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder? ( Bazinet, RP, 2009) |
| "Oxcarbazepine (OXC) is a keto-congener of carbamazepine, which has fewer side effects and drug interactions." | 2.44 | Oxcarbazepine in bipolar disorder: a critical review of the literature. ( Bria, P; Conte, G; Di Nicola, M; Janiri, L; Martinotti, G; Mazza, M; Mazza, S; Pozzi, G; Taranto, C, 2007) |
| "A major challenge in the treatment of bipolar depression is the tendency for antidepressant medications, particularly tricyclic antidepressants, to precipitate episodes of mania, or to increase cycle frequency or symptom intensity." | 2.44 | The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders. ( Bourin, M; Prica, C, 2007) |
| "Lamotrigine has obtained approval in several countries for the indication of preventing bipolar depressive episodes, which raises the question of differential efficacy of other antiepileptic drugs as mood stabilizers in the prevention of either depressive or hypo-/manic episodes." | 2.44 | Antiepileptic drugs and mood stability. ( Amann, B; Grunze, H; Trimble, M; Vieta, E, 2007) |
| "Oxcarbazepine is an antiepileptic drug that has been approved by the US FDA and is indicated for use as monotherapy or adjunctive therapy in the treatment of partial seizures in adults and children aged over 4 years." | 2.44 | Oxcarbazepine in the treatment of bipolar and schizoaffective disorders. ( Bernabarre, A; Bernardo, M; Leighton, C; Popova, E; Vieta, E, 2007) |
| " In this paper, we review studies using a neuropharmacological approach in unanesthetized rats, combined with kinetic, biochemical and molecular biology techniques, showing that chronic administration of three Food and Drug Administration-approved mood stabilizers (lithium, valproate and carbamazepine) at therapeutically relevant doses, selectively target the brain arachidonic acid (AA) cascade." | 2.44 | Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? ( Bazinet, RP; Lee, HJ; Rao, JS; Rapoport, SI, 2008) |
| "Carbamazepine has a long history in psychiatry and neurology." | 2.43 | Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder. ( Weisler, RH, 2005) |
| "Carbamazepine (CBZ) has a long history of successful use in epilepsy and, therefore, has a safety profile that is well characterised." | 2.43 | Practical considerations for carbamazepine use in bipolar disorder. ( Dostrow, V; Fuller, MA; Gazda, TD; Gupta, S, 2006) |
| " This formulation allows twice-daily dosing and minimizes plasma carbamazepine fluctuations." | 2.43 | Extended-release carbamazepine for acute bipolar mania: a review. ( Owen, RT, 2006) |
| " Also discussed are findings concerning the continuation of acute treatments, including antidepressants, into the maintenance phase; dosage adjustments for maintenance treatment; the rationale for combination treatments; and implications of comorbid substance abuse and strategies for its management." | 2.43 | Maintenance treatment of bipolar disorder: Applying research to clinical practice. ( Chou, JC; Fazzio, L, 2006) |
| "Agents introduced for the treatment of epilepsy have also been usedsimultaneously for psychiatric indications." | 2.43 | [Anticonvulsants treatment of psychiatric disorder in elderly patients]. ( Bidzan, L, 2006) |
| " Other agents frequently used as mood stabilizers in monotherapy and in combination with lithium are valproate and carbamazepine." | 2.42 | Drug interactions of lithium and other antimanic/mood-stabilizing medications. ( Dunner, DL, 2003) |
| "Oxcarbazepine was given to 56 inpatients (1." | 2.42 | Oxcarbazepine: clinical experience with hospitalized psychiatric patients. ( Albert, MJ; Baldessarini, RJ; Berry, JM; Centorrino, F; Fellman, V; Fogarty, KV; Kelleher, JP; Kidwell, JE; Koukopoulos, AE; Line, G, 2003) |
| "Lamotrigine has demonstrated efficacy in delaying time to depressive relapse." | 2.42 | Rethinking the treatment paradigm for bipolar depression: the importance of long-term management. ( Baldassano, CF; Ballas, CA; O'Reardon, JP, 2004) |
| "As for the treatment of bipolar depression, consensus seems to be emerging that combined treatment with a mood stabilizer and SSRI or SNRI is the first choice because TCA with a mood stabilizer increases the risk of switch to mania." | 2.42 | [Treatment standard for bipolar disorders]. ( Higuchi, T, 2004) |
| "Lamotrigine has demonstrated efficacy in both acute bipolar depression and maintenance efficacy in rapid cycling bipolar patients, especially those patients with bipolar II disorder, which is principally manifested as depression." | 2.41 | Novel treatments for bipolar disorder. ( Bowden, CL, 2001) |
| "Rapid cycling is a clinical subtype of bipolar mood disorder that has four or more episodes during the previous 12 months and has poor response to lithium (Li) prophylaxis treatment." | 2.40 | Algorithm for the treatment of rapid cycling. ( Yamada, K, 1999) |
| "The significant prevalence of substance use disorders among patients with psychiatric illnesses has attracted increasing interest." | 2.39 | The relationship between substance abuse and bipolar disorder. ( Brady, KT; Sonne, SC, 1995) |
| " For lithium, uncomplicated manic patients can be started at 15 mg/kg of body weight, with dosage increase every 3 to 4 days until response, complicating adverse effects, or a serum level of 1." | 2.39 | Dosing strategies and time course of response to antimanic drugs. ( Bowden, CL, 1996) |
| " Neuroleptic dosing of manic patients is probably too high and exposes patients to an unnecessary risk of side effects including tardive dyskinesia." | 2.38 | Treatment approaches for acute mania. ( Chou, JC; Sweeney, EA; Tuma, I, 1993) |
| " It is often necessary to have lithium combined with other psychopharmacological agents when efforts are aimed at either enhancing a less-than-optimal therapeutic effect or treating other symptoms as well." | 2.38 | [Drug combinations of lithium: reasons and limitations]. ( Lagomarsino, AJ, 1993) |
| "Prescribed drugs for the treatment of bipolar disorder, including mood stabilizers (i." | 1.72 | Prescribing changes for bipolar patients discharged from two public psychiatric hospitals in Taiwan, 2006-2019. ( Chan, HY; Chen, CC; Chou, FH; Lin, CH, 2022) |
| "Lithium carbonate was associated with increased risks of rash (PT), drug interaction (PT), and tubulointerstitial diseases (SMQ)." | 1.72 | Analysis of adverse drug events in patients with bipolar disorders using the Japanese Adverse Drug Event Report database. ( Nabekura, T; Uwai, Y, 2022) |
| "Hypothermia is a rare but serious condition that has been associated with various psychiatric medications." | 1.46 | Severe recurrent hypothermia in an elderly patient with refractory mania associated with atypical antipsychotic, valproic acid and oxcarbazepine therapy. ( Ajayi, OO; Holroyd, S, 2017) |
| " The objective of the study was to identify pharmacokinetic interactions of different mood stabilizers on the metabolism of risperidone (RIS) under natural conditions." | 1.43 | Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment. ( Gründer, G; Haen, E; Hiemke, C; Lammertz, SE; Paulzen, M; Schoretsanitis, G; Schruers, KR; Stegmann, B, 2016) |
| " This study was designed to evaluate the bidirectional carbamazepine-armodafinil pharmacokinetic drug-drug interaction." | 1.42 | Evaluation of the potential for pharmacokinetic drug-drug interaction between armodafinil and carbamazepine in healthy adults. ( Bond, M; Darwish, M; Hellriegel, ET; Robertson, P; Yang, R, 2015) |
| "Carbamazepine was used as a positive control." | 1.39 | The antimanic-like effect of phenytoin and carbamazepine on methylphenidate-induced hyperlocomotion: role of voltage-gated sodium channels. ( Andreatini, R; Biojone, C; Casarotto, PC; Correia, D; Guimarães, FS; Joca, SL; Martynhak, BJ; Pereira, M; Siba, IP; Tonelli, DA, 2013) |
| "Participants with bipolar I or schizoaffective disorder in this study were receiving complex medication treatments that were often discordant with recommendations made in contemporary major treatment guidelines." | 1.38 | Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice. ( Berk, L; Berk, M; Brnabic, AJ; de Castella, A; Dodd, S; Filia, K; Filia, S; Fitzgerald, PB; Kelin, K; Kulkarni, J; Lowry, AJ; Montgomery, W, 2012) |
| "A 23-year-old man had unilateral rubral tremors as a result of a midbrain lesion plus risperidone exposure for treatment of manic symptoms." | 1.35 | Unilateral rubral tremor following treatment with risperidone. ( Shen, YC, 2009) |
| " Adverse effects were rated before treatment onset, at day 3, then every week and at discharge or at discontinuation." | 1.35 | Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages. ( Droulout, T; Grolleau, A; Misdrahi, D; Molimard, M; Titier, K; Tournier, M; Verdoux, H, 2008) |
| " On the other hand, we found a gene dosage effect for mouse Sp4 gene in the modulation of sensorimotor gating, a putative endophenotype for both schizophrenia and bipolar disorder." | 1.35 | Transcription factor SP4 is a susceptibility gene for bipolar disorder. ( Geyer, MA; Greenwood, TA; Guo, S; He, L; Kelsoe, JR; Tang, W; Zhou, X, 2009) |
| " Therefore, the authors summarise adverse events of greatest prevalence and/or greatest severity based on data derived predominately from studies of geriatric patients with epilepsy and/or other non-psychiatric indications." | 1.33 | Safety and tolerability of mood-stabilising anticonvulsants in the elderly. ( Alldredge, B; Fenn, HH; Ketter, TA; Sommer, BR, 2006) |
| " Adjusting the maintenance dosage of H(2)-histamine antagonists has been recommended in elderly patients since age-related reduction in renal plasma flow, glomerular filtration rate and renal tubular function may be present, which can in turn elevate histamine levels in plasma and cerebrospinal fluid." | 1.31 | H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures. ( Bergemann, N; Diebold, K; Mundt, C; Roesch-Ely, D; Sartor, K; von Einsiedel, RW, 2002) |
| " lower dosage in Japan, emerged and caused the delay of publication of our results in Western journals." | 1.31 | [A history of investigation on the mood-stabilizing effect of carbamazepine in Japan]. ( Okuma, T, 2002) |
| "Carbamazepine (CBZ) has been widely used for treatment of manic states." | 1.31 | Carbamazepine suppresses methamphetamine-induced Fos expression in a regionally specific manner in the rat brain. Possible neural substrates responsible for antimanic effects of mood stabilizers. ( Fujiwara, Y; Hamamura, T; Kuroda, S; Lee, Y; Miki, M; Ohashi, K, 2000) |
| "It raises the possibility that recurrence after stopping carbamazepine may be less severe than the 'rebound mania' seen on lithium withdrawal." | 1.31 | Does 'rebound mania' occur after stopping carbamazepine? A pilot study. ( Hunt, NJ; Macritchie, KA, 2000) |
| "Carbamazepine is a second-line alternative." | 1.31 | Disodium valproate: new preparation. An alternative for acute mania after lithium failure or intolerance. ( , 2001) |
| "One patient had moderate confusion, and the other mild confusion and hypomania." | 1.30 | Combined valproate or carbamazepine and electroconvulsive therapy. ( Baraibar, G; Tohen, M; Zarate, CA, 1997) |
| "Lithium carbonate therapy was more effective for reducing manic symptoms in the late-onset group than in the early-onset group, without maintaining a prophylactic effect in either group, whereas carbamazepine was more effective in the early-onset group." | 1.30 | Comparison of early- and late-onset rapid cycling affective disorders: clinical course and response to pharmacotherapy. ( Aoki, S; Fujiwara, Y; Honda, T; Kuroda, S; Tanaka, Y, 1998) |
| "Carbamazepine users who were male or in the 30-49-year age range were significantly less likely to be tested for serum drug level." | 1.30 | Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder. ( Kupfer, DJ; Marcus, SC; Olfson, M; Pincus, HA; Zarin, DA, 1999) |
| "Carbamazepine augmentation was associated with a reduction of lithium doses in some patients, including a subgroup who had not tolerated lithium at usual therapeutic levels." | 1.30 | Carbamazepine augmentation in lithium-refractory bipolar patients: a prospective study on long-term prophlyactic effectiveness. ( Ardau, R; Bocchetta, A; Chillotti, C; Del Zompo, M; Severino, G, 1997) |
| " Extreme interindividual differences in both dosage and length of stay help in elucidating the apparently contradictory results of comparative investigations with small patient groups." | 1.29 | [General practice of acute inpatient treatment of mania. Retrospective comparative study of 100 patients at each of 2 psychiatric centers]. ( Adler, L; Hajak, G; Koller, M; Langer, C; Lehmann, K; Nordeck, I; Thomas, RS; Ulrich, M, 1994) |
| "Carbamazepine treatment of a patient with 48-hour rapid cycling led to a dampening of mood cycling, and prolonged rapid eye movement (REM) sleep latency." | 1.29 | The effect of carbamazepine on endocrine and sleep EEG variables in a patient with 48-hour rapid cycling, and healthy controls. ( Bahro, M; Berger, M; Gann, H; Hohagen, F; Müller, WE; Riemann, D, 1993) |
| "Treatment with carbamazepine was successful in both patients." | 1.29 | [Rapid cycling in bipolar disorders]. ( Hoogduin, CA; Knoppert-van der Klein, EA; Nolen, WA, 1994) |
| "The nortriptyline dose was therefore increased to 150 mg/day; the mean SNT rose to 402 +/- 69 nM (n = 4) and the depression disappeared." | 1.29 | Concomitant intake of nortriptyline and carbamazepine. ( Brøsen, K; Kragh-Sørensen, P, 1993) |
| "Carbamazepine treatment normalized REM sleep variables, damped the amplitude of mood cycling of the patient, increased TSH and decreased FT4." | 1.29 | 48-hour rapid cycling: results of psychopathometric, polysomnographic, PET imaging and neuro-endocrine longitudinal investigations in a single case. ( Berger, M; Dressing, H; Gann, H; Hohagen, F; Müller, WE; Riemann, D; Strauss, LG, 1993) |
| "Carbamazepine was started but had to be discontinued as the patient developed a generalized substance-induced skin rush." | 1.29 | [Successful hyposensitization treatment of a patient with schizoaffective psychosis and carbamazepine allergy]. ( Hermle, L; Spitzer, M, 1993) |
| " Monitering of BUP and its metabolites may ultimately prove useful in guiding clinicians dosing decisions, especially when mood stabilizers are combined with other psychotropic drugs in refractory bipolar patients." | 1.29 | Bupropion and anticonvulsant drug interactions. ( Lamparella, V; Masand, PS; Popli, AP; Tanquary, J, 1995) |
| "Treatment with haloperidol and lithium was unsuccessful but the addition of carbamazepine produced a dramatic response." | 1.29 | A patient with mania and photoconvulsive epilepsy. ( Corbett, AJ; Reid, WG; Roxanas, MG, 1996) |
| " Neither dosage nor serum levels of CBZ were in a higher range." | 1.28 | Asterixis induced by carbamazepine therapy. ( Leblhuber, F; Rittmannsberger, H, 1992) |
| " During the first week, the dosage was rapidly increased to 800 mg/day in order to produce steady-state plasma levels of carbamazepine on Day 7." | 1.28 | Carbamazepine and its 10,11-epoxide metabolite in acute mania: clinical and pharmacokinetic correlates. ( Alric, R; Blayac, JP; Cociglio, M; Hue, B; Lonjon, R; Petit, P; Pouget, R; Sluzewska, A, 1991) |
| "Its influence on the course of affective psychoses was studied in 67 patients in long-term treatment." | 1.28 | Political change and course of affective psychoses: Berlin 1989-90. ( Bohlken, J; Priebe, S, 1991) |
| "Lithium carbonate was administered, 600-1500 mg/day with serum levels of 0." | 1.28 | [Overcoming resistance to lithium prophylaxis]. ( Soucek, K, 1991) |
| "Bupropion was added to lithium and/or levothyroxine in four female and two male bipolar II patients who had established baselines of at least 2 years of rapid cycling that had not responded to several of the most commonly used anticycling interventions." | 1.28 | Bupropion as a promising approach to rapid cycling bipolar II patients. ( Akiskal, HS; Haykal, RF, 1990) |
| "Acetazolamide was given to 30 patients: Type I, puberal periodic psychosis, a psychosis whose onset occurs during the period of puberty and which appears repetitively with psychosis-like condition at about the same interval as the menstrual cycle (6 cases); Type II, a) presenile atypical psychosis which initially appears in patients in their 20s or 30s accompanied by manic-depressive cycles and shows acute confusional and dreamy states in the presenile period, incurable cases (7), b) atypical psychosis, in the narrow sense, cases which show acute hallucination, delusion, confusional and dreamy states accompanied by affective symptoms (8 cases); Type III, repetitively the atypical manic and depressive states, and atypical manic-depressive psychosis, and transient changes in consciousness, refractory cases (2); Type IV, atypical schizophrenia, which is considered to be schizophrenia but shows the abnormalities in electroencephalogram and emotional disorders (7 cases)." | 1.27 | Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis. ( Fukuma, E; Hamazoe, K; Hazama, H; Ichikawa, M; Inoue, H; Inoue, K; Omura, F; Umezawa, Y, 1984) |
| "Levels of carbamazepine and its -10,11-epoxide metabolite were measured in plasma and CSF of affectively ill patients treated only with carbamazepine for an average of 33 days at an average dosage of 1,055 mg/day." | 1.27 | Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. ( Ballenger, JC; Bunney, WE; Chatterji, DC; Greene, RF; Post, RM; Uhde, TW, 1983) |
| "Treatment with carbamazepine reduced CSF somatostatin (p less than ." | 1.27 | CSF somatostatin in affective illness and normal volunteers. ( Ballenger, JC; Gold, PW; Post, RM; Rubinow, DR, 1985) |
| "Carbamazepine was added to her treatment regimen with good results." | 1.27 | Bipolar illness following traumatic brain injury: treatment with lithium and carbamazepine. ( Hemsath, RH; Stewart, JT, 1988) |
| "Carbamazepine has been shown to have complex actions on multiple neurotransmitter and neuromodulator systems, and it is possible that paradoxical effects of this nature may occur in susceptible individuals, as has been found with other sedative and anticonvulsant agents." | 1.27 | Manic state with carbamazepine therapy of seizures. ( Drake, ME; Peruzzi, WT, 1986) |
| "Carbamazepine was found to cause statistically significant, but clinically insubstantial, decreases in white blood cell indexes." | 1.27 | Hematological effects of carbamazepine in patients with affective illness. ( Joffe, RT; Post, RM; Roy-Byrne, PP; Uhde, TW, 1985) |
| "Carbamazepine effectively treated the depression and mania was avoided." | 1.27 | Carbamazepine in bipolar-depressed disorder complicated by tricyclic antidepressant switching: case report. ( Finkel, JA; Nurnberg, HG, 1985) |
| "Carbamazepine was administered to nine patients with manic-depressive illness at doses ranging from 600 to 1600 mg per day, achieving blood levels between 6 and 11 microgram per milliliter." | 1.26 | Lack of effect of carbamazepine on gamma-aminobutyric acid in cerebrospinal fluid. ( Ballenger, JC; Bunney, WE; Hare, TA; Post, RM, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 168 (24.42) | 18.7374 |
| 1990's | 196 (28.49) | 18.2507 |
| 2000's | 238 (34.59) | 29.6817 |
| 2010's | 74 (10.76) | 24.3611 |
| 2020's | 12 (1.74) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, AM | 1 |
| Weinshilboum, RM | 1 |
| Frye, MA | 10 |
| Biernacka, JM | 1 |
| Kishi, T | 1 |
| Ikuta, T | 1 |
| Matsuda, Y | 1 |
| Sakuma, K | 1 |
| Okuya, M | 1 |
| Nomura, I | 1 |
| Hatano, M | 1 |
| Iwata, N | 1 |
| Bridwell, RE | 1 |
| Brown, S | 1 |
| Clerkin, S | 1 |
| Birdsong, S | 1 |
| Long, B | 1 |
| Lin, CH | 3 |
| Chan, HY | 1 |
| Chen, CC | 3 |
| Chou, FH | 1 |
| Uwai, Y | 1 |
| Nabekura, T | 1 |
| Leopold, S | 1 |
| Quante, A | 1 |
| Missio, G | 1 |
| Moreno, DH | 2 |
| Demetrio, FN | 2 |
| Soeiro-de-Souza, MG | 1 |
| Dos Santos Fernandes, F | 1 |
| Barros, VB | 1 |
| Moreno, RA | 2 |
| Clark, CT | 1 |
| van der Gaag, S | 1 |
| Kupka, RW | 2 |
| Bet, PM | 1 |
| Lee, JE | 1 |
| Min, KR | 1 |
| Kim, SH | 1 |
| Kim, AH | 1 |
| Kim, ST | 1 |
| McIntyre, RS | 1 |
| Berk, M | 3 |
| Brietzke, E | 1 |
| Goldstein, BI | 1 |
| López-Jaramillo, C | 1 |
| Kessing, LV | 1 |
| Malhi, GS | 1 |
| Nierenberg, AA | 1 |
| Rosenblat, JD | 1 |
| Majeed, A | 1 |
| Vieta, E | 11 |
| Vinberg, M | 1 |
| Young, AH | 5 |
| Mansur, RB | 1 |
| Ridout, KK | 1 |
| Young-Wolff, KC | 1 |
| Ridout, SJ | 1 |
| Irudayaraj, C | 1 |
| Innamuri, R | 1 |
| Kattula, D | 1 |
| Albright, A | 1 |
| Way, RT | 1 |
| Perret, LC | 1 |
| Lodovighi, MA | 1 |
| Perret, O | 1 |
| Ibrahim, EC | 1 |
| Philip, N | 1 |
| Azorin, JM | 1 |
| Belzeaux, R | 1 |
| Chu, CS | 1 |
| Lan, TH | 2 |
| Chou, PH | 2 |
| Ajayi, OO | 1 |
| Holroyd, S | 1 |
| Patel, N | 1 |
| Viguera, AC | 1 |
| Baldessarini, RJ | 3 |
| Graham, RK | 1 |
| Tavella, G | 1 |
| Parker, GB | 2 |
| Kopecek, M | 1 |
| Potmesil, P | 1 |
| Müller, DJ | 1 |
| Brandl, EJ | 1 |
| Degenhardt, F | 1 |
| Domschke, K | 1 |
| Grabe, H | 1 |
| Gruber, O | 1 |
| Hebebrand, J | 1 |
| Maier, W | 1 |
| Menke, A | 1 |
| Riemenschneider, M | 1 |
| Rietschel, M | 1 |
| Rujescu, D | 1 |
| Schulze, TG | 1 |
| Tebartz van Elst, L | 1 |
| Tüscher, O | 1 |
| Deckert, J | 1 |
| Pisanu, C | 2 |
| Heilbronner, U | 1 |
| Squassina, A | 2 |
| Jia, S | 1 |
| Li, B | 3 |
| Huang, J | 1 |
| Verkhratsky, A | 2 |
| Peng, L | 3 |
| Silva, EF | 1 |
| Silva, AI | 1 |
| Asth, L | 1 |
| Souza, LS | 1 |
| Zaveri, NT | 1 |
| Guerrini, R | 1 |
| Calo', G | 1 |
| Ruzza, C | 1 |
| Gavioli, EC | 1 |
| Chen, PH | 1 |
| Tsai, SY | 1 |
| Pan, CH | 1 |
| Chang, CK | 1 |
| Su, SS | 1 |
| Kuo, CJ | 2 |
| Musetti, L | 3 |
| Tundo, A | 1 |
| Benedetti, A | 2 |
| Massimetti, G | 1 |
| Cambiali, E | 1 |
| Pergentini, I | 2 |
| Del Grande, C | 2 |
| Dell'Osso, L | 3 |
| Miguel, SRPS | 1 |
| Lima, AFBS | 1 |
| Cruz, LN | 1 |
| Cohen, M | 1 |
| Zimmermann, JJ | 1 |
| Ziegelmann, PK | 1 |
| Fleck, MPA | 1 |
| Li, H | 1 |
| Zhou, DS | 1 |
| Chang, H | 1 |
| Wang, L | 1 |
| Liu, W | 2 |
| Dai, SX | 1 |
| Zhang, C | 1 |
| Cai, J | 1 |
| Li, X | 2 |
| Fan, W | 1 |
| Tang, W | 3 |
| Liu, F | 1 |
| He, Y | 1 |
| Bai, Y | 1 |
| Hu, Z | 1 |
| Xiao, X | 1 |
| Gao, L | 1 |
| Li, M | 1 |
| Giménez, A | 1 |
| Pacchiarotti, I | 2 |
| Gil, J | 1 |
| Murru, A | 2 |
| Gomes, SP | 1 |
| Pinzón, JE | 1 |
| Anmella, G | 1 |
| Gómez-Ramiro, M | 1 |
| Verdolini, N | 1 |
| Valentí, M | 1 |
| Goikolea, JM | 3 |
| Yang, SY | 1 |
| Liao, YT | 1 |
| Liu, HC | 1 |
| Chen, WJ | 1 |
| Wang, YC | 1 |
| Wang, EN | 1 |
| Wang, CC | 1 |
| Huang, CL | 1 |
| Huang, AC | 1 |
| Tonelli, DA | 1 |
| Pereira, M | 1 |
| Siba, IP | 1 |
| Martynhak, BJ | 1 |
| Correia, D | 1 |
| Casarotto, PC | 1 |
| Biojone, C | 1 |
| Guimarães, FS | 1 |
| Joca, SL | 1 |
| Andreatini, R | 1 |
| Ersoz Alan, B | 1 |
| Unal, D | 1 |
| Le Louarn, E | 1 |
| Barbaud, A | 1 |
| Trechot, P | 1 |
| Marcou, G | 1 |
| Lepoittevin, JP | 1 |
| Mauer, S | 1 |
| Alahmari, R | 1 |
| Vöhringer, PA | 1 |
| Vergne, DE | 1 |
| Lövdahl, H | 1 |
| Correa, E | 1 |
| Patkar, A | 1 |
| Pae, C | 1 |
| Strejilevich, S | 1 |
| Dalley, S | 1 |
| Ghaemi, SN | 4 |
| Schneider, MR | 1 |
| Klein, CC | 1 |
| Weber, W | 1 |
| Bitter, SM | 1 |
| Elliott, KB | 1 |
| Strakowski, SM | 2 |
| Adler, CM | 1 |
| DelBello, MP | 1 |
| Kara, NZ | 1 |
| Karpel, O | 1 |
| Toker, L | 1 |
| Agam, G | 1 |
| Belmaker, RH | 7 |
| Einat, H | 2 |
| Volkert, J | 1 |
| Zierhut, KC | 1 |
| Schiele, MA | 1 |
| Wenzel, M | 1 |
| Kopf, J | 1 |
| Kittel-Schneider, S | 1 |
| Reif, A | 1 |
| Darwish, M | 1 |
| Bond, M | 1 |
| Yang, R | 1 |
| Hellriegel, ET | 1 |
| Robertson, P | 1 |
| Muti, M | 1 |
| Marazziti, D | 1 |
| Turri, M | 1 |
| Cirronis, M | 1 |
| Corsi, M | 1 |
| Corsini, GU | 1 |
| Malas, NM | 1 |
| Ortiz-Aguayo, R | 1 |
| Meyer, V | 1 |
| Popovic, D | 1 |
| Hidalgo, D | 1 |
| León-Caballero, J | 1 |
| Cruceanu, C | 1 |
| Tan, PP | 1 |
| Rogic, S | 1 |
| Lopez, JP | 1 |
| Torres-Platas, SG | 1 |
| Gigek, CO | 1 |
| Alda, M | 2 |
| Rouleau, GA | 1 |
| Pavlidis, P | 1 |
| Turecki, G | 1 |
| Peselow, ED | 2 |
| Clevenger, S | 1 |
| IsHak, WW | 1 |
| Glue, P | 2 |
| Herbison, P | 1 |
| Tsai, CJ | 1 |
| Cheng, C | 1 |
| McInnis, MG | 1 |
| Chang, CL | 1 |
| Shansis, FM | 1 |
| Reche, M | 1 |
| Capp, E | 1 |
| Kerbusch-Herben, V | 1 |
| Cleton, A | 1 |
| Berwaerts, J | 1 |
| Vandebosch, A | 1 |
| Remmerie, B | 1 |
| Gorwood, P | 1 |
| Richard-Devantoy, S | 1 |
| Sentissi, O | 1 |
| Le Strat, Y | 1 |
| Olié, JP | 2 |
| Papadima, EM | 1 |
| Del Zompo, M | 3 |
| Schoretsanitis, G | 1 |
| Haen, E | 1 |
| Gründer, G | 1 |
| Stegmann, B | 1 |
| Schruers, KR | 1 |
| Hiemke, C | 1 |
| Lammertz, SE | 1 |
| Paulzen, M | 1 |
| Merizalde, M | 1 |
| Navalón, P | 1 |
| González, MF | 1 |
| Domínguez, A | 1 |
| Livianos, L | 1 |
| Martínez, JC | 1 |
| Yeh, YW | 1 |
| Wang, TY | 1 |
| Huang, CC | 2 |
| Chen, YC | 1 |
| Pearlstein, T | 1 |
| Shen, YC | 1 |
| Misdrahi, D | 1 |
| Tournier, M | 1 |
| Droulout, T | 1 |
| Grolleau, A | 1 |
| Titier, K | 1 |
| Molimard, M | 1 |
| Verdoux, H | 1 |
| Sümegi, A | 1 |
| Gau, SS | 1 |
| Chao, PF | 1 |
| Lin, YJ | 1 |
| Chang, CJ | 1 |
| Gau, CS | 1 |
| Juruena, MF | 1 |
| Ottoni, GL | 1 |
| Machado-Vieira, R | 1 |
| Carneiro, RM | 1 |
| Weingarthner, N | 1 |
| Marquardt, AR | 1 |
| Fleig, SS | 1 |
| Broilo, L | 1 |
| Busnello, EA | 1 |
| Ceron-Litvoc, D | 1 |
| Soares, BG | 1 |
| Geddes, J | 3 |
| Litvoc, J | 1 |
| de Lima, MS | 1 |
| Ketter, TA | 25 |
| Kakkar, AK | 1 |
| Rehan, HS | 1 |
| Unni, KE | 1 |
| Gupta, NK | 1 |
| Chopra, D | 1 |
| Kataria, D | 1 |
| El-Mallakh, RS | 4 |
| Salem, MR | 2 |
| Chopra, AS | 1 |
| Mickus, GJ | 2 |
| Penagaluri, P | 2 |
| Zhou, X | 1 |
| Greenwood, TA | 1 |
| Guo, S | 1 |
| He, L | 1 |
| Geyer, MA | 1 |
| Kelsoe, JR | 1 |
| Arvilommi, P | 1 |
| Suominen, K | 1 |
| Mantere, O | 1 |
| Leppämäki, S | 1 |
| Valtonen, HM | 1 |
| Isometsä, E | 1 |
| Adams, EN | 1 |
| Marks, A | 1 |
| Lizer, MH | 1 |
| Bazinet, RP | 4 |
| Teo, R | 1 |
| King, J | 1 |
| Dalton, E | 1 |
| Ryves, J | 1 |
| Williams, RS | 2 |
| Harwood, AJ | 2 |
| Strack, DK | 1 |
| Leckband, SG | 1 |
| Meyer, JM | 1 |
| Rubner, P | 1 |
| Koppi, S | 1 |
| Conca, A | 1 |
| Duggal, HS | 1 |
| Singh, I | 1 |
| Rosa, AR | 1 |
| Fountoulakis, K | 1 |
| Siamouli, M | 1 |
| Gonda, X | 1 |
| Mosolov, SN | 2 |
| Kostiukova, EG | 2 |
| Ladyzhenskiĭ, MIa | 1 |
| Hsiao, YT | 1 |
| Wei, IH | 1 |
| Grunze, H | 7 |
| Goodwin, GM | 1 |
| Bowden, C | 2 |
| Licht, RW | 2 |
| Möller, HJ | 4 |
| Kasper, S | 4 |
| Joshi, G | 1 |
| Wozniak, J | 3 |
| Mick, E | 2 |
| Doyle, R | 1 |
| Hammerness, P | 1 |
| Georgiopoulos, A | 1 |
| Kotarski, M | 1 |
| Aleardi, M | 1 |
| Williams, C | 1 |
| Walls, S | 1 |
| Biederman, J | 4 |
| Chopra, A | 1 |
| Movva, R | 1 |
| Campos, RN | 1 |
| Costa, LF | 1 |
| Bio, DS | 1 |
| Soeiro de Souza, MG | 1 |
| Garcia, CR | 1 |
| de Leon, J | 2 |
| Diaz, FJ | 1 |
| Spina, E | 1 |
| Williams, JM | 1 |
| Gandhi, KK | 1 |
| Benowitz, NL | 1 |
| Galbally, M | 1 |
| Roberts, M | 1 |
| Buist, A | 1 |
| Saleh, C | 1 |
| Post, RM | 61 |
| Weiss, SR | 4 |
| Tsouli, S | 1 |
| Maranis, S | 1 |
| Kyritsis, AP | 1 |
| Schweitzer, I | 1 |
| Deiana, V | 1 |
| Chillotti, C | 2 |
| Manchia, M | 1 |
| Pinna, M | 1 |
| Ardau, R | 2 |
| Severino, G | 2 |
| Grappi, S | 1 |
| Marchese, G | 1 |
| Secci, ME | 1 |
| De Montis, MG | 1 |
| Gambarana, C | 1 |
| Scheggi, S | 1 |
| Liu, HY | 1 |
| Potter, MP | 1 |
| Woodworth, KY | 1 |
| Yorks, DM | 1 |
| Petty, CR | 1 |
| Wozniak, JR | 1 |
| Faraone, SV | 2 |
| Lohoff, FW | 1 |
| Eguchi, E | 1 |
| Shimazu, K | 1 |
| Nishiguchi, K | 1 |
| Yorifuji, S | 1 |
| Tanaka, A | 1 |
| Kuwahara, T | 1 |
| Hydzik, P | 1 |
| Balicka-Slusarczyk, B | 1 |
| Jastrzebski, M | 1 |
| Terao, T | 1 |
| Vasudev, A | 2 |
| Macritchie, K | 2 |
| Vasudev, K | 2 |
| Watson, S | 3 |
| Leon, AC | 3 |
| Solomon, DA | 2 |
| Li, C | 1 |
| Fiedorowicz, JG | 1 |
| Coryell, WH | 1 |
| Endicott, J | 1 |
| Keller, MB | 1 |
| De León, OA | 1 |
| Katagiri, H | 1 |
| Takita, Y | 1 |
| Tohen, M | 10 |
| Higuchi, T | 2 |
| Kanba, S | 1 |
| Takahashi, M | 1 |
| Wada, K | 2 |
| Blake, T | 1 |
| Chen, CH | 1 |
| Lin, SK | 1 |
| Ito, K | 1 |
| Akita, Y | 1 |
| Ishida, N | 1 |
| Kasugai, C | 1 |
| Tamada, Y | 1 |
| Watanabe, D | 1 |
| Tensho, M | 1 |
| Chao, KC | 1 |
| Lu, ML | 1 |
| Shen, WW | 1 |
| Kulkarni, J | 2 |
| Filia, S | 1 |
| Berk, L | 1 |
| Filia, K | 1 |
| Dodd, S | 2 |
| de Castella, A | 1 |
| Brnabic, AJ | 1 |
| Lowry, AJ | 1 |
| Kelin, K | 2 |
| Montgomery, W | 2 |
| Fitzgerald, PB | 2 |
| Hertz, L | 2 |
| von Einsiedel, RW | 1 |
| Roesch-Ely, D | 1 |
| Diebold, K | 1 |
| Sartor, K | 1 |
| Mundt, C | 1 |
| Bergemann, N | 1 |
| Wolf, T | 1 |
| Müller-Oerlinghausen, B | 9 |
| Tuzun, U | 1 |
| Zoroglu, SS | 1 |
| Savas, HA | 2 |
| Cilli, AS | 1 |
| Algun, E | 1 |
| Sajatovic, M | 3 |
| Gonzalez-Pinto, A | 1 |
| Lalaguna, B | 1 |
| Pérez-Heredia, JL | 1 |
| Fernandez-Corres, B | 1 |
| Gutierrez, M | 1 |
| Micó, JA | 1 |
| Nasr, S | 1 |
| Keck, PE | 13 |
| McElroy, SL | 8 |
| Scott, J | 2 |
| Pope, M | 2 |
| Okuma, T | 8 |
| Goodwin, G | 1 |
| Baldwin, D | 1 |
| Licht, R | 1 |
| Hummel, B | 1 |
| Walden, J | 1 |
| Stampfer, R | 1 |
| Dittmann, S | 2 |
| Amann, B | 3 |
| Sterr, A | 1 |
| Schaefer, M | 1 |
| Hellewell, JS | 1 |
| Hartong, EG | 1 |
| Moleman, P | 1 |
| Hoogduin, CA | 2 |
| Broekman, TG | 1 |
| Nolen, WA | 5 |
| Ernst, CL | 1 |
| Goldberg, JF | 5 |
| Bown, CD | 1 |
| Wang, JF | 1 |
| Young, LT | 1 |
| Baethge, C | 2 |
| Smolka, MN | 1 |
| Gruschka, P | 1 |
| Berghöfer, A | 3 |
| Schlattmann, P | 1 |
| Bauer, M | 3 |
| Altshuler, L | 2 |
| Grof, P | 2 |
| Shelton, RC | 2 |
| Dunner, DL | 1 |
| Dietrich, DE | 1 |
| Kropp, S | 1 |
| Emrich, HM | 2 |
| Gnanadesikan, M | 1 |
| Freeman, MP | 3 |
| Gelenberg, AJ | 2 |
| Kowatch, RA | 4 |
| Sethuraman, G | 1 |
| Hume, JH | 2 |
| Kromelis, M | 2 |
| Weinberg, WA | 2 |
| Yatham, LN | 4 |
| Binder, C | 1 |
| Riccardelli, R | 1 |
| Leblanc, J | 1 |
| Connolly, M | 1 |
| Kusumakar, V | 1 |
| Chidori, S | 1 |
| Nishimura, R | 1 |
| Zaratiegui, R | 1 |
| Berv, DA | 1 |
| Klugman, J | 1 |
| Rosenquist, KJ | 1 |
| Hsu, DJ | 1 |
| Davanzo, P | 2 |
| Gunderson, B | 1 |
| Belin, T | 1 |
| Mintz, J | 4 |
| Pataki, C | 1 |
| Ott, D | 1 |
| Emley-Akanno, C | 1 |
| Montazeri, N | 1 |
| Oppenheimer, J | 1 |
| Strober, M | 1 |
| Greil, W | 13 |
| Kleindienst, N | 8 |
| Raja, M | 2 |
| Azzoni, A | 2 |
| Goodwin, FK | 4 |
| Fireman, B | 1 |
| Simon, GE | 1 |
| Hunkeler, EM | 1 |
| Lee, J | 1 |
| Revicki, D | 1 |
| Centorrino, F | 2 |
| Albert, MJ | 1 |
| Berry, JM | 1 |
| Kelleher, JP | 1 |
| Fellman, V | 1 |
| Line, G | 1 |
| Koukopoulos, AE | 1 |
| Kidwell, JE | 1 |
| Fogarty, KV | 1 |
| Sánchez-Moreno, J | 2 |
| Torrent, C | 2 |
| Benabarre, A | 2 |
| Colom, F | 2 |
| Martínez-Arán, A | 2 |
| Reinares, M | 1 |
| Comes, M | 3 |
| Corbella, B | 1 |
| Suzuki, H | 2 |
| Kimura, M | 2 |
| Sasaki, M | 1 |
| Harris, M | 1 |
| Chandran, S | 1 |
| Chakraborty, N | 1 |
| Healy, D | 1 |
| Sharma, P | 1 |
| Basu, D | 1 |
| Thapar, S | 1 |
| Lattanzi, L | 1 |
| Pini, S | 1 |
| Cassano, GB | 1 |
| Yonkers, KA | 1 |
| Wisner, KL | 3 |
| Stowe, Z | 1 |
| Leibenluft, E | 2 |
| Cohen, L | 1 |
| Miller, L | 1 |
| Manber, R | 1 |
| Viguera, A | 1 |
| Suppes, T | 3 |
| Weisler, RH | 10 |
| Kalali, AH | 5 |
| Jagadheesan, K | 1 |
| Thakur, A | 1 |
| Akhtar, S | 1 |
| Gallagher, P | 1 |
| Ritchie, JC | 2 |
| Ferrier, IN | 2 |
| Stahl, SM | 1 |
| Baldassano, CF | 2 |
| Ballas, CA | 1 |
| O'Reardon, JP | 1 |
| Jairam, R | 1 |
| Srinath, S | 1 |
| Girimaji, SC | 1 |
| Seshadri, SP | 1 |
| Hirschfeld, RM | 3 |
| Malek-Ahmadi, P | 1 |
| Hanretta, AT | 1 |
| Boufidou, F | 1 |
| Nikolaou, C | 1 |
| Alevizos, B | 1 |
| Liappas, IA | 1 |
| Christodoulou, GN | 1 |
| Jess, GE | 1 |
| Smith, DJ | 1 |
| Mackenzie, C | 1 |
| Crawford, C | 1 |
| Himmerich, H | 1 |
| Koethe, D | 1 |
| Schuld, A | 1 |
| Yassouridis, A | 1 |
| Pollmächer, T | 1 |
| Steinmann, C | 1 |
| Fric, M | 1 |
| Laux, G | 1 |
| Nikore, V | 1 |
| Yehya, N | 1 |
| Stevenson, L | 1 |
| Arban, R | 1 |
| Maraia, G | 1 |
| Brackenborough, K | 1 |
| Winyard, L | 1 |
| Wilson, A | 1 |
| Gerrard, P | 1 |
| Large, C | 1 |
| Mathiske-Schmidt, K | 1 |
| Hennen, J | 1 |
| Bschor, T | 1 |
| Adli, M | 1 |
| Hantouche, EG | 1 |
| Akiskal, HS | 3 |
| Lancrenon, S | 1 |
| Chatenêt-Duchêne, L | 1 |
| Citrome, L | 1 |
| Swann, AC | 4 |
| Cutler, AJ | 3 |
| Sheikh, R | 1 |
| Kang, J | 1 |
| Weller, R | 1 |
| Weller, EB | 1 |
| Kovács, G | 1 |
| Muzina, DJ | 1 |
| Elhaj, O | 2 |
| Gajwani, P | 2 |
| Gao, K | 2 |
| Calabrese, JR | 14 |
| Revicki, DA | 1 |
| Ahearn, EP | 1 |
| Palmer, C | 1 |
| Forsthoff, A | 1 |
| Muzina, D | 1 |
| Howland, RH | 1 |
| Leclercq, V | 1 |
| Lacaille, S | 1 |
| Delpierre, S | 1 |
| Karoubi, E | 1 |
| Legrain, S | 1 |
| Fuller, MA | 2 |
| Andrews, G | 1 |
| Page, AC | 1 |
| Swainston Harrison, T | 1 |
| Keating, GM | 1 |
| Mitchell, PB | 3 |
| Rao, JS | 3 |
| Chang, L | 1 |
| Rapoport, SI | 3 |
| Lee, HJ | 3 |
| Soultanian, C | 1 |
| Perisse, D | 1 |
| Révah-Levy, A | 1 |
| Luque, R | 1 |
| Mazet, P | 1 |
| Cohen, D | 1 |
| Danielyan, A | 1 |
| Pratoomsri, W | 2 |
| Sohn, CH | 2 |
| Solomons, K | 1 |
| Lam, RW | 2 |
| Negin, B | 1 |
| Murphy, TK | 2 |
| Wang, PW | 2 |
| Conway, CR | 1 |
| Chibnall, JT | 1 |
| Nelson, LA | 2 |
| McGuire, JM | 1 |
| Abraham, PF | 1 |
| Baram, VY | 1 |
| Grossberg, GT | 1 |
| Carroll, BJ | 2 |
| Mendhekar, DN | 2 |
| Mehta, R | 1 |
| Arora, M | 1 |
| Praharaj, SK | 1 |
| Goodnick, PJ | 1 |
| Hirschfeld, R | 2 |
| Gazda, T | 2 |
| Swann, A | 1 |
| Kalali, A | 1 |
| Aggarwal, P | 1 |
| Aggarwal, A | 1 |
| Fenn, HH | 2 |
| Sommer, BR | 1 |
| Alldredge, B | 1 |
| Phillips, H | 2 |
| Daban, C | 1 |
| Bowden, CL | 10 |
| Karren, NU | 1 |
| Bialer, M | 1 |
| Bora, E | 1 |
| Vahip, S | 1 |
| Akdeniz, F | 1 |
| Ginsberg, LD | 8 |
| Goicoechea, M | 1 |
| Best, B | 1 |
| Capparelli, E | 1 |
| Haubrich, R | 1 |
| Dostrow, V | 1 |
| Gupta, S | 1 |
| Gazda, TD | 1 |
| Nasrallah, HA | 1 |
| Owen, RT | 1 |
| Kalra, H | 1 |
| Dalal, PK | 1 |
| Allet, L | 1 |
| Janca, A | 1 |
| Wagner, KD | 1 |
| Emslie, GJ | 2 |
| Findling, RL | 1 |
| Wilens, TE | 2 |
| McCague, K | 1 |
| D'Souza, J | 1 |
| Wamil, A | 1 |
| Lehman, RB | 1 |
| Berv, D | 1 |
| Linden, D | 1 |
| Takamiya, M | 1 |
| Aoki, Y | 1 |
| Niitsu, H | 1 |
| Saigusa, K | 1 |
| Baath, NS | 1 |
| Hong, J | 1 |
| Sattar, SP | 1 |
| Cipriani, A | 1 |
| Rendell, JM | 1 |
| Geddes, JR | 2 |
| Pushpal, D | 1 |
| Shamshul, HN | 1 |
| MacMillan, CM | 1 |
| Korndörfer, SR | 1 |
| Rao, S | 1 |
| Fleisher, CA | 1 |
| Mezzacappa, E | 1 |
| Gonzalez-Heydrich, J | 1 |
| Bond, DJ | 1 |
| Yumru, M | 1 |
| Kurt, E | 1 |
| Kaya, MC | 1 |
| Selek, S | 1 |
| Savas, E | 1 |
| Oral, ET | 1 |
| Atagun, I | 1 |
| Chou, JC | 3 |
| Fazzio, L | 1 |
| Holly, P | 1 |
| Zhang, ZJ | 1 |
| Kang, WH | 1 |
| Li, Q | 1 |
| Tan, QR | 1 |
| Waslick, B | 1 |
| Lysne, DH | 1 |
| Peterson, T | 1 |
| Erickson, K | 1 |
| Uriell, M | 1 |
| Uhde, T | 2 |
| Ballenger, JC | 15 |
| Stoner, SC | 1 |
| Lea, JW | 1 |
| Marken, PA | 1 |
| Sommi, RW | 1 |
| Dahmen, MM | 1 |
| Bidzan, L | 1 |
| Montero-Lomelí, M | 1 |
| Galvão, D | 1 |
| Morais, BB | 1 |
| Nardi, AE | 1 |
| Kilbourne, AM | 1 |
| Post, EP | 1 |
| Bauer, MS | 2 |
| Zeber, JE | 1 |
| Copeland, LA | 1 |
| Good, CB | 1 |
| Pincus, HA | 2 |
| Reeves, RR | 1 |
| Burke, RS | 1 |
| Parker, JD | 1 |
| Ramsay, E | 1 |
| Nanry, K | 1 |
| Thompson, T | 1 |
| Mazza, M | 2 |
| Di Nicola, M | 1 |
| Martinotti, G | 1 |
| Taranto, C | 1 |
| Pozzi, G | 1 |
| Conte, G | 1 |
| Janiri, L | 1 |
| Bria, P | 2 |
| Mazza, S | 2 |
| Severus, WE | 2 |
| O'Neill, A | 1 |
| Garnham, J | 1 |
| Munro, A | 1 |
| Slaney, C | 1 |
| Macdougall, M | 1 |
| Passmore, M | 1 |
| Duffy, A | 1 |
| O'Donovan, C | 1 |
| Teehan, A | 1 |
| Lange-Asschenfeldt, C | 1 |
| Blaeser, I | 1 |
| Supprian, T | 1 |
| Majczenko, TG | 1 |
| Stewart, JT | 2 |
| Bourin, M | 1 |
| Prica, C | 1 |
| Kelly, DI | 1 |
| Hynan, LS | 1 |
| Snow, DE | 1 |
| Sureddi, S | 1 |
| Foster, B | 1 |
| Curley, E | 1 |
| Trimble, M | 1 |
| Popova, E | 1 |
| Leighton, C | 1 |
| Bernabarre, A | 1 |
| Bernardo, M | 1 |
| Yerevanian, BI | 4 |
| Koek, RJ | 2 |
| Nifle, C | 1 |
| Couratier, M | 1 |
| Jallade, C | 1 |
| Sarfati, Y | 1 |
| Mignon, F | 1 |
| Pico, F | 1 |
| Sahoo, S | 1 |
| Madaan, V | 1 |
| Chang, KD | 2 |
| Collins, JC | 1 |
| McFarland, BH | 1 |
| Krüger, S | 1 |
| Prager, P | 1 |
| Smith, LA | 1 |
| Cornelius, V | 1 |
| Warnock, A | 1 |
| Tacchi, MJ | 1 |
| Taylor, D | 1 |
| de Castella, AR | 1 |
| Brnabic, A | 1 |
| Granger, RE | 1 |
| Soares-Weiser, K | 1 |
| Bravo Vergel, Y | 1 |
| Beynon, S | 1 |
| Dunn, G | 1 |
| Barbieri, M | 1 |
| Duffy, S | 1 |
| Gilbody, S | 1 |
| Palmer, S | 1 |
| Woolacott, N | 1 |
| Ascher, JA | 1 |
| DeVeaugh-Geiss, J | 1 |
| Evoniuk, G | 1 |
| Lutz, UC | 1 |
| Wiatr, G | 1 |
| Gaertner, HJ | 1 |
| Bartels, M | 1 |
| Unei, H | 1 |
| Ikeda, H | 1 |
| Murakami, T | 1 |
| Tanigawa, K | 1 |
| Kihira, K | 1 |
| Smulevich, AB | 1 |
| Bergstrom, R | 1 |
| Quinlan, T | 1 |
| Osuntokun, O | 1 |
| Wang, WV | 1 |
| Oliff, HS | 1 |
| Martenyi, F | 1 |
| Kryzhanovskaya, LA | 1 |
| Cruz, N | 1 |
| García-Campayo, J | 1 |
| de Arce, R | 1 |
| Manuel Crespo, J | 1 |
| Vallès, V | 1 |
| Pérez-Blanco, J | 1 |
| Roca, E | 1 |
| Manuel Olivares, J | 1 |
| Moríñigo, A | 1 |
| Fernández-Villamor, R | 1 |
| Preskorn, SH | 1 |
| Keck, P | 1 |
| Yassa, R | 3 |
| Uhde, TW | 23 |
| Rubinow, DR | 6 |
| Gold, PW | 5 |
| Squillace, KM | 1 |
| Kanter, GL | 1 |
| Ciccone, JR | 1 |
| Roy-Byrne, PP | 5 |
| Joffe, RT | 14 |
| Kwamie, Y | 1 |
| Persad, E | 1 |
| Stancer, H | 1 |
| Klein, E | 2 |
| Smith, C | 1 |
| Bunney, WE | 4 |
| Bental, E | 1 |
| Lerer, B | 6 |
| Wunderlich, HP | 1 |
| Grünes, JU | 1 |
| Neumann, J | 1 |
| Zahlten, W | 1 |
| Wolff, EA | 1 |
| Chaudhry, RP | 1 |
| Waters, BG | 1 |
| Keisling, R | 1 |
| Moss, GR | 1 |
| James, CR | 1 |
| Altmann, H | 1 |
| Dose, M | 1 |
| von Zerssen, D | 2 |
| Berrettini, W | 1 |
| Kellner, C | 1 |
| Shukla, S | 2 |
| Godwin, CD | 1 |
| Long, LE | 1 |
| Miller, MG | 3 |
| Udhe, TW | 1 |
| Inoue, H | 1 |
| Hazama, H | 5 |
| Hamazoe, K | 1 |
| Ichikawa, M | 1 |
| Omura, F | 1 |
| Fukuma, E | 1 |
| Inoue, K | 4 |
| Umezawa, Y | 1 |
| Fogelson, DL | 1 |
| Vovin, RIa | 2 |
| Digilov, AG | 2 |
| Skorik, AI | 2 |
| Hoaken, PC | 1 |
| Kaplan, AS | 1 |
| Garfinkel, PE | 1 |
| Darby, PL | 1 |
| Garner, DM | 1 |
| Robertson, GL | 1 |
| Kaye, W | 1 |
| Chen, J | 1 |
| Kishimoto, A | 3 |
| Ogura, C | 1 |
| Eckmann, F | 1 |
| Jann, MW | 1 |
| Saklad, SR | 1 |
| Ereshefsky, L | 1 |
| Nelson, HB | 1 |
| Lewis, HA | 1 |
| Bacher, NM | 1 |
| Reiss, AL | 1 |
| O'Donnell, DJ | 1 |
| Lesser, I | 1 |
| Putnam, FW | 1 |
| Berrettini, WH | 2 |
| Inanaga, K | 3 |
| Otsuki, S | 3 |
| Sarai, K | 3 |
| Takahashi, R | 3 |
| Mori, A | 2 |
| Watanabe, S | 2 |
| Arima, S | 1 |
| Tanaka, K | 1 |
| Fukui, Y | 1 |
| Kato, N | 1 |
| Lipinski, JF | 2 |
| Pope, HG | 2 |
| Potter, WZ | 3 |
| Murphy, DL | 1 |
| Wehr, TA | 2 |
| Linnoila, M | 1 |
| Forrest, DV | 1 |
| Chatterji, DC | 1 |
| Greene, RF | 1 |
| Warren, JA | 1 |
| Steinbook, RM | 1 |
| Folks, DG | 2 |
| King, LD | 1 |
| Dowdy, SB | 1 |
| Petrie, WM | 1 |
| Jack, RA | 1 |
| Koomen, JC | 1 |
| Swenson, BR | 1 |
| Edwards, P | 1 |
| Privitera, MR | 1 |
| Greden, JF | 1 |
| Gardner, RW | 1 |
| Roach, N | 1 |
| Murphy, P | 1 |
| Hare, TA | 1 |
| Ghose, K | 1 |
| Silverstone, T | 6 |
| Romans, S | 1 |
| Gitlin, MJ | 2 |
| Swendsen, J | 1 |
| Heller, TL | 1 |
| Hammen, C | 2 |
| Small, JG | 3 |
| Klapper, MH | 3 |
| Marhenke, JD | 2 |
| Milstein, V | 3 |
| Woodham, GC | 1 |
| Kellams, JJ | 2 |
| Parekh, PI | 1 |
| Worthington, K | 1 |
| Campbell, M | 1 |
| Cueva, JE | 1 |
| Werder, SF | 1 |
| Schou, M | 1 |
| Dardennes, R | 1 |
| Even, C | 1 |
| Bange, F | 1 |
| Heim, A | 1 |
| Dantzler, A | 1 |
| Salzman, C | 1 |
| DasGupta, K | 1 |
| Jefferson, JW | 3 |
| Steckler, TL | 1 |
| Vanelle, JM | 1 |
| Loo, H | 1 |
| Galinowski, A | 1 |
| de Carvalho, W | 1 |
| Bourdel, MC | 1 |
| Brochier, P | 1 |
| Bouvet, O | 1 |
| Brochier, T | 1 |
| Adler, L | 1 |
| Ulrich, M | 1 |
| Lehmann, K | 1 |
| Nordeck, I | 1 |
| Langer, C | 1 |
| Thomas, RS | 1 |
| Hajak, G | 1 |
| Koller, M | 1 |
| Gross, R | 1 |
| Grunhaus, L | 1 |
| Patterson, BD | 1 |
| Woyshville, MJ | 3 |
| Brady, KT | 2 |
| Sonne, SC | 1 |
| Kramlinger, KG | 2 |
| Phillips, KA | 1 |
| Tuma, I | 1 |
| Sweeney, EA | 1 |
| Fieve, RR | 1 |
| Difiglia, C | 1 |
| Sanfilipo, MP | 1 |
| Mielke, DH | 1 |
| George, MS | 5 |
| Guidotti, A | 1 |
| Rubinow, D | 2 |
| Pan, B | 1 |
| Mikalauskas, K | 1 |
| Hemet, C | 1 |
| Chassagne, P | 1 |
| Levade, MH | 1 |
| Heron, F | 1 |
| Fortier-Beaulieu, M | 1 |
| Doucet, J | 1 |
| Bercoff, E | 1 |
| Denicoff, KD | 8 |
| Meglathery, SB | 1 |
| Tandeciarz, SI | 1 |
| Tyrer, SP | 2 |
| Brittlebank, AD | 1 |
| White, E | 1 |
| Cheung, P | 1 |
| Mirchandani, IC | 1 |
| Young, RC | 1 |
| Baischer, W | 1 |
| Wagner, A | 1 |
| Seidler, D | 1 |
| Musalek, M | 1 |
| Laggner, A | 1 |
| Castillo, J | 2 |
| Herbstein, J | 1 |
| Dubovsky, SL | 2 |
| Thomas, M | 1 |
| Hijazi, A | 1 |
| Murphy, J | 1 |
| Lagomarsino, AJ | 1 |
| Hunt, N | 2 |
| Pagliaro, LA | 1 |
| Pagliaro, AM | 1 |
| Simhandl, C | 1 |
| Denk, E | 1 |
| Thau, K | 1 |
| Ludwig-Mayerhofer, W | 3 |
| Steller, B | 1 |
| Czernik, A | 3 |
| Giedke, H | 2 |
| Osterheider, M | 2 |
| Rudolf, GA | 2 |
| Sauer, H | 3 |
| Tegeler, J | 2 |
| Riemann, D | 2 |
| Gann, H | 2 |
| Hohagen, F | 2 |
| Bahro, M | 1 |
| Müller, WE | 2 |
| Berger, M | 2 |
| Schaff, MR | 1 |
| Fawcett, J | 2 |
| Zajecka, JM | 1 |
| Knoppert-van der Klein, EA | 1 |
| Pardoen, D | 1 |
| Bauwens, F | 1 |
| Tracy, A | 1 |
| Martin, F | 1 |
| Mendlewicz, J | 1 |
| Kröber, HL | 1 |
| Brøsen, K | 1 |
| Kragh-Sørensen, P | 1 |
| Strauss, LG | 1 |
| Dressing, H | 1 |
| Glod, CA | 1 |
| Mathieu, J | 1 |
| Mas, F | 1 |
| Prichep, LS | 1 |
| Alper, K | 1 |
| Dilsaver, SC | 2 |
| Shoaib, AM | 1 |
| Bowers, TC | 1 |
| Hermle, L | 1 |
| Spitzer, M | 1 |
| Altshuler, LL | 3 |
| Szuba, MP | 1 |
| Finch, NN | 1 |
| Popli, AP | 1 |
| Tanquary, J | 1 |
| Lamparella, V | 1 |
| Masand, PS | 1 |
| Scull, DA | 1 |
| Trimble, MR | 1 |
| Leo, RJ | 1 |
| Cannuli, AR | 1 |
| Robinson, D | 1 |
| Luby, V | 1 |
| Dangel, C | 1 |
| Buxton, E | 1 |
| Beattie, M | 1 |
| Kraemer, H | 1 |
| Yesavage, JA | 1 |
| Ashton, AK | 1 |
| Wolin, RE | 1 |
| Zarate, CA | 2 |
| Hegarty, JI | 1 |
| Froeschl, M | 1 |
| Zarate, SB | 1 |
| Fatemi, SH | 1 |
| Kujawa, M | 2 |
| Sachs, GS | 3 |
| Marcoux, AW | 1 |
| Boyle, N | 1 |
| Lawlor, BA | 1 |
| Jenkins, JB | 1 |
| Schroeder, DH | 1 |
| Pazzaglia, PJ | 6 |
| Marangell, LB | 4 |
| Callahan, AM | 4 |
| Hinton, ML | 1 |
| Chao, J | 1 |
| Prien, RF | 2 |
| Rush, AJ | 2 |
| McDonald, WM | 1 |
| Nemeroff, CB | 4 |
| Emilien, G | 1 |
| Maloteaux, JM | 1 |
| Seghers, A | 1 |
| Charles, G | 1 |
| Swann, SC | 1 |
| Chen, YW | 1 |
| Shoaib, A | 1 |
| Joe, B | 1 |
| Krajewski, KJ | 1 |
| Gruber, N | 1 |
| Tsai, Y | 1 |
| Reetz-Kokott, U | 1 |
| Denicoff, K | 3 |
| Leverich, GS | 9 |
| Bennett, JA | 2 |
| Lenox, RH | 1 |
| McNamara, RK | 1 |
| Watterson, JM | 1 |
| Watson, DG | 1 |
| Manji, HK | 2 |
| Chen, G | 2 |
| Hsiao, JK | 1 |
| Risby, ED | 1 |
| Masana, MI | 1 |
| Keitner, GI | 2 |
| Ryan, CE | 1 |
| Miller, IW | 2 |
| Manto, MU | 1 |
| Jacquy, J | 1 |
| Hildebrand, J | 1 |
| Fritze, J | 1 |
| Schneider, B | 1 |
| Maurer, K | 1 |
| Roxanas, MG | 1 |
| Corbett, AJ | 1 |
| Reid, WG | 1 |
| Volkmann, GS | 1 |
| Schröder, S | 1 |
| Truman, CJ | 1 |
| Richter, P | 1 |
| Schöchlin, C | 2 |
| Erazo, N | 2 |
| Schmidt, S | 2 |
| Engel, RR | 1 |
| Wetterling, T | 1 |
| Baraibar, G | 1 |
| Gerhart, C | 1 |
| Semple, W | 1 |
| Callahan, A | 1 |
| Leverich, G | 1 |
| Frye, M | 1 |
| Shimizu, E | 1 |
| Kodama, K | 1 |
| Sakamoto, T | 1 |
| Komatsu, N | 1 |
| Yamanouchi, N | 1 |
| Okada, S | 1 |
| Sato, T | 1 |
| Smith-Jackson, EE | 5 |
| Bryan, AL | 3 |
| Ali, SO | 6 |
| Yasui, N | 1 |
| Otani, K | 1 |
| Kaneko, S | 1 |
| Shimoyama, R | 1 |
| Ohkubo, T | 1 |
| Sugawara, K | 1 |
| Disney, ER | 1 |
| Pascualy, M | 1 |
| Tsuang, D | 1 |
| Shores, M | 1 |
| Agustin, C | 1 |
| Krause, E | 1 |
| Spain, W | 1 |
| Bird, T | 1 |
| Peskind, E | 1 |
| Brent, NB | 1 |
| Perel, JM | 1 |
| Malloy, FW | 1 |
| Golay, SJ | 1 |
| Medlock, CE | 1 |
| Garno, JL | 2 |
| Kocsis, JH | 2 |
| Portera, L | 2 |
| Weiss, RD | 1 |
| Greenfield, SF | 1 |
| Najavits, LM | 1 |
| Soto, JA | 1 |
| Wyner, D | 1 |
| Griffin, ML | 1 |
| Melgarejo Moreno, PJ | 1 |
| Hellín Meseguer, D | 1 |
| Ruiz Macía, JA | 1 |
| Baptista, T | 1 |
| Araujo, H | 1 |
| Rada, P | 1 |
| Hernández, L | 1 |
| Tueth, MJ | 1 |
| Evans, DL | 2 |
| Fujiwara, Y | 2 |
| Honda, T | 1 |
| Tanaka, Y | 1 |
| Aoki, S | 1 |
| Kuroda, S | 3 |
| Boerlin, HL | 1 |
| Zoellner, LA | 1 |
| Hammen, CL | 1 |
| Sanderson, DR | 1 |
| Cates, M | 1 |
| Powers, R | 1 |
| Yang, YY | 1 |
| Deng, HC | 1 |
| Wang, BH | 1 |
| Kimbrell, TA | 2 |
| Cora-Locatelli, G | 2 |
| Luckenbaugh, D | 2 |
| Bostic, JQ | 1 |
| Prince, J | 1 |
| Daly, J | 1 |
| Spencer, T | 1 |
| Garcia-Jetton, J | 1 |
| Russell, R | 1 |
| Bebchuk, JM | 1 |
| Moore, GJ | 1 |
| Glitz, D | 1 |
| Hasanat, KA | 1 |
| Woolston, JL | 1 |
| Grundy, S | 1 |
| Kane, JM | 1 |
| Stoll, AL | 1 |
| Rueter, S | 1 |
| Zboyan, HA | 1 |
| Diamond, E | 1 |
| Cress, KK | 1 |
| Shulman, KI | 1 |
| Herrmann, N | 1 |
| Marcus, SC | 1 |
| Olfson, M | 1 |
| Zarin, DA | 1 |
| Kupfer, DJ | 2 |
| Kaufman, KR | 1 |
| Goldstein, TR | 1 |
| Smith-Jackson, E | 1 |
| Pacheco, MA | 1 |
| Jope, RS | 1 |
| Vanstraelen, M | 1 |
| Motohashi, N | 1 |
| Yamada, K | 1 |
| Valle, J | 1 |
| Ayuso-Gutierrez, JL | 1 |
| Abril, A | 1 |
| Ayuso-Mateos, JL | 1 |
| Wolfson, M | 1 |
| Bersudsky, Y | 1 |
| Zinger, E | 1 |
| Simkin, M | 1 |
| Davanzo, PA | 1 |
| McCracken, JT | 1 |
| Oostervink, F | 1 |
| Hoenderboom, AC | 1 |
| Lee, Y | 1 |
| Hamamura, T | 1 |
| Ohashi, K | 1 |
| Miki, M | 1 |
| Chaudron, LH | 1 |
| Elstner, S | 1 |
| Sperling, W | 1 |
| Soares, JC | 1 |
| Gershon, S | 7 |
| Craven, C | 1 |
| Murphy, M | 1 |
| Carmody, TJ | 1 |
| Bucci, JP | 1 |
| Goswami, U | 1 |
| Kohli, K | 1 |
| Bocchetta, A | 1 |
| Griswold, KS | 1 |
| Pessar, LF | 1 |
| Macritchie, KA | 2 |
| Mahmood, T | 1 |
| Hunt, NJ | 1 |
| Bottlender, R | 1 |
| Rudolf, D | 1 |
| Strauss, A | 1 |
| van Calker, D | 1 |
| Maj, M | 1 |
| Chengappa, KN | 3 |
| Levine, J | 3 |
| Mallinger, AG | 1 |
| Hardan, A | 1 |
| Vagnucci, A | 1 |
| Pollock, B | 1 |
| Luther, J | 1 |
| Buttenfield, J | 1 |
| Verfaille, S | 1 |
| Rathore, D | 1 |
| Atzert, R | 1 |
| Solai, L | 1 |
| Parepally, H | 1 |
| Levin, H | 1 |
| Moffa, N | 1 |
| Delaney, J | 1 |
| Brar, JS | 1 |
| Ramadasan, P | 1 |
| Chaudhury, S | 1 |
| Vaishampayne, S | 1 |
| John, TR | 1 |
| Mayan, H | 1 |
| Golubev, N | 1 |
| Dinour, D | 1 |
| Farfel, Z | 1 |
| Gyulai, L | 1 |
| Gergel, IP | 1 |
| Oakes, R | 1 |
| Pitts, CD | 1 |
| Richards, JA | 1 |
| Burdick, KE | 1 |
| Yamada, N | 1 |
| Yamauchi, Y | 1 |
| Teitelbaum, M | 1 |
| Osuch, EA | 1 |
| Huggins, T | 1 |
| Hardy-Baylé, MC | 1 |
| Sollinger, AB | 1 |
| Shelton, MD | 1 |
| Rapport, DJ | 2 |
| Kimmel, SE | 1 |
| Caban, S | 1 |
| Shaldubina, A | 1 |
| Szechtman, H | 1 |
| Shimon, H | 1 |
| Zolezzi, M | 1 |
| Gabbay, V | 1 |
| O'Dowd, MA | 1 |
| Asnis, GM | 1 |
| Cheng, L | 1 |
| Mudge, AW | 1 |
| Ko, JY | 1 |
| Katzow, JJ | 1 |
| Jimerson, DC | 1 |
| Watanabe, M | 2 |
| Hellekson, C | 1 |
| Buckland, R | 1 |
| Price, T | 1 |
| Ghodhbane, T | 1 |
| Syvälahti, E | 1 |
| Welcker, M | 1 |
| Schattenkirchner, M | 1 |
| Rittmannsberger, H | 1 |
| Leblhuber, F | 1 |
| Fischer, P | 1 |
| Schumann, C | 1 |
| Naske, R | 1 |
| Vuckovic, A | 1 |
| Friedman, LM | 1 |
| Chuang, DM | 1 |
| Gerner, RH | 1 |
| Stanton, A | 1 |
| Coxhead, N | 1 |
| Cookson, J | 2 |
| Modestin, J | 1 |
| Schwarzenbach, F | 1 |
| Weller, M | 2 |
| Kornhuber, J | 2 |
| Beckmann, H | 1 |
| Bruce-Jones, W | 1 |
| Divish, MM | 1 |
| Sheftel, G | 1 |
| Boyle, A | 1 |
| Kalasapudi, VD | 1 |
| Papolos, DF | 1 |
| Lachman, HM | 1 |
| Cole, JO | 1 |
| de los Heros, R | 1 |
| Farrer, RJ | 1 |
| Leinonen, E | 1 |
| Lillsunde, P | 1 |
| Laukkanen, V | 1 |
| Ylitalo, P | 1 |
| Blackwell, MJ | 1 |
| Keltner, NL | 1 |
| O'Connell, RA | 1 |
| Mayo, JA | 1 |
| Sciutto, MS | 1 |
| Petit, P | 1 |
| Lonjon, R | 1 |
| Cociglio, M | 1 |
| Sluzewska, A | 1 |
| Blayac, JP | 1 |
| Hue, B | 1 |
| Alric, R | 1 |
| Pouget, R | 1 |
| Cooper, SA | 1 |
| Collacott, RA | 1 |
| Bohlken, J | 1 |
| Priebe, S | 1 |
| Di Costanzo, E | 1 |
| Schifano, F | 1 |
| Soucek, K | 1 |
| Gernaat, HB | 1 |
| Van de Woude, J | 1 |
| Touw, DJ | 1 |
| Miller, MJ | 1 |
| Small, IF | 1 |
| Yamashita, I | 1 |
| Itoh, H | 1 |
| Ellicott, A | 1 |
| Gitlin, M | 1 |
| Brown, G | 1 |
| Jamison, K | 1 |
| Finzen, A | 1 |
| Cohen, LS | 2 |
| Heller, VL | 2 |
| Dalkin, T | 1 |
| Lee, AS | 1 |
| Delucchi, GA | 2 |
| Whybrow, PC | 1 |
| Winokur, A | 1 |
| Mauri, MC | 1 |
| Percudani, M | 1 |
| Regazzetti, MG | 1 |
| Altamura, AC | 1 |
| Haykal, RF | 1 |
| Rosoff, AS | 2 |
| Sheehan, JD | 1 |
| Shelley, RK | 1 |
| Moshchevitin, SIu | 1 |
| Mathis, P | 1 |
| Feder, R | 1 |
| Gadde, K | 1 |
| Chen, PJ | 1 |
| Stuppaeck, C | 1 |
| Barnas, C | 1 |
| Miller, C | 1 |
| Schwitzer, J | 1 |
| Fleischhacker, WW | 1 |
| Simon, LT | 1 |
| Hsu, B | 1 |
| Adornato, BT | 1 |
| Kessler, AJ | 1 |
| Barklage, NE | 1 |
| Onady, AA | 1 |
| Murphy, DJ | 1 |
| Gannon, MA | 1 |
| McGennis, A | 1 |
| Livingston, M | 1 |
| Sasaki, T | 1 |
| Saito, S | 1 |
| Aihara, M | 1 |
| Ohsawa, J | 1 |
| Ikezawa, Z | 1 |
| Kissling, W | 1 |
| Riehl, T | 1 |
| Bäuml, J | 1 |
| Binz, U | 1 |
| Wendt, G | 1 |
| Estrade, JF | 1 |
| Samuel-Lajeunesse, B | 1 |
| Bakchine, S | 1 |
| Lacomblez, L | 1 |
| Benoit, N | 1 |
| Parisot, D | 1 |
| Chain, F | 1 |
| Lhermitte, F | 1 |
| Spurkland, I | 1 |
| Vandvik, IH | 1 |
| Fruzzetti, AE | 1 |
| Norman, WH | 1 |
| Brown, WA | 1 |
| Arana, GW | 2 |
| Santos, AB | 1 |
| Knax, EP | 1 |
| Wurthmann, C | 1 |
| Hartung, HP | 1 |
| Dengler, W | 1 |
| Gerhardt, P | 1 |
| Brown, D | 1 |
| von Bardeleben, U | 1 |
| Wiedemann, K | 1 |
| Stalla, GK | 1 |
| Müller, OA | 1 |
| Holsboer, F | 1 |
| Reichlin, S | 1 |
| Cookson, JC | 1 |
| Cook, BL | 1 |
| Risse, SC | 1 |
| Barnes, R | 1 |
| Chouinard, G | 1 |
| Clower, CG | 1 |
| Menza, MA | 1 |
| Easton, J | 1 |
| Flaum, MA | 1 |
| Frank, DL | 1 |
| Goldberg, IC | 1 |
| Michell, MY | 1 |
| Wise, SS | 1 |
| Myers, WC | 1 |
| Carrera, F | 1 |
| Borsook, D | 1 |
| Richardson, GS | 1 |
| Moore-Ede, MC | 1 |
| Brennan, MJ | 1 |
| Lovett, L | 1 |
| Watkins, SE | 1 |
| Shaw, DM | 1 |
| Hemsath, RH | 1 |
| Servant, D | 1 |
| Danel, T | 1 |
| Goudemand, M | 1 |
| MacDonald, C | 1 |
| Kutcher, SP | 1 |
| Sovner, R | 1 |
| Lusznat, RM | 1 |
| Murphy, DP | 1 |
| Nunn, CM | 1 |
| Moore, NC | 2 |
| Meyendorff, E | 4 |
| Garbutt, JC | 1 |
| Gillette, GM | 1 |
| Pleak, RR | 1 |
| Birmaher, B | 1 |
| Gavrilescu, A | 1 |
| Abichandani, C | 1 |
| Williams, DT | 1 |
| Epstein, S | 1 |
| Molloy, M | 1 |
| Greenblatt, DJ | 1 |
| Hashimoto, R | 1 |
| Ozaki, N | 1 |
| Ohta, T | 1 |
| Kasahara, Y | 1 |
| Kaneda, N | 1 |
| Nagatsu, T | 1 |
| Jansen, GS | 1 |
| Broekman, M | 1 |
| Zhao, GF | 1 |
| Lykke, J | 1 |
| Magelund, CG | 1 |
| Price, WA | 1 |
| DiMarzio, LR | 1 |
| Rivelli, M | 1 |
| Nelson, WH | 1 |
| Iskandar, H | 1 |
| Nastase, C | 1 |
| Camille, Y | 1 |
| Gross, RA | 1 |
| Herridge, P | 1 |
| Nelson, MV | 1 |
| Rosenbaum, JF | 1 |
| Frankenburg, FR | 1 |
| Cohen, BM | 1 |
| McKnelly, WV | 1 |
| Seidel, M | 1 |
| Joyce, PR | 1 |
| Aksenova, IO | 1 |
| Firulev, AA | 1 |
| Xu, ZJ | 1 |
| Brayley, J | 1 |
| Yellowlees, P | 1 |
| Klein, EM | 1 |
| Madakasira, S | 1 |
| Greenberg, WM | 1 |
| Moore, N | 2 |
| Cho, SR | 2 |
| Post, R | 1 |
| Kramlinger, K | 1 |
| Cabrera, J | 1 |
| Albrecht, J | 1 |
| Minichiello, MD | 1 |
| Xu, LX | 1 |
| Fawcett, RG | 1 |
| Laird, LK | 1 |
| Knox, EP | 1 |
| Lieber, AL | 1 |
| Bourgeois, M | 1 |
| Degeilh, B | 1 |
| Etchépare, JJ | 1 |
| Sudreau, N | 1 |
| Géraud, M | 1 |
| Cantor, C | 1 |
| Brewerton, TD | 1 |
| Morin, J | 1 |
| Granger, B | 1 |
| Palladino, A | 1 |
| Drake, ME | 1 |
| Peruzzi, WT | 1 |
| Malt, U | 1 |
| Gonçalves, N | 1 |
| Stoll, KD | 1 |
| Elphick, M | 1 |
| Strömgren, LS | 1 |
| Boller, S | 1 |
| Fast, DK | 1 |
| Jones, BD | 1 |
| Kusalic, M | 1 |
| Erickson, M | 1 |
| Canterbury, RJ | 1 |
| Kravitz, HM | 1 |
| Hodgman, CH | 1 |
| Arap Mengech, HN | 1 |
| Nurnberg, HG | 1 |
| Finkel, JA | 1 |
| Chan, K | 1 |
| Bow, J | 1 |
| Matsumoto, H | 1 |
| Ogura, A | 1 |
| Schrub, JC | 1 |
| Wolf, LM | 1 |
| Courtois, H | 1 |
| Vuillermet, P | 1 |
| Marel, U | 1 |
| Inose, T | 1 |
| Hirata, I | 1 |
| Kawajiwara, A | 1 |
| Iwata, T | 1 |
| Tano, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Tolerability of the Combination of LIthium and CArbamazepine Compared to Lithium and VALproic Acid in the Treatment of Young Bipolar Patients[NCT00976794] | Phase 4 | 40 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| Homeopathic Treatment in Pregnant Women With Overweight and Mental Disorder: a Double Blinded Controlled Clinical Trial[NCT00942097] | Phase 2/Phase 3 | 134 participants (Actual) | Interventional | 2009-08-31 | Completed | ||
| Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder[NCT02456896] | Phase 4 | 50 participants (Actual) | Interventional | 2015-06-30 | Completed | ||
| Nicotine Intake in Smokers With Schizophrenia[NCT00382915] | 276 participants (Actual) | Observational | 2006-10-31 | Completed | |||
| Orally-Disintegrating vs. Regular Olanzapine Tablets: Effects on Weight and GI Hormones[NCT00384332] | Phase 4 | 20 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| An Exploratory Randomized Open Comparison of Oxtellar XR® vs Oxcarbazepine IR (Trileptal®) for the Treatment of Bipolar Depression[NCT03567681] | Phase 4 | 120 participants (Anticipated) | Interventional | 2018-06-13 | Enrolling by invitation | ||
| A Randomised Double-Blinded Placebo-Controlled Trial to Assess the Efficacy and Safety of Scopolamine Compared to Placebo in Individuals With Bipolar Disorder Who Are Experiencing a Depressive Episode[NCT04211961] | Phase 2 | 50 participants (Anticipated) | Interventional | 2021-03-23 | Recruiting | ||
| A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder[NCT04210804] | Phase 2 | 80 participants (Actual) | Interventional | 2014-04-01 | Completed | ||
| Carbamazepine Extended-Release for the Treatment of Bipolar Depression[NCT00203567] | Phase 4 | 25 participants (Actual) | Interventional | 2005-08-31 | Completed | ||
| Investigation of the Effects of in Vivo Lithium Treatment on Gene Expression Levels Using Lymphoblastoid Cell Lines From Human Healthy Subjects[NCT01565759] | Phase 1 | 20 participants (Anticipated) | Interventional | 2012-05-31 | Recruiting | ||
| Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder[NCT00190892] | Phase 4 | 120 participants | Interventional | 2004-09-30 | Completed | ||
| A Multi-center, Randomized, Double-blind, Parallel Group, Placebo-controlled 52 Weeks Clinical Trial to Evaluate Efficacy and Safety of Oxcarbazepine p.o.(300-1200 mg/Day) as Adjuvant Therapy in the Bipolar Disorder I or II Treatment[NCT00154323] | Phase 4 | 55 participants (Actual) | Interventional | 2003-01-31 | Completed | ||
| Prophylactic Use of Immediate Postpartum Sertraline to Prevent Postpartum Depression: A Double Blind Randomized Placebo Controlled Trial[NCT02235064] | 2 participants (Actual) | Interventional | 2014-07-31 | Terminated (stopped due to Low recruitment, completion of funding cycle) | |||
| A Randomised Trial on the Usefulness of Supportive Text Messages in the Treatment of Depressed Patients With Co-morbid Alcohol Dependency Syndrome[NCT01037868] | 56 participants (Actual) | Interventional | 2009-09-30 | Completed | |||
| Pilot Evaluation of Levetiracetam (Keppra® (Registered Trademark)) in Bipolar Illness[NCT00015769] | Phase 2 | 30 participants | Interventional | 2001-04-30 | Completed | ||
| Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study in Adolescents With Bipolar Disorder[NCT00391001] | Phase 1 | 4 participants (Actual) | Interventional | 2006-02-28 | Terminated | ||
| Omega-3 Fatty Acids in Bipolar Disorder Prophylaxis[NCT00010868] | Phase 2 | 0 participants | Interventional | 2000-07-31 | Completed | ||
| A Combination of Cytidine and Omega-3 Fatty Acids in Bipolar Disorder: Are There Additive or Synergistic Mood Stabilizing Effects?[NCT00854737] | Phase 2 | 90 participants (Actual) | Interventional | 2004-07-31 | Completed | ||
| Supplementation of Antidepressants With Fatty Acid Therapy[NCT00963196] | 78 participants (Anticipated) | Interventional | 2009-09-30 | Withdrawn (stopped due to End of allotted time for subject recruiting.) | |||
| Targeted Alterations in n-3 and n-6 Fatty Acids for the Management of Mood Variability in the Maintenance Phase of Bipolar Disorder[NCT02272010] | 83 participants (Actual) | Interventional | 2014-10-31 | Completed | |||
| Imaging Framework for Testing GABAergic/Glutamatergic Drugs in Bipolar Alcoholics[NCT03220776] | Phase 2 | 54 participants (Actual) | Interventional | 2017-08-07 | Completed | ||
| Pilot Study on the Clinical Utility of the Tulsa Life Chart: A Graphical Representation of Patient Life History[NCT05523843] | 130 participants (Anticipated) | Observational | 2022-09-12 | Enrolling by invitation | |||
| A Preliminary Study of the Efficacy and Safety of Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency[NCT01379469] | Phase 2 | 20 participants (Actual) | Interventional | 2012-01-31 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Serum BDNF was estimated by ELISA using human BDNF ELISA kit from Boster Biological Technology Co. Ltd., Pleasanton, CA. (NCT02456896)
Timeframe: Baseline and 4 weeks
| Intervention | pg/ml (Mean) |
|---|---|
| Healthy Control | 23.1 |
| Oxcarbazepine | 90.7 |
"The YMRS total score ranges from 0 to 60 where higher scores indicate more severe mania.~Spearman's rank correlation coefficient (Spearman's ρ) was calculated for measuring correlation between YMRS score and serum BDNF." (NCT02456896)
Timeframe: At baseline
| Intervention | Spearman's ρ (Number) |
|---|---|
| Healthy Control | -0.59 |
| Oxcarbazepine | -0.59 |
Montgomery Asberg Depression Rating Scale (MADRS) total score. Construct: Depression severity. Scores below represent mean change scores, endpoint minus baseline. Minimum total score: 0 (no depression). Maximum total score: 60 (severe depression). Lower (more negative) scores indicate a better outcome. There are no subscales. (NCT00384332)
Timeframe: 10 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| Arm 1 | -15.5 |
| Arm 2 | -15.5 |
Change in weight from baseline to endpoint in kilograms. Reported as weight in Kilograms at Baseline, Weeks 1, 4, 6, and 8 (NCT00384332)
Timeframe: 10 weeks
| Intervention | kilograms (Mean) | ||||
|---|---|---|---|---|---|
| Baseline | Week 1 | Week 4 | Week 6 | Week 8 | |
| Arm 1- ODT | 76.0 | 77.4 | 77.8 | 78.9 | 79.1 |
| Arm 2- SOT | 76.1 | 77.6 | 78.3 | 79.4 | 80.1 |
The Antidepressant Side-Effect Checklist (ASEC) was employed to detect any adverse reaction to treatment regimens (NCT02235064)
Timeframe: Discharge from hospital to 12 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 1 |
"Patients met with single psychiatrist (co-investigator), blinded to group assignment, who evaluated the patient using Edinburgh Postpartum Depression Screen, Hamilton Depression Rating Scale, Global Assessment of Functioning Scale, and clinical assessment~0 = No postpartum depression up to 12 weeks following discharge from hospital~1 = Postpartum depression up to 12 weeks following discharge from hospital" (NCT02235064)
Timeframe: Discharge from hospital to 12 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 12 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 4 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 8 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 12 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 4 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 8 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 12 weeks postpartum
| Intervention | Grams (Mean) |
|---|---|
| Sertraline | 5301 |
| Placebo | 4734 |
(NCT02235064)
Timeframe: 4 weeks postpartum
| Intervention | Grams (Mean) |
|---|---|
| Sertraline | 3033 |
| Placebo | 2750 |
(NCT02235064)
Timeframe: 8 weeks postpartum
| Intervention | Grams (Mean) |
|---|---|
| Sertraline | 5301 |
| Placebo | 3685 |
Concentrations of GABA+, referenced to unsuppressed water and corrected for within-voxel CSF proportion, in dorsal anterior cingulate cortex measured via Proton Magnetic Resonance Spectroscopy (i.e., MEGA-PRESS). (NCT03220776)
Timeframe: Day 5 of each experimental condition
| Intervention | mmol/kg (Mean) |
|---|---|
| N-Acetylcysteine | 3.90 |
| Gabapentin | 3.93 |
| Placebo Oral Tablet | 3.73 |
Concentrations of Glx (i.e., glutamate + glutamine), referenced to unsuppressed water and corrected for within-voxel CSF proportion, in dorsal anterior cingulate cortex measured via Proton Magnetic Resonance Spectroscopy. (NCT03220776)
Timeframe: Day 5 of each experimental condition
| Intervention | mmol/kg (Mean) |
|---|---|
| N-Acetylcysteine | 21.59 |
| Gabapentin | 21.69 |
| Placebo Oral Tablet | 22.25 |
181 reviews available for carbamazepine and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Genetics and antiepileptic mood stabilizer treatment response in bipolar disorder: what do we know?
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; La | 2021 |
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; | 2022 |
[Effects of lithium, valproic acid, carbamazepine and antipsychotic agents on cognition in bipolar disorders-A systematic review].
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cognition; | 2023 |
Psychotropic drug use in perinatal women with bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Elimination Routes; Fe | 2020 |
Bipolar disorders.
Topics: Adolescent; Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; B | 2020 |
Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Bre | 2018 |
[Pharmacogenetics in psychiatry: state of the art].
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Asian People; ATP Bin | 2018 |
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.
Topics: Antidepressive Agents; Bipolar Disorder; Carbamazepine; Humans; Lithium Compounds; Narration; Pharma | 2018 |
Adverse outcomes during pregnancy and major congenital malformations in infants of patients with bipolar and schizoaffective disorders treated with antiepileptic drugs: A systematic review.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Female; Humans | 2019 |
Management of adverse effects of mood stabilizers.
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Disease Ma | 2015 |
Comparative efficacy and acceptability of combined antipsychotics and mood stabilizers versus individual drug classes for acute mania: Network meta-analysis.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Double-Blind | 2015 |
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Epigenesis, Genetic; Epigenomics; Humans; Lithium | 2018 |
Perinatal depression: treatment options and dilemmas.
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Case-Control Studies; Cyclohexan | 2008 |
[Mood stabilizers--past, present and future].
Topics: Affect; Antimanic Agents; Bipolar Disorder; Calcium; Carbamazepine; Depressive Disorder; gamma-Amino | 2008 |
Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Hospitalization; Humans; Lithium Compounds; Psych | 2009 |
Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
Topics: Acute Disease; Affect; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agent | 2008 |
Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
Topics: Animals; Anticonvulsants; Antidepressive Agents; Arachidonic Acid; Bipolar Disorder; Brain; Carbamaz | 2009 |
Frequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature.
Topics: Anticonvulsants; Austria; Bipolar Disorder; Carbamazepine; Combined Modality Therapy; Electroconvuls | 2009 |
Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.
Topics: Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Cy | 2011 |
Mood stabilizers in pregnancy: a systematic review.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepin | 2010 |
Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders.
Topics: Amygdala; Animals; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug Resistance; Drug Tolerance | 2011 |
Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivi | 2011 |
[Therapeutic evidence for manic episode].
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; | 2011 |
Oxcarbazepine for acute affective episodes in bipolar disorder.
Topics: Acute Disease; Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Child; Humans; | 2011 |
[Mood stabilizers].
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Humans; Lamotrigine; Lithium; Triazines; Valproic | 2012 |
[Mood stabilizer].
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Humans; Lamotrigine; Lithium Compounds; Triazines | 2012 |
Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Administration Schedule; | 2002 |
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.
Topics: Antidepressive Agents; Antimanic Agents; Biological Psychiatry; Bipolar Disorder; Carbamazepine; Ele | 2002 |
Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Humans; Liver; Oxcarbazepine; Tissue Distribution | 2002 |
New approaches in managing bipolar depression.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Clini | 2003 |
Antidepressant properties of anticonvulsant drugs for bipolar disorder.
Topics: Acetates; Affect; Amines; Anticonvulsants; Antidepressive Agents; Bipolar Disorder; Carbamazepine; C | 2003 |
Treating bipolar depression.
Topics: Acetates; Affect; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; | 2003 |
Long-term therapy of bipolar illness.
Topics: Affect; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Co | 2003 |
Drug interactions of lithium and other antimanic/mood-stabilizing medications.
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; Humans; Lithi | 2003 |
[Oxcarbazepine in the treatment of affective and schizoaffective disorders].
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Human | 2003 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar | 2003 |
[Mood disorder in childhood and adolescence].
Topics: Bipolar Disorder; Carbamazepine; Depressive Disorder, Major; Diagnostic and Statistical Manual of Me | 2003 |
Concepts in the treatment of bipolar disorder.
Topics: Affect; Antimanic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Controlled Clin | 2003 |
Oxcarbazepine: clinical experience with hospitalized psychiatric patients.
Topics: Age Factors; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Fo | 2003 |
[Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
Topics: Acute Disease; Algorithms; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiaze | 2003 |
[Organic manic disorder].
Topics: Bipolar Disorder; Brain Diseases; Carbamazepine; Clonazepam; Diagnostic and Statistical Manual of Me | 2003 |
[Organic bipolar disorder].
Topics: Bipolar Disorder; Brain Diseases; Carbamazepine; Humans; International Classification of Diseases; L | 2003 |
[Organic mixed affective disorder].
Topics: Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Cerebral Infarction; Femal | 2003 |
Management of bipolar disorder during pregnancy and the postpartum period.
Topics: Adolescent; Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbam | 2004 |
Newer anticonvulsants in the treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Dep | 2004 |
Bipolar disorder.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Fema | 2004 |
Bipolar disorder.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Fema | 2004 |
Bipolar disorder.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Fema | 2004 |
Bipolar disorder.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Fema | 2004 |
Rethinking the treatment paradigm for bipolar depression: the importance of long-term management.
Topics: Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Ch | 2004 |
A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
Topics: Acute Disease; Anticonvulsants; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic | 2004 |
[Treatment standard for bipolar disorders].
Topics: Algorithms; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine | 2004 |
Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Hospital | 2005 |
Latest therapies for bipolar disorder. Looking beyond lithium.
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Thera | 2005 |
Treatment of mania in children and adolescents.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Child; Humans; | 2005 |
[Pharmacotherapeutic trends at the beginning of the millennium in Hungary: pharmacotherapy of bipolar patients. Part II].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder | 2004 |
Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder.
Topics: Acute Disease; Amines; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Cyclohexa | 2005 |
Antiepileptic drugs in mood-disordered patients.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Depressive Disorder; Humans; Lamotrigine; Treatmen | 2005 |
Anticonvulsant drug therapies.
Topics: Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Depressive Di | 2005 |
Extended-release carbamazepine capsules : in bipolar I disorder.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Delayed-Action Preparations; Humans | 2005 |
Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder.
Topics: Analgesics, Non-Narcotic; Animals; Bipolar Disorder; Carbamazepine; Chemistry, Pharmaceutical; Drug | 2005 |
Management options for bipolar disorder in children and adolescents.
Topics: Adolescent; Benzodiazepines; Bipolar Disorder; Carbamazepine; Child; Clozapine; Dibenzothiazepines; | 2005 |
Clinical use of carbamazepine for bipolar disorders.
Topics: Bipolar Disorder; Carbamazepine; Humans; Randomized Controlled Trials as Topic | 2005 |
Anticonvulsants in the treatment of bipolar mania.
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Humans; Oxcarbazepine; Randomize | 2006 |
Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Bipolar Disorder; Body Weight; Capsules; Carbamazepine; Ca | 2006 |
Anticonvulsants in bipolar disorder.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Humans; Lamotrigine; Triazines; Valproic Acid | 2006 |
New antiepileptic drugs that are second generation to existing antiepileptic drugs.
Topics: Amines; Animals; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Drug | 2006 |
Practical considerations for carbamazepine use in bipolar disorder.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Delayed-Action Preparat | 2006 |
Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Humans; Valproic Acid | 2006 |
Extended-release carbamazepine for acute bipolar mania: a review.
Topics: Acute Disease; Animals; Antimanic Agents; Bipolar Disorder; Carbamazepine; Delayed-Action Preparatio | 2006 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; D | 2006 |
Oxcarbazepine in the treatment of bipolar disorder: a review.
Topics: Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Double-Blind Method; Guidelines as Topic; Hum | 2006 |
Maintenance treatment of bipolar disorder: Applying research to clinical practice.
Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepin | 2006 |
Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Evaluation; Humans; Practice Guidelines as T | 2007 |
Historical review of carbamazepine for the treatment of bipolar disorder.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Delayed-Acti | 2007 |
[Anticonvulsants treatment of psychiatric disorder in elderly patients].
Topics: Aged; Anticonvulsants; Anxiety Disorders; Bipolar Disorder; Carbamazepine; Epilepsy; Humans; Mental | 2006 |
Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia.
Topics: Aged; Aged, 80 and over; Amines; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; | 2007 |
Oxcarbazepine in bipolar disorder: a critical review of the literature.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Humans; Oxcarbazepine; P | 2007 |
The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.
Topics: Affective Symptoms; Animals; Antimanic Agents; Bipolar Disorder; Carbamazepine; Depressive Disorder; | 2007 |
Antiepileptic drugs and mood stability.
Topics: Affect; Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Humans; Lamotrig | 2007 |
Oxcarbazepine in the treatment of bipolar and schizoaffective disorders.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Dose-Response Relationsh | 2007 |
[Anticonvulsants in the treatment of bipolar disorder].
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Drug T | 2007 |
Pharmacotherapeutic strategies for pediatric bipolar disorder.
Topics: Adolescent; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine | 2007 |
[Bipolar disorders: the disease of extreme emotions].
Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antimanic Age | 2007 |
Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials.
Topics: Affect; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Brief Psychiatric Rating Scale; Ca | 2007 |
A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disor | 2007 |
Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.
Topics: Adult; Aged; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as | 2008 |
Oxcarbazepine in the maintenance treatment of bipolar disorder.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Humans; Lithium Compounds; Oxcarbazepine; Randomi | 2008 |
Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?
Topics: Antimanic Agents; Arachidonic Acid; Bipolar Disorder; Brain; Carbamazepine; Humans; Lithium; Valproi | 2008 |
ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Breast Feed | 2008 |
Use of the anticonvulsant carbamazepine in primary and secondary affective illness: clinical and theoretical implications.
Topics: Affective Disorders, Psychotic; Animals; Antidepressive Agents; Antipsychotic Agents; Bipolar Disord | 1982 |
Approaches to the evaluation and treatment of rapid-cycling affective illness.
Topics: Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Clorgyline; Female; Humans; Lithium; Male; Pe | 1984 |
Treatment of mood disorders with antiepileptic medications: clinical and theoretical implications.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Clonazepam; Depressive D | 1983 |
Kindling and carbamazepine in affective illness.
Topics: Affective Disorders, Psychotic; Amphetamine; Amygdala; Animals; Bipolar Disorder; Carbamazepine; Coc | 1982 |
Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Topics: Adolescent; Alprazolam; Anticonvulsants; Antipsychotic Agents; Anxiety, Separation; Bipolar Disorder | 1995 |
An update on the diagnosis and treatment of mania in bipolar disorder.
Topics: Bipolar Disorder; Carbamazepine; Diagnosis, Differential; Humans; Lithium; Psychotherapy; Valproic A | 1995 |
Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis.
Topics: Bipolar Disorder; Carbamazepine; Double-Blind Method; Humans; Lithium Carbonate; Randomized Controll | 1995 |
Treatment of bipolar depression.
Topics: Antidepressive Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Lithium; | 1995 |
Treatment of mania in the medically ill.
Topics: Bipolar Disorder; Carbamazepine; Comorbidity; Humans; Lithium; Metabolic Clearance Rate; Neurocognit | 1994 |
Lithium- and carbamazepine-associated sinus node dysfunction: nine-year experience in a psychiatric hospital.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Synergism; Drug | 1994 |
A medication algorithm for treatment of bipolar rapid cycling?
Topics: Algorithms; Bipolar Disorder; Carbamazepine; Clozapine; Controlled Clinical Trials as Topic; Drug Ad | 1995 |
The relationship between substance abuse and bipolar disorder.
Topics: Alcoholism; Bipolar Disorder; Carbamazepine; Comorbidity; Diagnosis, Dual (Psychiatry); Hospitalizat | 1995 |
Predictors of response to divalproex and lithium.
Topics: Bipolar Disorder; Carbamazepine; Comorbidity; Drug Administration Schedule; Drug Therapy, Combinatio | 1995 |
Treatment approaches for acute mania.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dyskinesia, Drug-Induced; Fe | 1993 |
Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association.
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; C | 1994 |
Management of mania in the elderly: an update.
Topics: Acute Disease; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamaze | 1993 |
[Drug combinations of lithium: reasons and limitations].
Topics: Antidepressive Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; L | 1993 |
The rationale for long-term antidepressant therapy.
Topics: Antidepressive Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Depressive Disorde | 1993 |
The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.
Topics: Bipolar Disorder; Carbamazepine; Humans; Lithium Carbonate; Prognosis; Valproic Acid | 1993 |
Pharmacological issues in the treatment of bipolar disorder: focus on mood-stabilizing compounds.
Topics: Anticonvulsants; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; Female; | 1993 |
Lithium therapy: limitations and alternatives in the treatment of bipolar disorders.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Humans; Lithium; Patient Compliance; Tranquilizing | 1995 |
Outcome in the pharmacologic treatment of bipolar disorder.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Follow-Up Studies; Huma | 1996 |
Predictors of response to mood stabilizers.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Comorbidity; Humans; Li | 1996 |
Bipolar mood disorder: practical strategies for acute and maintenance phase treatment.
Topics: Acute Disease; Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Clinical T | 1996 |
Role of newer medications for bipolar disorder.
Topics: Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; | 1996 |
The diagnosis and treatment of mania in the elderly.
Topics: Age of Onset; Aged; Anticonvulsants; Bipolar Disorder; Carbamazepine; Diagnosis, Differential; Dose- | 1996 |
Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis.
Topics: Bipolar Disorder; Carbamazepine; Humans; Lithium; Valproic Acid | 1996 |
A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures.
Topics: Affect; Amygdala; Animals; Anticonvulsants; Bipolar Disorder; Carbamazepine; Disease Progression; Dr | 1996 |
The place of anticonvulsant therapy in bipolar illness.
Topics: Affect; Anticonvulsants; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clonazepam; Drug | 1996 |
Dosing strategies and time course of response to antimanic drugs.
Topics: Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Adminis | 1996 |
Health-economic implications of the onset of action of antimanic agents.
Topics: Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Administration Schedule; Dru | 1996 |
Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy.
Topics: Adenylyl Cyclases; Animals; Bipolar Disorder; Carbamazepine; Cell Line; Glioma; GTP-Binding Proteins | 1996 |
Polypharmacy in bipolar I disorder.
Topics: Bipolar Disorder; Carbamazepine; Humans; Lithium; Valproic Acid | 1996 |
Additive effects, but no synergistic interaction of stressful life-events and genetic loading in affective disorders.
Topics: Age of Onset; Aged; Antimanic Agents; Bipolar Disorder; Carbamazepine; Depressive Disorder; Female; | 1996 |
Rational polypharmacy in the bipolar affective disorders.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Calcium Channel Bloc | 1996 |
Algorithms for bipolar mania.
Topics: Algorithms; Anti-Anxiety Agents; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiaze | 1997 |
Drug treatment of mania: a critical review.
Topics: Anti-Anxiety Agents; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipol | 1998 |
Special considerations: use of lithium in children, adolescents, and elderly populations.
Topics: Abnormalities, Drug-Induced; Acetates; Adolescent; Adult; Age Factors; Aged; Amines; Anticonvulsants | 1998 |
Anticonvulsants and antipsychotics in the treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Clinical T | 1998 |
Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Topics: Bipolar Disorder; Calcium-Calmodulin-Dependent Protein Kinases; Carbamazepine; Gene Expression; Glyc | 1999 |
Anticonvulsant therapy and suicide risk in affective disorders.
Topics: Amitriptyline; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Female; Follow | 1999 |
Case study: carbamazepine treatment of juvenile-onset bipolar disorder.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Carbamazepine; Child; Female; Genetic Predisposition | 1999 |
Management of acute mania.
Topics: Acute Disease; Algorithms; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; | 1999 |
Mood-stabilizing drugs in depression.
Topics: Acute Disease; Anticonvulsants; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Diso | 1999 |
Tardive dyskinesia in affective disorders.
Topics: Adult; Affective Disorders, Psychotic; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipol | 1999 |
Bipolar disorder in old age.
Topics: Acute Disease; Adult; Age Factors; Aged; AIDS Dementia Complex; Antidepressive Agents; Antimanic Age | 1999 |
Treatment of aggression in patients with bipolar disorder.
Topics: Aggression; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Combined Modality Therapy; Drug T | 1999 |
Rapid cycling bipolar affective disorder in people with intellectual disability: a systematic review.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Down Syndrome; Humans; Intellectual Disability; L | 1999 |
Algorithms for the pharmacotherapy of bipolar disorder.
Topics: Acute Disease; Algorithms; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combinat | 1999 |
Algorithm for the treatment of rapid cycling.
Topics: Algorithms; Antimanic Agents; Bipolar Disorder; Carbamazepine; Clonazepam; Cyclothymic Disorder; Dru | 1999 |
The place of anticonvulsants and other putative mood stabilisers in the treatment of bipolar disorder.
Topics: Affect; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Hu | 1999 |
Mood stabilizers in the treatment of juvenile bipolar disorder. Advances and controversies.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Carbamazepine; Child; Clinical Trials as Topic; Drug | 2000 |
[Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
Topics: Adult; Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Dose-Response | 2000 |
Mood stabilizers during breastfeeding: a review.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Breast Feeding; Carbamazepine; Cyclohexanecarbo | 2000 |
The psychopharmacologic specificity of the lithium ion: origins and trajectory.
Topics: Anticonvulsants; Australia; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; History, 20t | 2000 |
Management of bipolar disorder.
Topics: Adolescent; Adult; Age Distribution; Antimanic Agents; Bipolar Disorder; Carbamazepine; Child, Presc | 2000 |
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamaz | 2000 |
The high affinity inositol transport system--implications for the pathophysiology and treatment of bipolar disorder.
Topics: Antimanic Agents; Biological Transport, Active; Bipolar Disorder; Carbamazepine; Carrier Proteins; D | 2000 |
The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Lithium Compou | 2000 |
Novel treatments for bipolar disorder.
Topics: Acetates; Amines; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Therapy, Combin | 2001 |
Special issues in the treatment of paediatric bipolar disorder.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Child; Humans; Lithium; Valp | 2001 |
Diagnostic and therapeutic dilemmas in the management of pediatric-onset bipolar disorder.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Anticonvulsants; Antipsychotic Agents; Attention Defic | 2001 |
Cognitive side effects of anticonvulsants.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cognition Disorders; Cyclohexane | 2001 |
Rapid cycling bipolar disease: new concepts and treatments.
Topics: Anticonvulsants; Bipolar Disorder; Calcium; Calcium Channel Blockers; Carbamazepine; Combined Modali | 2001 |
Developments in mood stabilisers.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Elect | 2001 |
Bipolar disorder.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Lithium Compounds; S | 2002 |
Current research on rapid cycling bipolar disorder and its treatment.
Topics: Acute Disease; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Drug | 2001 |
Clinical correlates of therapeutic response in bipolar disorder.
Topics: Affect; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combi | 2001 |
Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature.
Topics: Affect; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Clinical Trial | 2002 |
Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies.
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Brain; Carbamazepine; gamma-Aminobutyric Acid; | 2002 |
The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
Topics: Acetates; Acute Disease; Amines; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; | 2001 |
Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; gamma-Aminobutyric Acid; Gene Expression Regulatio | 2002 |
Perspectives in the treatment of the psychoneurological disorders: affective disorders.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Mood Disorders; Peptide Frag | 1979 |
Anticonvulsants in the treatment of bipolar disorder.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Clonazepam; Drug Therapy, Combination; Electroconv | 1992 |
Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature.
Topics: Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Hum | 1992 |
Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Humans; Lithium Carbonate; Valproic Acid | 1992 |
Recent advances in treatment of acute mania.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Ca | 1991 |
Treatment of bipolar disorder.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Humans; Lithium; Valproic Acid | 1991 |
Antiepileptic drugs in affective illness. Clinical and theoretical implications.
Topics: Acute Disease; Anticonvulsants; Benzodiazepines; Bipolar Disorder; Carbamazepine; Depression; Drug T | 1991 |
[Carbamazepine in the treatment of mania and prevention of recurrence of manic-depressive disorders].
Topics: Bipolar Disorder; Carbamazepine; Humans; Recurrence | 1991 |
Alternative prophylactic treatments to lithium in bipolar disorders.
Topics: Alprazolam; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clonazepam; Humans; Lithium; | 1990 |
Non-lithium treatment for bipolar disorder.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Clonazepam; Drug Therapy | 1990 |
[Tegretol in psychiatry].
Topics: Bipolar Disorder; Carbamazepine; Humans; Psychotic Disorders | 1990 |
Emerging perspectives on valproate in affective disorders.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Lithium; Lithium Carbonat | 1989 |
Phenomenology of rapid cycling manic depression and its treatment with valproate.
Topics: Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans | 1989 |
Alternatives to lithium for preventive treatment of bipolar disorder.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Human | 1989 |
[Secondary mania. Diagnostic problems (apropos of a case of secondary mania in partial complex epilepsy crisis)].
Topics: Bipolar Disorder; Carbamazepine; Cerebral Cortex; Epilepsy, Temporal Lobe; Female; Humans; Middle Ag | 1989 |
Drug treatment of bipolar depression and mania.
Topics: Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Bromocriptine; Carbamazepine; Choline | 1985 |
Pharmacologic treatment of agitation associated with dementia.
Topics: Affective Symptoms; Aged; Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antipsychotic Agents; | 1986 |
Approaches to the treatment of lithium-resistant mania.
Topics: Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Combined Modality Therapy; Electroconvulsive | 1988 |
The use of anticonvulsants in manic-depressive illness.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Humans; Lithium | 1988 |
Time course of clinical effects of carbamazepine: implications for mechanisms of action.
Topics: Affect; Bipolar Disorder; Carbamazepine; Depressive Disorder; Humans; Sleep; Time Factors | 1988 |
Carbamazepine in treatment and prophylaxis of manic-depressive disorder.
Topics: Adult; Bipolar Disorder; Carbamazepine; Double-Blind Method; Female; Humans; Lithium; Middle Aged; T | 1985 |
Alternative therapies for bipolar disorder.
Topics: Ascorbic Acid; Bipolar Disorder; Bupropion; Carbamazepine; Choline; Clonazepam; Clonidine; Clorgylin | 1985 |
124 trials available for carbamazepine and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Brazil; Carbamazepine; Drug Therapy, Combinat | 2019 |
Bipolar Disorder Mixed Episodes: A Pragmatic Trial of a Public Health Treatment Effectiveness.
Topics: Adult; Algorithms; Antimanic Agents; Bipolar Disorder; Brazil; Carbamazepine; Female; Humans; Lithiu | 2018 |
Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Female; Follow-Up Studies; Humans; Lithium | 2016 |
Evaluating response to mood stabilizers in patients with mixed depression: A study of agreement between three different mania rating scales and a depression rating scale.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Depressive Disorder; Diagnostic and Statis | 2016 |
Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Depression; Double-Blind Method; Drug Resi | 2009 |
Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study.
Topics: Acute Disease; Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Double-Bli | 2009 |
Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study.
Topics: Adult; Affect; Antimanic Agents; Bipolar Disorder; Capsules; Carbamazepine; Chemistry, Pharmaceutica | 2009 |
[Comparative efficacy and tolerability of carbamazepine and oxcarbazepine during long therapy of patients with bipolar and schizoaffective disorders].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Dose-Re | 2009 |
A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.
Topics: Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Body Weight; Carb | 2010 |
A blinded, randomized comparison of immediate-release and extended-release carbamazepine capsules in manic and depressed bipolar subjects.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Capsules; Carbamazepine; Delayed-Action Preparations; Dou | 2010 |
LICAVAL: combination therapy in acute and maintenance treatment of bipolar disorder.
Topics: Acute Disease; Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Cognition; Drug | 2010 |
Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Topics: Adult; Affect; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazep | 2012 |
The influence of successful prophylactic drug treatment on cognitive dysfunction in bipolar disorders.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Cognition Disorders; Depressive Disord | 2002 |
Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Che | 2002 |
Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cross-Over Studies; Dose-Response Relations | 2002 |
Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Female; Humans; Lithiu | 2003 |
Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Disease Progression; Drug Administration S | 2003 |
Combination pharmacotherapy in children and adolescents with bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorde | 2003 |
Risperidone in acute and continuation treatment of mania.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Administration | 2003 |
Adjunctive topiramate in bipolar II disorder.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Resistance; Drug The | 2003 |
Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination | 2004 |
A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
Topics: Acute Disease; Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Delayed-Action Preparations | 2004 |
A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Capsules; Carbamazepine; Delayed-Action Preparations; Dou | 2004 |
Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder?
Topics: Adult; Age Factors; Anticonvulsants; Attitude to Health; Bipolar Disorder; Carbamazepine; Female; Hu | 2004 |
A prospective 4-5 year follow-up of juvenile onset bipolar disorder.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazep | 2004 |
Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Body Mass Index; Body Weight; Carbamazepine; Female; Huma | 2005 |
Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Hospital | 2005 |
Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adult; Antimanic Agents; Ataxia; Bipolar Disorder; Carbamazepine; Delayed-Action Prep | 2005 |
Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Costs; Drug Therapy, | 2005 |
An open-label trial of adjunctive oxcarbazepine for bipolar disorder.
Topics: Anticonvulsants; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Ther | 2006 |
Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cognition; Female; Humans; Lamotrigine; Mal | 2006 |
A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
Topics: Adolescent; Age Factors; Ambulatory Care; Anticonvulsants; Bipolar Disorder; Carbamazepine; Child; D | 2006 |
The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Depressive Disorder, Majo | 2007 |
Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Dose-Response Relationshi | 2007 |
Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
Topics: Adult; Affect; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Com | 2007 |
The Bipolar Comprehensive Outcomes Study (BCOS): baseline findings of an Australian cohort study.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Bipolar Disorder; Ca | 2008 |
Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; | 2008 |
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combina | 2008 |
Switching from other agents to extended-release carbamazepine in acute mania.
Topics: Acute Disease; Adult; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Delayed-Ac | 2008 |
Use of the anticonvulsant carbamazepine in primary and secondary affective illness: clinical and theoretical implications.
Topics: Affective Disorders, Psychotic; Animals; Antidepressive Agents; Antipsychotic Agents; Bipolar Disord | 1982 |
Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness.
Topics: Bipolar Disorder; Brain; Carbamazepine; Clinical Trials as Topic; Depressive Disorder; Double-Blind | 1983 |
Prophylactic efficacy of carbamazepine in manic-depressive illness.
Topics: Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method | 1983 |
Therapeutic and prophylactic effects of carbamazepine in bipolar disorders.
Topics: Adult; Bipolar Disorder; Carbamazepine; Chlorpromazine; Clinical Trials as Topic; Double-Blind Metho | 1983 |
Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Th | 1984 |
[Antidepressive therapy with carbamazepine (Finlepsin)].
Topics: Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; | 1983 |
Profile of clinical efficacy and side effect of carbamazepine in psychiatric illness: relationship to blood and CSF levels of carbamazepine and its -10,11-epoxide metabolite.
Topics: Biotransformation; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Depressive Disorder; D | 1984 |
The efficacy of carbamazepine in affective illness.
Topics: Antidepressive Agents; Bipolar Disorder; Carbamazepine; Central Nervous System; Clinical Trials as T | 1984 |
Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report.
Topics: Adolescent; Adult; Analgesics; Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as | 1983 |
Treatment of mood disorders with antiepileptic medications: clinical and theoretical implications.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Clonazepam; Depressive D | 1983 |
Selective response to the anticonvulsant carbamazepine in manic-depressive illness: a case study.
Topics: Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Female; Humans; Lithium; Middle A | 1984 |
Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation.
Topics: Arginine Vasopressin; Bipolar Disorder; Blood; Carbamazepine; Diuresis; Humans; Osmolar Concentratio | 1983 |
A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness.
Topics: Adolescent; Adult; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Evaluation; Humans; Mi | 1981 |
Clorgyline. A new treatment for patients with refractory rapid-cycling disorder.
Topics: Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Clorgyline; Double-Blind Method; D | 1982 |
Carbamazepine in manic-depressive illness: a new treatment.
Topics: Adult; Bipolar Disorder; Carbamazepine; Female; Humans; Lithium; Male; Middle Aged; Psychiatric Stat | 1980 |
Lithium combined with carbamazepine or haloperidol in the treatment of mania.
Topics: Adult; Aged; Bipolar Disorder; Brief Psychiatric Rating Scale; Carbamazepine; Drug Combinations; Fem | 1995 |
Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
Topics: Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder; Double-Blind Method; Drug Administratio | 1995 |
Rash complicating carbamazepine treatment.
Topics: Adult; Anxiety Disorders; Bipolar Disorder; Carbamazepine; Depressive Disorder; Double-Blind Method; | 1994 |
The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Delayed-Action Preparations; Depressive Di | 1993 |
The recruitment process for a multicenter study on the long-term prophylactic treatment of affective disorders.
Topics: Adult; Affective Disorders, Psychotic; Amitriptyline; Bipolar Disorder; Carbamazepine; Depressive Di | 1993 |
The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
Topics: Adult; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination | 1996 |
Risperidone in the treatment of mania.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Confidence Intervals; D | 1996 |
Carbamazepine but not valproate induces bupropion metabolism.
Topics: Adult; Antidepressive Agents; Biotransformation; Bipolar Disorder; Bupropion; Carbamazepine; Cytochr | 1995 |
Personality differences between patients with major depression and bipolar disorder--the impact of minor symptoms on self-ratings of personality.
Topics: Adult; Aged; Amitriptyline; Bipolar Disorder; Carbamazepine; Defense Mechanisms; Depressive Disorder | 1997 |
Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Female; Humans; Lithium Carbonate; Ma | 1997 |
Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder.
Topics: Adult; Aged; Ambulatory Care; Bipolar Disorder; Carbamazepine; Drug Resistance; Drug Therapy, Combin | 1997 |
Psychosensory symptoms in bipolar disorder.
Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Cross-Over Stu | 1997 |
Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.
Topics: Adult; Aged; Ambulatory Care; Bipolar Disorder; Carbamazepine; Cross-Over Studies; Depressive Disord | 1997 |
Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Breast Feeding; Carbamazepine; Depression, Postpartum; Fem | 1998 |
Bipolar depression and antidepressant-induced mania: a naturalistic study.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; C | 1998 |
Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Depressive Disor | 1998 |
Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Carbamazepine; Chemoprevention; Female; | 1998 |
Anticonvulsant therapy and suicide risk in affective disorders.
Topics: Amitriptyline; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Female; Follow | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder.
Topics: Adrenergic Uptake Inhibitors; Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Tricycl | 1999 |
The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; Enzyme Induction; Femal | 1999 |
Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Female; Humans; Lithium Carbonate; Male; P | 1999 |
A history of substance abuse complicates remission from acute mania in bipolar disorder.
Topics: Acute Disease; Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Comorb | 1999 |
Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients.
Topics: Affect; Bipolar Disorder; Carbamazepine; Comorbidity; Double-Blind Method; Drug Therapy, Combination | 1999 |
Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
Topics: Acute Disease; Adolescent; Age Factors; Antimanic Agents; Bipolar Disorder; Carbamazepine; Child; Do | 2000 |
Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antimanic Agents; Bipolar Disorder; Carbamazepine; Ch | 2000 |
Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Female; Humans; Lithium; Male; Middle Aged | 2000 |
Inositol as an add-on treatment for bipolar depression.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Blood-Brain Barrier; Carbamazepine; Drug | 2000 |
Topiramate as add-on treatment for patients with bipolar mania.
Topics: Acetates; Adult; Aged; Amines; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Body Mass Index; | 1999 |
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.
Topics: Adult; Aged; Ambulatory Care; Anticonvulsants; Antidepressive Agents, Tricyclic; Bipolar Disorder; C | 2001 |
Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men.
Topics: Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder, Major; Dexamethasone; Female; Humans; H | 2001 |
Utility of the daily prospective National Institute of Mental Health Life-Chart Method (NIMH-LCM-p) ratings in clinical trials of bipolar disorder.
Topics: Adult; Aged; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Cross-Over Studies; | 2002 |
The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
Topics: Acetates; Acute Disease; Amines; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; | 2001 |
Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Female; Humans; Lithium Carbonate; Long-Te | 2002 |
Oxcarbazepine treatment of refractory bipolar disorder: a retrospective chart review.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Female; Humans; Male; Middle Aged; Oxcarbaz | 2002 |
Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Chlorpromazine; Clinical Trials as Topic; | 1979 |
Therapeutic effects of carbamazepine in affective illness: a preliminary report.
Topics: Adult; Affective Symptoms; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Depression; Do | 1978 |
Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature.
Topics: Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Hum | 1992 |
Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Double-Blind Method; Electrocardiography; Female; Huma | 1992 |
Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Longitud | 1991 |
Carbamazepine, lithium, and life course of bipolar affective disorder.
Topics: Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Lithium | 1991 |
Carbamazepine compared with lithium in the treatment of mania.
Topics: Acute Disease; Adult; Age Factors; Aged; Bipolar Disorder; Carbamazepine; Double-Blind Method; Educa | 1991 |
Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Double-Blind Method; | 1990 |
Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Depressive | 1990 |
Non-lithium treatment for bipolar disorder.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Clonazepam; Drug Therapy | 1990 |
Carbamazepine prophylaxis in refractory affective disorders: a focus on long-term follow-up.
Topics: Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder; Drug Therapy, Combination; Female; Foll | 1990 |
Carbamazepine in the prophylaxis of mood disorders.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Depressive Disorder; Female; Follow-Up Studies; Humans | 1990 |
Phenomenology of rapid cycling manic depression and its treatment with valproate.
Topics: Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans | 1989 |
Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania.
Topics: Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, | 1989 |
Rapid cycling affective disorders in the mentally retarded.
Topics: Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Drug Therapy, Combination; Female; | 1989 |
Carbamazepine in bipolar affective disorder.
Topics: Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Drug Therapy, Combi | 1989 |
Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.
Topics: Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, | 1989 |
Manic-like state after bilateral orbitofrontal and right temporoparietal injury: efficacy of clonidine.
Topics: Adult; Behavior; Bipolar Disorder; Brain; Carbamazepine; Clonidine; Cognition; Female; Frontal Lobe; | 1989 |
Carbamazepine compared to haloperidol in acute mania.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Chlor | 1989 |
Effects of carbamazepine on cerebrospinal fluid somatostatin.
Topics: Adrenocorticotropic Hormone; Bipolar Disorder; Carbamazepine; Depressive Disorder; gamma-Aminobutyri | 1985 |
Correlates of antimanic response to carbamazepine.
Topics: Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Dose-Response Relat | 1987 |
The use of benzodiazepines in the treatment of manic-depressive illness.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ga | 1988 |
Psychobiologic aspects of the treatment of primary mania.
Topics: Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Drug T | 1988 |
The use of anticonvulsants in manic-depressive illness.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Humans; Lithium | 1988 |
Carbamazepine vs lithium in the treatment and prophylaxis of mania.
Topics: Adolescent; Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; F | 1988 |
[Carbamazepine therapy of manic depressive psychosis and schizo-affective psychosis].
Topics: Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Humans; Schizophrenia | 1987 |
Antidepressant effects of carbamazepine.
Topics: Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Depressive Disorder; Double-Blind | 1986 |
Carbamazepine for treatment-resistant depressions?
Topics: Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Depressive Disorder; Humans | 1986 |
Sedative or antimanic effects of carbamazepine and treatment of behavioral dyscontrol.
Topics: Adult; Bipolar Disorder; Borderline Personality Disorder; Carbamazepine; Clinical Trials as Topic; F | 1986 |
Carbamazepine versus lithium in mania: a double-blind study.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Female; | 1987 |
[Carbamazepine in manic syndromes. A controlled double-blind study].
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Th | 1985 |
Carbamazepine in bipolar illness.
Topics: Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; | 1985 |
Carbamazepine and lithium: different profiles in affective disorder?
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Do | 1985 |
An open clinical trial of carbamazepine in treatment-resistant bipolar and schizo-affective psychotics.
Topics: Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; | 1985 |
Are the psychotropic effects of carbamazepine in manic-depressive illness mediated through the limbic system?
Topics: Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Electroencephalograp | 1985 |
392 other studies available for carbamazepine and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Neurologic toxicity of carbamazepine in treatment of trigeminal neuralgia.
Topics: Adult; Bipolar Disorder; Carbamazepine; Epilepsy; Female; Humans; Neuralgia; Trigeminal Neuralgia | 2022 |
Prescribing changes for bipolar patients discharged from two public psychiatric hospitals in Taiwan, 2006-2019.
Topics: Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bip | 2022 |
Analysis of adverse drug events in patients with bipolar disorders using the Japanese Adverse Drug Event Report database.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug | 2022 |
[Carbamazepine and quetiapine: a neglected, but highly relevant interaction].
Topics: Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Psychotropic Drugs; Quetiapine Fumara | 2020 |
Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug-Related Side Effects | 2020 |
A Change in Blood Carbamazepine Levels Associated With Cannabis Use: Implications for Clinical Practice.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Cannabinoid Receptor Modulators; Carbamazepine; Drug Inte | 2021 |
Carbamazepine-induced delayed-onset agranulocytosis in a case of bipolar disorder with Kikuchi's disease.
Topics: Agranulocytosis; Bipolar Disorder; Carbamazepine; Histiocytic Necrotizing Lymphadenitis; Humans; Lym | 2021 |
Lithium toxicity and prolonged delirium.
Topics: Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Delirium; Depression; Dose | 2017 |
Treatment of Comorbid Bipolar Disorder Improves Disabilities and Neuropsychological Functioning in DiGeorge Syndrome: A Case Report.
Topics: Adult; Anti-Infective Agents; Bipolar Disorder; Carbamazepine; Cognitive Dysfunction; Comorbidity; D | 2017 |
Associations between use of mood stabilizers and risk of cataract: A population-based nested case-control study.
Topics: Adult; Aged; Antimanic Agents; Bipolar Disorder; Carbamazepine; Case-Control Studies; Cataract; Data | 2018 |
Severe recurrent hypothermia in an elderly patient with refractory mania associated with atypical antipsychotic, valproic acid and oxcarbazepine therapy.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combinat | 2017 |
Mood-Stabilizing Anticonvulsants, Spina Bifida, and Folate Supplementation: Commentary.
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Dietary Supplements; Female; Fol | 2018 |
How long does the pharmacokinetic interaction between carbamazepine and quetiapine last after carbamazepine withdrawal?
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; F | 2017 |
Regulation of Glycogen Content in Astrocytes via Cav-1/PTEN/AKT/GSK-3β Pathway by Three Anti-bipolar Drugs.
Topics: Animals; Animals, Newborn; Antimanic Agents; Astrocytes; Bipolar Disorder; Carbamazepine; Caveolin 1 | 2018 |
Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test.
Topics: Aggression; Agonistic Behavior; Animals; Anxiety; Bipolar Disorder; Carbamazepine; Cycloheptanes; De | 2019 |
Mood stabilisers and risk of stroke in bipolar disorder.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Cross-O | 2019 |
Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Prescriptions; Drug Therapy, Combinat | 2018 |
Interactome Analyses implicated CAMK2A in the genetic predisposition and pharmacological mechanism of Bipolar Disorder.
Topics: Animals; Bipolar Disorder; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Carbamazepine; Cells, | 2019 |
Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
Topics: Adolescent; Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar | 2013 |
Effects of lithium and carbamazepine on spatial learning and depressive behavior in a rat model of bipolar disorder induced by ouabain.
Topics: Animals; Bipolar Disorder; Carbamazepine; Depression; Disease Models, Animal; Learning; Lithium; Mal | 2013 |
The antimanic-like effect of phenytoin and carbamazepine on methylphenidate-induced hyperlocomotion: role of voltage-gated sodium channels.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Carbamazepine; Disease Models, Animal; Dose-Response Re | 2013 |
Mania after termination of epilepsy treatment: a case report.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Monitoring; | 2013 |
The use of three-dimensional similarity in assessing the risk of cross-reactivity between carbamazepine and psychotropic drugs.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug Interactions; Humans; Neuralgia; Psychotropic | 2014 |
International prescribing patterns for mood illness: the International Mood Network (IMN).
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Asia; Bipolar Disorder; Carbamazepine | 2014 |
The effects of carbamazepine on prefrontal activation in manic youth with bipolar disorder.
Topics: Adolescent; Antimanic Agents; Attention; Bipolar Disorder; Carbamazepine; Cerebral Cortex; Female; H | 2014 |
Chronic oral carbamazepine treatment elicits mood-stabilising effects in mice.
Topics: Administration, Oral; Affect; Animals; Bipolar Disorder; Carbamazepine; Depression; Disease Models, | 2014 |
Predominant polarity in bipolar disorder and validation of the polarity index in a German sample.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents; Antipsychotic Agents; Bipolar | 2014 |
Evaluation of the potential for pharmacokinetic drug-drug interaction between armodafinil and carbamazepine in healthy adults.
Topics: Adult; Anticonvulsants; Benzhydryl Compounds; Bipolar Disorder; Carbamazepine; Cytochrome P-450 CYP3 | 2015 |
Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; | 2015 |
Development of mania with carbamazepine for treatment of seizure disorder in a 7-year-old boy.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Child; Epilepsy; Humans; Male | 2015 |
Transcriptome sequencing of the anterior cingulate in bipolar disorder: dysregulation of G protein-coupled receptors.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Case-Control Studies; Cell Line; Female; G | 2015 |
The rapid suicide protection of mood stabilizers on patients with bipolar disorder: A nationwide observational cohort study in Taiwan.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Carbamazepine; Cohort Studies; Female; | 2016 |
Targeting astrocytes in bipolar disorder.
Topics: Animals; Antidepressive Agents; Astrocytes; Bipolar Disorder; Carbamazepine; Humans; Valproic Acid | 2016 |
Effect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-state.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Area Under Curve; ATP Binding Cassette Transporter, S | 2014 |
The number of past manic episodes is the best predictor of antidepressant-emergent manic switch in a cohort of bipolar depressed patients.
Topics: Adult; Affect; Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Depre | 2016 |
Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; | 2016 |
Manic espisode, confusional syndrome and reversible splenial lesion after abrupt withdrawal of oxcarbazepine.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Confusion; Female; Humans; Magnetic Resonance Imag | 2017 |
Late-onset hypersensitivity reaction with leukopenia and thrombocytopenia induced by oxcarbazepine treatment in a patient with schizoaffective disorder.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Diagnostic and Statistical Manual of Mental Disord | 2008 |
Unilateral rubral tremor following treatment with risperidone.
Topics: Anticonvulsants; Antipsychotic Agents; Ataxia; Behavior Therapy; Bipolar Disorder; Brain; Carbamazep | 2009 |
Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages.
Topics: Adolescent; Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Dose-Response | 2008 |
The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
Topics: Acetaminophen; Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Case-Contr | 2008 |
Transcription factor SP4 is a susceptibility gene for bipolar disorder.
Topics: Adolescent; Adult; Animals; Antimanic Agents; Asian People; Bipolar Disorder; Carbamazepine; Case-Co | 2009 |
Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipol | 2010 |
Carbamazepine-induced hyperammonemia.
Topics: Adult; Aggression; Akathisia, Drug-Induced; Antimanic Agents; Bipolar Disorder; Carbamazepine; Human | 2009 |
PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Carbamazepine; Chemotaxis; Humans; Inositol; Lithium Co | 2009 |
Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Cytochrome P-450 Enzyme | 2009 |
New-onset vascular mania in a patient with chronic depression.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Dementia, Vascular; Depress | 2009 |
Oxcarbazepine-related neutropenia: a case report.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Female; Humans; Neutropenia; Oxcarbazepine | 2010 |
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; C | 2010 |
Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dose-Respon | 2010 |
Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.
Topics: Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Bipolar Disorder; Carbamazepine; Cotinine; Cy | 2010 |
How to treat DBS-induced mania?
Topics: Aged; Bipolar Disorder; Carbamazepine; Clozapine; Deep Brain Stimulation; Female; Humans; Male; Midd | 2011 |
Fluconazole-carbamazepine interaction in a patient with bipolar disorder.
Topics: Adult; Antifungal Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; Fema | 2011 |
Anticonvulsant hypersensitivity syndrome: a rare and serious complication.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Anticonvulsants; Antipsychotic Agents; Bipolar Di | 2011 |
A retrospective case series of bipolar patients with adjunctive carbamazepine in long-term lithium treatment: evaluation of the effectiveness.
Topics: Bipolar Disorder; Carbamazepine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lithium | 2011 |
Morphine sensitization as a model of mania: comparative study of the effects of repeated lithium or carbamazepine administration.
Topics: Analgesics, Opioid; Animals; Anticonvulsants; Antimanic Agents; Appetitive Behavior; Bipolar Disorde | 2011 |
The future of psychiatric pharmacogenomics.
Topics: Antipsychotic Agents; Arrhythmias, Cardiac; Biomarkers, Pharmacological; Bipolar Disorder; Carbamaze | 2011 |
Granulomatous interstitial nephritis associated with atypical drug-induced hypersensitivity syndrome induced by carbamazepine.
Topics: Aged; Bipolar Disorder; C-Reactive Protein; Carbamazepine; Drug Eruptions; Eosinophilia; Female; Gra | 2012 |
[Cardiologic interaction carbamazepine with atypical neuroleptics. Acute mixed carbamazepine and quetiapine intoxication--case report].
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Arrhythmias, Cardiac; Bipolar Disorde | 2011 |
Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: a 30-year observational study.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Female; Humans; Lamotrigine; Lithium Compou | 2012 |
Response to nimodipine in ultradian bipolar cycling after amygdalohippocampectomy.
Topics: Antimanic Agents; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Depressive Disorder; Fe | 2012 |
Three medication pathways for bipolar disorder.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; Hu | 2012 |
Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Fem | 2012 |
Painless thyroiditis in drug-induced hypersensitivity syndrome with prolonged reactivation of herpesviruses.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Cytomegalovirus; Drug Eruptions; Herpesvirus 6, H | 2013 |
Use of carbamazepine and lamotrigine in a Taiwanese diabetic patient with bipolar disorder.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Diabetes Complications; Drug Therapy, Combination | 2012 |
Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Australia; B | 2012 |
Cell-specific mRNA alterations in Na+, K+-ATPase α and β isoforms and FXYD in mice treated chronically with carbamazepine, an anti-bipolar drug.
Topics: Animals; Astrocytes; Bipolar Disorder; Carbamazepine; Female; Isoenzymes; Male; Membrane Glycoprotei | 2013 |
H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures.
Topics: Aged; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Epilepsy; Famotidine; Fema | 2002 |
A 5-year-old boy with recurrent mania successfully treated with carbamazepine.
Topics: Age Factors; Antimanic Agents; Bipolar Disorder; Carbamazepine; Child; Child, Preschool; Humans; Mal | 2002 |
Oxcarbazepine-induced syndrome of inappropriate secretion of antidiuretic hormone.
Topics: Aged; Anticonvulsants; Bipolar Disorder; Carbamazepine; Humans; Hyponatremia; Inappropriate ADH Synd | 2002 |
Treatment of bipolar disorder in older adults.
Topics: Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; | 2002 |
Oxcarbazepine for mood disorders.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Comorbidity; Domestic Violence; Drug Admini | 2002 |
Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization.
Topics: Adolescent; Aged; Antimanic Agents; Biological Availability; Bipolar Disorder; Carbamazepine; Drug T | 2002 |
[A history of investigation on the mood-stabilizing effect of carbamazepine in Japan].
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as To | 2002 |
Attenuation of N-methyl-D-aspartate-mediated cytoplasmic vacuolization in primary rat hippocampal neurons by mood stabilizers.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Carbamazepine; Cell Survival; Cells, Cultured; Cytoplas | 2003 |
[Interactions of mood stabilizers].
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combinati | 2003 |
Oxcarbazepine treatment of bipolar disorder.
Topics: Adolescent; Adult; Ambulatory Care; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug Administr | 2003 |
Mood stabilizers in hospitalized children with bipolar disorder: a retrospective review.
Topics: Analysis of Variance; Anticonvulsants; Bipolar Disorder; Carbamazepine; Child; Child, Hospitalized; | 2003 |
Oxcarbazepine, risperidone and atenolol overdose with benign outcome.
Topics: Adrenergic beta-Antagonists; Adult; Alcoholism; Anticonvulsants; Antipsychotic Agents; Atenolol; Bip | 2003 |
Suicide risk in bipolar disorder during treatment with lithium and divalproex.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Female; Humans; Lithium Compou | 2003 |
Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders.
Topics: Adult; Akathisia, Drug-Induced; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Brief Psychiatr | 2003 |
Mood-stabilizers: the archeology of the concept.
Topics: Affect; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Concept Formation; Forec | 2003 |
"Mood-stabilizers: the archeology of the concept"--by M Harris, S Chandran, N Chakraborty and D Healy: a commentary.
Topics: Affect; Antimanic Agents; Bipolar Disorder; Carbamazepine; Concept Formation; Forecasting; History, | 2003 |
Latency and outcome of prophylaxis in bipolar disorder: role of severity as a confounding variable?
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Confounding Factors, Epidemiologic; Female; Human | 2004 |
Irreversible priapism during olanzapine and lithium therapy.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Huma | 2004 |
Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Corticotropin-Relea | 2004 |
Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels.
Topics: Affect; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combin | 2004 |
Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Female; Humans; Oxcarbazepine; | 2004 |
Cytokine production in bipolar affective disorder patients under lithium treatment.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Cytokines; Down-Regulatio | 2004 |
Carbamazepine and rebound mania.
Topics: Analgesics, Non-Narcotic; Bipolar Disorder; Carbamazepine; Humans; Male; Middle Aged; Neuralgia; Sub | 2004 |
[Erythema multiforme caused by carbamazepine].
Topics: Anticonvulsants; Bipolar Disorder; Borderline Personality Disorder; Carbamazepine; Dose-Response Rel | 2004 |
Oxcarbazepine treatment of juvenile-onset bipolar disorder.
Topics: Adolescent; Age of Onset; Bipolar Disorder; Carbamazepine; Child; Humans; Male; Oxcarbazepine | 2004 |
Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Bipolar Disorder; Carbamazepine; Central Nervous Syst | 2005 |
Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; De | 2005 |
Extended-release carbamazepine (Equetro) for bipolar disorder.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Delayed-Action Preparations; Double-Blind Method; | 2005 |
Drug treatments for bipolar disorder: 1--Acute manic or depressive episodes.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disor | 2005 |
[Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimanic Agents; Bipolar Disorder; Brain Diseases; | 2005 |
Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new data.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; Humans; Randomized Controlled | 2005 |
Outcome measurement, outcome management and monitoring.
Topics: Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Bipolar Disorder; Carbamazepine; | 2005 |
Extended-release carbamazepine capsules: a viewpoint.
Topics: Antimanic Agents; Bipolar Disorder; Capsules; Carbamazepine; Clinical Trials as Topic; Delayed-Actio | 2005 |
Extended-release carbamazepine capsules: a viewpoint.
Topics: Antimanic Agents; Bipolar Disorder; Capsules; Carbamazepine; Clinical Trials as Topic; Delayed-Actio | 2005 |
Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder.
Topics: Acyl Coenzyme A; Animals; Anticonvulsants; Antimanic Agents; Arachidonic Acid; Bipolar Disorder; Bra | 2006 |
Cotard's syndrome in adolescents and young adults: a possible onset of bipolar disorder requiring a mood stabilizer?
Topics: Adolescent; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Body Image; Carbamazepine; Delusion | 2005 |
Oxcarbazepine add-on in the treatment of refractory bipolar disorder.
Topics: Adult; Aged; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Hu | 2005 |
Priapism associated with oxcarbazepine, aripiprazole, and lithium.
Topics: Adolescent; Affective Symptoms; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazol | 2005 |
Mania associated with multiple paraphilias.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Male; Middle Aged; | 2006 |
Stevens-Johnson syndrome (SJS) leading to resolution of mania.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug | 2006 |
Classical mania associated with dengue infection.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Dengue; Haloperidol; Humans; India; Ma | 2006 |
Safety and tolerability of mood-stabilising anticonvulsants in the elderly.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug In | 2006 |
Woman on the verge.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Female; Humans; Physician-Patient Relations; Preg | 2006 |
Woman on the verge.
Topics: Adaptation, Psychological; Antimanic Agents; Attitude to Health; Bipolar Disorder; Carbamazepine; Fe | 2006 |
Sustained attention deficits in manic and euthymic patients with bipolar disorder.
Topics: Adult; Anticonvulsants; Antimanic Agents; Arousal; Attention Deficit Disorder with Hyperactivity; Bi | 2006 |
Carbamazepine extended-release capsules in the treatment of bipolar disorder.
Topics: Antimanic Agents; Bipolar Disorder; Capsules; Carbamazepine; Delayed-Action Preparations; Humans | 2006 |
Carbamazepine extended-release capsules: a retrospective review of its use in children and adolescents.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Capsules; Carbamazepine; Child; Child, Preschool; De | 2006 |
Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Capsules; Carbamazepine; Delayed-Action | 2006 |
Outcomes and length of treatment with carbamazepine extended-release capsules in bipolar disorder.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Capsules; Carbamazepine; Delayed-Action | 2006 |
Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Anxiety Disorders; Attention Deficit Disorder with Hypera | 2006 |
Predictors of response to carbamazepine extended-release capsules treatment in bipolar disorder.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Capsules; Carbamazepine; Delayed-Action Preparations; Dia | 2006 |
Safety and efficacy of carbamazepine extended-release capsules in patients with bipolar disorder: QD vs BID.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Capsules; Carbamazepine; Child; Child, | 2006 |
A retrospective analysis of changing from alternative agents to carbamazepine extended-release capsules in bipolar disorder.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Capsul | 2006 |
Concurrent use of efavirenz and oxcarbazepine may not affect efavirenz plasma concentrations.
Topics: Adult; Alkynes; Anti-HIV Agents; Anticonvulsants; Benzoxazines; Bipolar Disorder; Carbamazepine; Cyc | 2006 |
Oxcarbazepine in a carbamazepine-intolerant patient with bipolar affective disorder: a case report.
Topics: Adult; Anticonvulsants; Antimanic Agents; Basal Ganglia Diseases; Bipolar Disorder; Carbamazepine; D | 2006 |
RETRACTED: Chronic administration of carbamazepine down-regulates AP-2 DNA-binding activity and AP-2alpha protein expression in rat frontal cortex.
Topics: Animals; Anticonvulsants; Antimanic Agents; Arachidonic Acid; Bipolar Disorder; Carbamazepine; Down- | 2007 |
Flying almost blind.
Topics: Adolescent; Age Factors; Anticonvulsants; Bipolar Disorder; Carbamazepine; Child; Humans; Outcome As | 2006 |
A case of carbamazepine overdose with focal myocarditis.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Overdose; Female; Humans; Lymphocytes | 2006 |
Possible carbamazepine toxicity with terbinafine.
Topics: Bipolar Disorder; Carbamazepine; Drug Interactions; Humans; Male; Middle Aged; Naphthalenes; Terbina | 2006 |
Tiagabine withdrawal-emergent mania.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug | 2006 |
A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder.
Topics: Adolescent; Adult; Aggression; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Child; Drug A | 2006 |
Atypical antipsychotics related metabolic syndrome in bipolar patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Carbama | 2007 |
Women on the verge.
Topics: Adult; Bipolar Disorder; Carbamazepine; Decision Making; Female; Humans; Pregnancy; Pregnancy Compli | 2006 |
Oxcarbazepine and pediatric bipolar disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Carbamazepine; Central | 2006 |
The diagnostic and pharmacological variances of bipolar disorder versus attention-deficit/hyperactivity disorder.
Topics: Adolescent; Age of Onset; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Bipolar Di | 2006 |
Erythrocyte phosphoglucomutase activity of bipolar I patients currently using lithium or carbamazepine.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Brief Psychiatric Rating Scale; Carbamazepine | 2007 |
Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Cardiovascular Diseases; Drug Monitori | 2007 |
Characteristics of psychotic patients with foreign accent syndrome.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; C | 2007 |
Two case reports of oral ulcers with lamotrigine several weeks after oxcarbazepine withdrawal.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Drug Synergism; Female; Humans | 2007 |
Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study.
Topics: Adult; Aged; Aged, 80 and over; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Dis | 2007 |
Bipolar switching after carbamazepine withdrawal.
Topics: Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Humans; Male; Substa | 2007 |
Oxcarbazepine treatment of refractory bipolar illness.
Topics: Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Male; | 2007 |
Efficacy and safety of oxcarbazepine in bipolar disorder.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Humans; Oxcarba | 2007 |
Bipolar pharmacotherapy and suicidal behavior Part 3: impact of antipsychotics.
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Thera | 2007 |
[Transient high-intensity T2 signal in the splenium of the corpus callosum in a non-epileptic patient].
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Corpus Callosum; Diffusion Magnetic Resonance Ima | 2007 |
Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine.
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Female; Hospitalization; Humans; | 2007 |
Aripiprazole in a patient susceptible to urinary side effects of antipsychotics.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Drug Th | 2007 |
Divalproex, lithium and suicide among Medicaid patients with bipolar disorder.
Topics: Adult; Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Emerge | 2008 |
Oxcarbazepine treatment during breast-feeding: a case report.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Breast Feeding; Carbamazepine; Child, Preschool; Depressiv | 2007 |
Detoxication treatment for carbamazepine and lithium overdose.
Topics: Adult; Bayes Theorem; Bipolar Disorder; Carbamazepine; Charcoal; Drug Overdose; Female; Gastric Lava | 2008 |
Deconstructing a medication regimen.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benztropine; Biotransformation; Bipolar Disorder | 2008 |
Carbamazepine: an alternative to lithium therapy?
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Male | 1982 |
Case report of a possible interaction between neuroleptics and carbamazepine.
Topics: Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Delirium; Drug Interactions; Female; Haloperi | 1984 |
The use of carbamazepine as an adjunctive medication in the treatment of affective disorders: a clinical report.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Depressive Diso | 1984 |
[Carbamazepine in the treatment of affective disorders].
Topics: Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans | 1984 |
Biological relationships between mania and melancholia.
Topics: Affective Disorders, Psychotic; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; D | 1982 |
Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness.
Topics: Adult; Affective Disorders, Psychotic; Aged; Bipolar Disorder; Carbamazepine; Cyclic AMP; Cyclic GMP | 1982 |
Lithium and carbamazepine interaction: possible neurotoxicity.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Synergism; Drug Therapy, Combination; Female; Humans; L | 1983 |
Carbamazepine and lithium carbonate in the treatment of refractory affective disorders.
Topics: Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder; Humans; Lithium; Lithium Carbonate; Mal | 1983 |
Carbamazepine and lithium carbonate synergism in mania.
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Carbamazepine; Drug Synergism; Drug Therapy | 1983 |
Carbamazepine and lithium carbonate synergism in mania.
Topics: Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Com | 1984 |
The effects of carbamazepine on the thyrotropin response to thyrotropin-releasing hormone.
Topics: Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder; Female; Humans; Hypothalamo-Hypophyseal | 1984 |
Lithium-carbamazepine neurotoxicity and risk factors.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Humans | 1984 |
Thyroid function and affective illness: a reappraisal.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Depressive Disorder; Electroconvu | 1984 |
Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis.
Topics: Acetazolamide; Adolescent; Adult; Bipolar Disorder; Carbamazepine; Electroencephalography; Female; H | 1984 |
Using carbamazepine effectively.
Topics: Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Female; Humans | 1984 |
[Preventive treatment of affective psychoses with finlepsin].
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Resistance; Female; Humans; Lithium; Male; Middle Aged; | 1984 |
Carbamazepine in the treatment of aggressive behavior in schizophrenic patients: a case report.
Topics: Adult; Aggression; Bipolar Disorder; Carbamazepine; Humans; Male; Schizophrenia, Paranoid | 1984 |
Carbamazepine in the treatment of bulimia.
Topics: Adult; Ambulatory Care; Bipolar Disorder; Carbamazepine; Double-Blind Method; Feeding and Eating Dis | 1983 |
Long-term prophylactic effects of carbamazepine in affective disorder.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Female; Humans; Male; Middle Aged; Time Factors | 1983 |
[Carbamazepine in the prevention and therapy of affective psychoses].
Topics: Adult; Bipolar Disorder; Carbamazepine; Female; Humans; Male | 1983 |
Carbamazepine for patients with affective target symptoms.
Topics: Bipolar Disorder; Carbamazepine; Female; Humans; Male; Mood Disorders | 1984 |
Cost effectiveness of carbamazepine in refractory bipolar illness.
Topics: Bipolar Disorder; Carbamazepine; Electroconvulsive Therapy; Hospitalization; Humans; Male; Middle Ag | 1984 |
Verapamil and depression.
Topics: Bipolar Disorder; Carbamazepine; Depressive Disorder; Drug Therapy, Combination; Dyskinesia, Drug-In | 1984 |
Carbamazepine-induced mania in two children: case report.
Topics: Age Factors; Bipolar Disorder; Carbamazepine; Chemical Phenomena; Chemistry; Child; Depressive Disor | 1984 |
Carbamazepine and desipramine: a toxic reaction.
Topics: Adult; Bipolar Disorder; Carbamazepine; Desipramine; Drug Interactions; Female; Humans | 1984 |
A lithium and carbamazepine combination in the treatment of bipolar disorder--a preliminary report.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Lithium | 1981 |
Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients.
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Carbamazepine; Drug Synergism; Drug Therapy | 1982 |
Bipolar illness after right hemispherectomy. A response to lithium carbonate and carbamazepine.
Topics: Bipolar Disorder; Carbamazepine; Cerebral Decortication; Cerebral Palsy; Drug Therapy, Combination; | 1982 |
Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Depressive Disorder; Female; Humans; Male; Middle Aged | 1983 |
Case report of carbamazepine-induced reticulocytes.
Topics: Adult; Bipolar Disorder; Carbamazepine; Erythrocyte Count; Female; Humans; Reticulocytes | 1983 |
Rapid cycling.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Depressive Disorder; Humans | 1983 |
Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Resistance; Female; Humans; Lithium; Male; Middle Aged | 1983 |
Carbamazepine treatment of selected affectively disordered inpatients.
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Carbamazepine; Female; Humans; Lithium; Mal | 1982 |
Interference by carbamazepine with the dexamethasone suppression test.
Topics: Adolescent; Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder; Dexamethasone; Diagnosis, D | 1982 |
Bipolar affective disorder: report of a case treated with carbamazepine (Tegretol).
Topics: Adult; Bipolar Disorder; Carbamazepine; Humans; Male | 1982 |
Lack of effect of carbamazepine on gamma-aminobutyric acid in cerebrospinal fluid.
Topics: Adult; Bipolar Disorder; Carbamazepine; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged | 1980 |
Differential sensitivity to the effects of psychotropic drugs: psychotics vs normals; Asian vs Western populations.
Topics: Bipolar Disorder; Carbamazepine; Chlorpromazine; Cross-Cultural Comparison; Dose-Response Relationsh | 1981 |
Interaction between lithium and carbamazepine.
Topics: Bipolar Disorder; Carbamazepine; Drug Interactions; Humans; Lithium; Male; Middle Aged; Polyuria | 1980 |
The prevention of relapse in bipolar disorder.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chemoprevention; Humans; Lit | 1995 |
Relapse and impairment in bipolar disorder.
Topics: Adaptation, Psychological; Adult; Ambulatory Care; Bipolar Disorder; Carbamazepine; Drug Therapy, Co | 1995 |
Mortality-lowering effect of prophylactic lithium treatment: a look at the evidence.
Topics: Alcoholism; Amitriptyline; Bipolar Disorder; Carbamazepine; Humans; Lithium; Mortality; Suicide | 1995 |
Valproate and carbamazepine join lithium as primary treatments for bipolar disorder.
Topics: Bipolar Disorder; Carbamazepine; Electroconvulsive Therapy; Humans; Lithium; Valproic Acid | 1995 |
Maintenance ECT in intractable manic-depressive disorders.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Combined Modality Th | 1994 |
[General practice of acute inpatient treatment of mania. Retrospective comparative study of 100 patients at each of 2 psychiatric centers].
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Commitment of Mentally Ill; Dose-Respo | 1994 |
Lithium: the present and the future.
Topics: Acute Disease; Bipolar Disorder; Carbamazepine; Depressive Disorder; Drug Interactions; Female; Huma | 1995 |
Choosing lithium, anticonvulsant, or electroconvulsant therapy for mood disorders.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Electroconvul | 1995 |
Possible interaction between metronidazole and carbamazepine.
Topics: Bipolar Disorder; Carbamazepine; Drug Interactions; Erythromycin; Female; Humans; Metronidazole; Mid | 1994 |
Lithium prophylaxis of bipolar illness. The value of combination treatment.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Di | 1994 |
Anticonvulsant therapy for mood disorders.
Topics: Affect; Anticonvulsants; Bipolar Disorder; Carbamazepine; Humans; Lithium; Valproic Acid | 1994 |
CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI.
Topics: Adult; Bipolar Disorder; Carbamazepine; Carrier Proteins; Depressive Disorder; Diazepam Binding Inhi | 1994 |
Aseptic meningitis secondary to carbamazepine treatment of manic-depressive illness.
Topics: Aged; Bipolar Disorder; Carbamazepine; Drug Hypersensitivity; Female; Humans; Meningitis, Aseptic | 1994 |
Efficacy of carbamazepine compared with other agents: a clinical practice survey.
Topics: Attitude of Health Personnel; Bipolar Disorder; Carbamazepine; Drug Utilization; Electroconvulsive T | 1994 |
Misdiagnosis of bipolar affective disorder as personality disorder.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Combined Mo | 1993 |
Depot antipsychotics in bipolar affective disorder.
Topics: Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Delayed-Action Preparations; Dos | 1993 |
[Carbamazepine poisoning: protracted course with development of intestinal atony and hepatic toxicity].
Topics: Adult; Bipolar Disorder; Carbamazepine; Chemical and Drug Induced Liver Injury; Coma; Drug Overdose; | 1994 |
Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1994 |
Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder.
Topics: Bipolar Disorder; Blood Platelets; Calcium; Carbamazepine; Cells, Cultured; Humans; Lithium; Lymphoc | 1994 |
Is there a lithium withdrawal syndrome?
Topics: Bipolar Disorder; Carbamazepine; Humans; Lithium; Recurrence; Substance Withdrawal Syndrome; Treatme | 1994 |
Carbamazepine-induced Stevens-Johnson syndrome.
Topics: Adult; Bipolar Disorder; Carbamazepine; Debridement; Drug Eruptions; Female; Humans; Stevens-Johnson | 1993 |
Effects of carbamazepine and lithium on affective disorders.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Bipolar Disorder; Carbamazepine; Female; H | 1993 |
The effect of carbamazepine on endocrine and sleep EEG variables in a patient with 48-hour rapid cycling, and healthy controls.
Topics: Adult; Affect; Bipolar Disorder; Carbamazepine; Clonidine; Electroencephalography; Hormones; Humans; | 1993 |
Divalproex sodium in the treatment of refractory affective disorders.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Depressive Disorder; Drug Therapy, Combination; Female | 1993 |
[Rapid cycling in bipolar disorders].
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Female; Humans; Lithium; Male; Time F | 1994 |
Self-esteem in recovered bipolar and unipolar out-patients.
Topics: Adult; Aged; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Combined Modality Therapy; Depr | 1993 |
[Bipolar patients in remission: personality disorders and changes in personality].
Topics: Adult; Bipolar Disorder; Carbamazepine; Cyclothymic Disorder; Depressive Disorder; Female; Hospitali | 1993 |
Concomitant intake of nortriptyline and carbamazepine.
Topics: Aged; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Humans; | 1993 |
48-hour rapid cycling: results of psychopathometric, polysomnographic, PET imaging and neuro-endocrine longitudinal investigations in a single case.
Topics: Bipolar Disorder; Carbamazepine; Cerebral Cortex; Circadian Rhythm; Clonidine; Dose-Response Relatio | 1993 |
Expanding uses of anticonvulsants in the treatment of bipolar disorder.
Topics: Bipolar Disorder; Carbamazepine; Clonazepam; Humans; Valproic Acid | 1993 |
Treatment resistant depression in a case of minor head injury: an electrophysiological hypothesis.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Cerebral Cortex; Depressive Disorder; | 1993 |
[Successful hyposensitization treatment of a patient with schizoaffective psychosis and carbamazepine allergy].
Topics: Adult; Bipolar Disorder; Carbamazepine; Desensitization, Immunologic; Drug Administration Schedule; | 1993 |
Bupropion and anticonvulsant drug interactions.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Bipolar Disorder; Bupropion; Carbamazepine; Dose-Resp | 1995 |
Mania precipitated by carbamazepine withdrawal.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Electroencephalo | 1995 |
Porphyria cutanea tarda associated with carbamazepine treatment.
Topics: Bipolar Disorder; Carbamazepine; Humans; Male; Middle Aged; Porphyria Cutanea Tarda | 1996 |
Trends in pharmacotherapy of Schizoaffective and bipolar affective disorders: a 5-year naturalistic study.
Topics: Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Drug Therapy, Combination; Drug Utilizati | 1996 |
Nefazodone-induced carbamazepine toxicity.
Topics: Adult; Bipolar Disorder; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; | 1996 |
Carbamazepine-lithium drug interaction.
Topics: Bipolar Disorder; Carbamazepine; Drug Interactions; Female; Humans; Lithium; Middle Aged; Seizures | 1996 |
Desensitization to carbamazepine-induced skin rash.
Topics: Adult; Bipolar Disorder; Carbamazepine; Desensitization, Immunologic; Drug Eruptions; Female; Humans | 1996 |
National Institute of Mental Health Workshop Report on the Treatment of Bipolar Disorder.
Topics: Antidepressive Agents; Bipolar Disorder; Carbamazepine; Education; Humans; Lithium; Valproic Acid | 1996 |
Treatment of bipolar depression with carbamazepine: results of an open study.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Dose-Response Relat | 1996 |
[Has drug treatment of manic disorders changed in clinical routine practice? Retrospective analysis of treatment modalities and results in a university psychiatric clinic].
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; | 1996 |
Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Topics: Animals; Bipolar Disorder; Blotting, Western; Carbamazepine; Cell Line; Dose-Response Relationship, | 1996 |
Cerebellar ataxia in upper limbs triggered by addition of carbamazepine to lithium treatment.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Cerebellar Ataxia; Drug Interactions; Drug Therap | 1996 |
A patient with mania and photoconvulsive epilepsy.
Topics: Adolescent; Anticonvulsants; Bipolar Disorder; Brain; Carbamazepine; Drug Therapy, Combination; Elec | 1996 |
[Changes in the blood picture with combination carbamazepine, perazine and antibiotic treatment].
Topics: Adult; Amoxicillin; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Leuk | 1996 |
Acute treatment of bipolar disorder with adjunctive risperidone in outpatients.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Hum | 1997 |
Combined valproate or carbamazepine and electroconvulsive therapy.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; | 1997 |
Association between mood-stabilizing medication and mental health resource use in the management of acute mania.
Topics: Acute Disease; Adult; Aged; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug | 1997 |
Recovery from neuroendocrinological abnormalities and frontal hypoperfusion after remission in a case with rapid cycling bipolar disorder.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Clonazepam; Dexamethasone; Drug Therapy, Combinati | 1997 |
Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients.
Topics: Aged; Anti-Bacterial Agents; Anticonvulsants; Bipolar Disorder; Carbamazepine; Central Nervous Syste | 1997 |
Frontal-complex partial status epilepticus misdiagnosed as bipolar affective disorder in a 75-year-old man.
Topics: Aged; Bipolar Disorder; Carbamazepine; Diagnostic Errors; Electroencephalography; Epilepsy, Frontal | 1997 |
Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Breast Feeding; Carbamazepine; Female; Fluoxetine; Humans; | 1998 |
Topographic EEG studies of mania.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Electroencephalography; Female; Halope | 1998 |
Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
Topics: Adult; Analysis of Variance; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Drug The | 1998 |
Medication compliance among patients with bipolar disorder and substance use disorder.
Topics: Adult; Benzodiazepines; Bipolar Disorder; Carbamazepine; Comorbidity; Female; Humans; Lithium; Male; | 1998 |
[Eosinophilic ulcers of the tongue as an adverse reaction to carbamazepine].
Topics: Aged; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Eosinophilia; Humans; Male; Tongue Dis | 1998 |
Congenital neuroblastoma in a boy born to a woman with bipolar disorder treated with carbamazepine during pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Gland Neoplasms; Adult; Anticonvulsants; Bipolar Disorder; Carb | 1998 |
Comparison of early- and late-onset rapid cycling affective disorders: clinical course and response to pharmacotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antimanic Agents; Bipolar Disorde | 1998 |
Use of mood stabilizers by hospitalized geriatric patients with bipolar disorder.
Topics: Aged; Analysis of Variance; Antimanic Agents; Bipolar Disorder; Carbamazepine; Female; Geriatric Psy | 1998 |
Concomitant rash and blood dyscrasias in geriatric psychiatry patients treated with carbamazepine.
Topics: Aged; Antimanic Agents; Bipolar Disorder; Carbamazepine; Exanthema; Female; Humans; Male; Paraprotei | 1998 |
The increasing use of anticonvulsants in prophylactic treatment of bipolar disorder.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Bipolar Disorder; Carbamazepine; Female; Humans; Lithium; | 1998 |
The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; | 1998 |
Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Li | 1999 |
Valproate with lithium and carbamazepine in bipolar disorder.
Topics: Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Cross-Over Studies; Dose-Response Relatio | 1999 |
Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder.
Topics: Adolescent; Adult; Bipolar Disorder; Blood Chemical Analysis; Carbamazepine; Case Management; Drug M | 1999 |
Carbamazepine, hepatotoxicity, organic solvents, and paints.
Topics: Alcohol Drinking; Anticonvulsants; Bipolar Disorder; Carbamazepine; Chemical and Drug Induced Liver | 1999 |
Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antipsychotic Agents; Bipolar Disorder; Calcium; Calc | 1999 |
Evaluation of thyroid function in lithium-naive bipolar patients.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Female; Humans; Hypothyroidism; Lithium; M | 1999 |
Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations.
Topics: Antimanic Agents; Astrocytoma; Bipolar Disorder; Brain; Brain Neoplasms; Carbamazepine; Dose-Respons | 2000 |
Carbamazepine suppresses methamphetamine-induced Fos expression in a regionally specific manner in the rat brain. Possible neural substrates responsible for antimanic effects of mood stabilizers.
Topics: Amphetamine-Related Disorders; Animals; Antimanic Agents; Bipolar Disorder; Body Weight; Brain; Carb | 2000 |
[The carbamazepine hypersensitivity syndrome. Differential diagnosis and a representative case history].
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug Eruptions; Female; Humans | 2000 |
Carbamazepine treatment of bipolar disorder in an adolescent with cerebral palsy.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Carbamazepine; Cerebral Palsy; Humans; Male; Treatme | 2000 |
Carbamazepine augmentation in lithium-refractory bipolar patients: a prospective study on long-term prophlyactic effectiveness.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Fem | 1997 |
Treatment of bipolar affective disorder.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Risk Factors | 2000 |
Twin concordance for bipolar disorder and migraines.
Topics: Adult; Bipolar Disorder; Carbamazepine; Comorbidity; Diseases in Twins; Female; Humans; Migraine Dis | 2000 |
Does 'rebound mania' occur after stopping carbamazepine? A pilot study.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Follow-Up Studies; Hum | 2000 |
Valproate and other anticonvulsants for psychiatric disorders.
Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Anti-Anxiety Agents; Anticonvulsants; Bipolar | 2000 |
Difficulties in diagnosis and management of bipolar disorder: three case presentations.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Combined Modality The | 2000 |
Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antimanic Agents; Bipolar Disorder; Carbamazepine; De | 2001 |
Pharmacologic loading in the treatment of acute mania.
Topics: Acute Disease; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Dose-Response Rel | 2000 |
Stevens-Johnson syndrome due to carbamazepine.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Eruptions; Female; Humans; Male; Stevens-Johnson Syndro | 2000 |
Lithium intoxication due to carbamazepine-induced renal failure.
Topics: Acute Kidney Injury; Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug Interactions; Hum | 2001 |
Carbamazepine treatment of corticosteroid-induced mood disorder.
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Administration Schedu | 2001 |
Oxcarbazepine in bipolar disorder.
Topics: Affect; Aggression; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Child; D | 2001 |
Disodium valproate: new preparation. An alternative for acute mania after lithium failure or intolerance.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Drug Approval; France; | 2001 |
[Manic syndrome: diagnostic trends and principles of treatment].
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chl | 1998 |
Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder.
Topics: Administration, Oral; Animals; Anticonvulsants; Bipolar Disorder; Brain; Carbamazepine; Disease Mode | 2002 |
Antituberculosis agents and carbamazepine.
Topics: Adult; Antitubercular Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; Female; Humans; Tu | 2002 |
Combined antidepressant treatment: a risk factor for switching in bipolar patients.
Topics: Anticonvulsants; Antidepressive Agents; Bipolar Disorder; Bupropion; Carbamazepine; Drug Administrat | 2002 |
A common mechanism of action for three mood-stabilizing drugs.
Topics: Animals; Animals, Newborn; Antimanic Agents; Bipolar Disorder; Calcium-Calmodulin-Dependent Protein | 2002 |
Nonadherence with mood stabilizers: prevalence and predictors.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Attitude of Health Personnel; Attitude to Health; Bip | 2002 |
Organic personality disturbance: a case of apparent atypical cyclic affective disorder.
Topics: Adult; Bipolar Disorder; Carbamazepine; Electroencephalography; Epilepsy, Temporal Lobe; Female; Hum | 1979 |
[A brief and recurrent violence].
Topics: Adult; Alcoholism; Bipolar Disorder; Carbamazepine; Diagnosis, Differential; Female; Humans; Lithium | 1992 |
[Epilepsy drugs in the treatment of manic disorders].
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Humans; Lithium | 1991 |
Carbamazepine-induced systemic lupus erythematosus.
Topics: Adult; Antibodies, Antinuclear; Bipolar Disorder; Carbamazepine; Female; Humans; Lupus Erythematosus | 1992 |
Asterixis induced by carbamazepine therapy.
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1992 |
Antidepressant-associated mania.
Topics: Adult; Bipolar Disorder; Carbamazepine; Fluvoxamine; Humans; Lithium; Male | 1992 |
Combined valproate and carbamazepine treatment of bipolar disorder.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Lithium Carbonate; Male; | 1992 |
Algorithm for patient management of acute manic states: lithium, valproate, or carbamazepine?
Topics: Acute Disease; Algorithms; Bipolar Disorder; Carbamazepine; Humans; Lithium; Valproic Acid | 1992 |
Effect of psychopharmacotherapy on suicide risk in discharged psychiatric inpatients.
Topics: Adult; Bipolar Disorder; Carbamazepine; Community Mental Health Centers; Female; Follow-Up Studies; | 1992 |
[Electroconvulsive therapy in treatment of acute life threatening catatonia in toxic epidermal necrolysis (Lyell syndrome)].
Topics: Adult; Bipolar Disorder; Carbamazepine; Catatonia; Drug Therapy, Combination; Electroconvulsive Ther | 1992 |
Life events and relapse in bipolar affective disorder.
Topics: Adult; Aged; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Cohort Studies; Female; Humans; | 1992 |
Contingent tolerance and reresponse to carbamazepine: a case study in a patient with trigeminal neuralgia and bipolar disorder.
Topics: Aged; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Drug Therapy, Combination; Drug | 1992 |
Lyell syndrome and lethal catatonia: a case for ECT.
Topics: Adult; Bipolar Disorder; Carbamazepine; Catatonia; Electroconvulsive Therapy; Female; Humans; Steven | 1992 |
The treatment of affective disorder with carbamazepine: prophylactic synergism of lithium and carbamazepine combination.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Drug Synergism; Drug Therapy, Combination; Female; Hum | 1992 |
Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action.
Topics: Adrenal Gland Neoplasms; Animals; Antipsychotic Agents; Bipolar Disorder; Carbachol; Carbamazepine; | 1991 |
Thrombocytopenia associated with carbamazepine: a case series.
Topics: Adolescent; Adult; Bipolar Disorder; Carbamazepine; Female; Humans; Male; Middle Aged; Thrombocytope | 1991 |
Effects of carbamazepine on serum antidepressant concentrations in psychiatric patients.
Topics: Adult; Age Factors; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Depressiv | 1991 |
Rapid-cycling manic-depressive illness following subarachnoid haemorrhage.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium Carbonate | 1991 |
Alternatives to lithium in the treatment of bipolar disorder.
Topics: Bipolar Disorder; Carbamazepine; Humans; Valproic Acid | 1991 |
PDQ-R personality disorders in bipolar patients.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Drug Therapy | 1991 |
Carbamazepine and its 10,11-epoxide metabolite in acute mania: clinical and pharmacokinetic correlates.
Topics: Acute Disease; Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Female; Humans; Male; Middl | 1991 |
Manic episodes in Down's syndrome: two case reports.
Topics: Adult; Bipolar Disorder; Carbamazepine; Down Syndrome; Humans; Lithium; Male; Middle Aged | 1991 |
Political change and course of affective psychoses: Berlin 1989-90.
Topics: Affective Disorders, Psychotic; Berlin; Bipolar Disorder; Carbamazepine; Cross-Sectional Studies; De | 1991 |
[Overcoming resistance to lithium prophylaxis].
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Drug Resistance; Drug Therapy, Combination | 1991 |
Fluoxetine and parkinsonism in patients taking carbamazepine.
Topics: Aged; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Fluoxet | 1991 |
Life events and the course of bipolar disorder.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Female; Follow-Up Stu | 1990 |
On the use of anticonvulsants for manic depression during pregnancy.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Bipolar Disorder; Carbamazepine; Female; Humans; Infan | 1990 |
Carbamazepine and forme fruste neuroleptic malignant syndrome.
Topics: Bipolar Disorder; Body Temperature; Carbamazepine; Drug Overdose; Drug Therapy, Combination; Female; | 1990 |
Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Female; Humans; Hypothyroidism; Lithium; Lithium Carbo | 1990 |
Bupropion as a promising approach to rapid cycling bipolar II patients.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Bupropion; Carbamazepine; Clinical Protocols; Drug T | 1990 |
Leucopenia secondary to carbamazepine despite concurrent lithium treatment.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Leukocyte Count; Leukopen | 1990 |
[Use of electroconvulsive therapy for breaking the continual course of drug-resistant affective and schizoaffective psychoses].
Topics: Bipolar Disorder; Carbamazepine; Drug Resistance; Electroconvulsive Therapy; Humans; Lithium; Lithiu | 1990 |
Fluoxetine-induced mania.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithi | 1990 |
Diltiazem effect on carbamazepine levels in manic depression.
Topics: Bipolar Disorder; Carbamazepine; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Dru | 1990 |
[The efficacy and blood concentration monitoring of carbamazepine on mania].
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Female; Humans; Male; Midd | 1990 |
Carbamazepine-induced aseptic meningitis.
Topics: Alcoholism; Bipolar Disorder; Carbamazepine; Disulfiram; Drug Interactions; Humans; Male; Meningitis | 1990 |
Factors associated with relapse during maintenance treatment of affective disorders.
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1990 |
Mood disorders in the psychoneurologic borderland: three cases of responsiveness to carbamazepine.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Depressive Disorder; Drug Therapy, Combinat | 1989 |
Carbamazepine auto- and hetero-induction complicating clinical care.
Topics: Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female | 1989 |
[Comparative features of the preventive action of carbamazepine and lithium carbonate in affective and schizoaffective psychoses].
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Carbamazepine; Depression; Drug Evaluation; | 1989 |
Carbamazepine update.
Topics: Arrhythmias, Cardiac; Bipolar Disorder; Carbamazepine; Humans; Mental Disorders | 1989 |
Maintaining remission in mood disorders.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Depressive Disorder; Dose-Respons | 1989 |
Exacerbation of psoriasis during lithium treatment.
Topics: Adult; Biopsy; Bipolar Disorder; Carbamazepine; Female; Humans; Immunohistochemistry; Lithium; Patch | 1989 |
Rapid cycling depression in adolescence. A case treated with family therapy and carbamazepine.
Topics: Adolescent; Bipolar Disorder; Carbamazepine; Family; Family Therapy; Female; Humans | 1989 |
The effect of anticonvulsants on the dexamethasone suppression test.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Depressive Disorder; Dexamethasone; Epileps | 1989 |
Refractory rapid cycling unipolar depression responds to lithium and carbamazepine treatment.
Topics: Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder; Drug Therapy, Combination; Female; Huma | 1989 |
[Kleine-Levin syndrome. The provocation of manic symptoms by an antidepressant and a therapeutic trial of carbamazepine].
Topics: Adolescent; Bipolar Disorder; Carbamazepine; Clomipramine; Disorders of Excessive Somnolence; Drug E | 1989 |
Interactions between carbamazepine and birth control pills.
Topics: Adult; Bipolar Disorder; Carbamazepine; Contraceptives, Oral; Drug Interactions; Female; Humans; Pre | 1989 |
Exaggerated corticotrophic cell response to human corticotropin-releasing hormone in two patients during long-term carbamazepine treatment.
Topics: Adrenocorticotropic Hormone; Adult; Bipolar Disorder; Carbamazepine; Corticotropin-Releasing Hormone | 1988 |
CSF somatostatin in affective illness and normal volunteers.
Topics: Bipolar Disorder; Carbamazepine; Depressive Disorder; Desipramine; Humans; Imipramine; Lithium; Lith | 1985 |
Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Resistance; Drug Therapy, Combina | 1985 |
Relationship between cerebrospinal fluid somatostatin and peripheral thyroid hormones with carbamazepine treatment.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Female; Humans; Male; Middle Aged; Somatostatin; Thyro | 1985 |
Carbamazepine in the treatment of tardive dyskinesia.
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Dyskinesia, Drug-Induced; Female; Human | 1986 |
NIMH report. Carbamazepine: treatment option for bipolar patients.
Topics: Bipolar Disorder; Carbamazepine; Drug Interactions; Humans; Lithium | 1989 |
Carbamazepine-induced mania with hypersexuality in a 9-year-old boy.
Topics: Bipolar Disorder; Carbamazepine; Child; Child Behavior Disorders; Depressive Disorder; Humans; Male; | 1989 |
GABA and circadian timekeeping: implications for manic-depression and sleep disorders.
Topics: 4-Aminobutyrate Transaminase; Acetylcholine; Aldehyde Oxidoreductases; Animals; Benzodiazepines; Bip | 1986 |
The use of alternative drug therapy in nine patients with recurrent affective disorder resistant to conventional prophylaxis.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Mi | 1986 |
Bipolar illness following traumatic brain injury: treatment with lithium and carbamazepine.
Topics: Adult; Bipolar Disorder; Brain Injuries; Carbamazepine; Female; Humans; Lithium; Lithium Carbonate; | 1988 |
Lithium therapy in carbamazepine-induced agranulocytosis.
Topics: Adult; Agranulocytosis; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Lithium; | 1988 |
Hematological effects of lithium potentiation of carbamazepine in patients with affective illness.
Topics: Adult; Bipolar Disorder; Blood Cell Count; Carbamazepine; Depressive Disorder; Drug Synergism; Drug | 1988 |
Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disorder.
Topics: Adult; Attention; Bipolar Disorder; Carbamazepine; Cognition; Female; Humans; Lithium; Lithium Carbo | 1988 |
A clinically significant interaction between carbamazepine and valproic acid.
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1988 |
Three cases of carbamazepine toxicity.
Topics: Adult; Anemia, Aplastic; Bipolar Disorder; Carbamazepine; Chemical and Drug Induced Liver Injury; Dr | 1985 |
Apparent complex partial seizures in a bipolar patient after withdrawal of carbamazepine.
Topics: Bipolar Disorder; Carbamazepine; Clonazepam; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Fem | 1988 |
Mania and neuropsychiatric excitation following carbamazepine.
Topics: Adolescent; Aggression; Akathisia, Drug-Induced; Attention Deficit Disorder with Hyperactivity; Bipo | 1988 |
Carbamazepine-induced reduction of plasma alprazolam concentrations: a clinical case report.
Topics: Adult; Alprazolam; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Hu | 1988 |
Plasma biopterin levels of patients with affective disorders.
Topics: Adult; Biopterins; Bipolar Disorder; Carbamazepine; Depressive Disorder; Drug Therapy, Combination; | 1988 |
Measuring plasma levels of carbamazepine. A pharmacokinetic study in patients with affective disorders.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Female; Humans; Male; Middle Aged; Mood Disorders | 1988 |
[The use of carbamazepine in mental diseases].
Topics: Adolescent; Adult; Bipolar Disorder; Carbamazepine; Child; Female; Humans; Male; Middle Aged; Schizo | 1988 |
Verapamil-carbamazepine neurotoxicity.
Topics: Bipolar Disorder; Carbamazepine; Drug Synergism; Drug Therapy, Combination; Female; Humans; Middle A | 1988 |
Carbamazepine-associated asterixis and hyperammonemia.
Topics: Adult; Ammonia; Bipolar Disorder; Carbamazepine; Humans; Male; Movement Disorders; Posture | 1988 |
Carbamazepine and hyponatremia in patients with affective disorder.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Chlorides; Depressive Disorder; Female; Hospitalizatio | 1988 |
A maniclike illness associated with right frontal arteriovenous malformation.
Topics: Adolescent; Bipolar Disorder; Carbamazepine; Female; Frontal Lobe; Humans; Intracranial Arteriovenou | 1988 |
Interaction of danazol and carbamazepine.
Topics: Bipolar Disorder; Carbamazepine; Danazol; Drug Interactions; Drug Therapy, Combination; Endometriosi | 1988 |
Prescribing lithium for pregnant women.
Topics: Adult; Bipolar Disorder; Carbamazepine; Female; Gestational Age; Haloperidol; Humans; Infant, Newbor | 1988 |
Long-term response to carbamazepine: a retrospective study.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Drug Therapy, Combination; Fem | 1988 |
Carbamazepine: single versus multiple dosing.
Topics: Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Humans; Patient Compliance | 1988 |
[Combined recurrence-preventive treatment of manic-depressive disease with lithium and carbamazepine or oxcarbazepine].
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Middle A | 1988 |
Carbamazepine in rapid cycling bipolar affective disorder.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Male; Mi | 1988 |
[Effectiveness of finlepsin in the prophylactic therapy of phasic affective psychoses].
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Carbamazepine; Chronic Disease; Drug Evalua | 1987 |
[Care of mania patients treated by carbamazepine].
Topics: Bipolar Disorder; Carbamazepine; Humans; Male; Middle Aged | 1987 |
An interaction between haloperidol and carbamazepine in a patient with cerebral palsy.
Topics: Adult; Bipolar Disorder; Carbamazepine; Cerebral Palsy; Diabetes Mellitus, Type 1; Dose-Response Rel | 1987 |
Lithium and carbamazepine therapy in a patient with manic depressive illness: clinical effects, interactions and side effects.
Topics: Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Middle Aged | 1987 |
Carbamazepine treatment of mania: clinical and biochemical aspects.
Topics: Biochemical Phenomena; Biochemistry; Bipolar Disorder; Carbamazepine; Drug Synergism; Forecasting; H | 1986 |
[Combined preventive treatment of recurrent manic-depressive disease with lithium and carbamazepine or oxcarbazepine].
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Male; Mi | 1987 |
Motor activity in depressed patients treated with carbamazepine.
Topics: Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder; Female; Humans; Male; Middle Aged; Moto | 1987 |
[Therapeutic effect of carbamazepine in 55 cases of mania].
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Humans; Male; Middle Aged | 1987 |
Erythema multiforme major in a patient treated with carbamazepine.
Topics: Adult; Bipolar Disorder; Carbamazepine; Humans; Male; Stevens-Johnson Syndrome | 1987 |
The use of carbamazepine and lithium in controlling a case of chronic rapid cycling.
Topics: Adult; Bipolar Disorder; Carbamazepine; Chronic Disease; Female; Humans; Lithium | 1987 |
Treatment of rapid cycling bipolar patients.
Topics: Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Isocarboxazid; Lithium; Phenelzi | 1987 |
[Carbamazepine in monotherapy in manic states; a series of 15 patients].
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Female; Humans; Intestinal Abs | 1987 |
Carbamazepine and ECT: a paradoxical combination.
Topics: Bipolar Disorder; Carbamazepine; Combined Modality Therapy; Electroconvulsive Therapy; Female; Human | 1986 |
Lithium counteracts carbamazepine-induced leukopenia while increasing its therapeutic effect.
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1986 |
Effect of carbamazepine on body weight in affectively ill patients.
Topics: Adult; Bipolar Disorder; Body Weight; Carbamazepine; Depressive Disorder; Double-Blind Method; Femal | 1986 |
Effects of carbamazepine on serum electrolytes in affectively ill patients.
Topics: Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder; Dose-Response Relationship, Drug; Elect | 1986 |
[Carbamazepine: a new perspective in the treatment of affective diseases].
Topics: Bipolar Disorder; Carbamazepine; Epilepsy, Temporal Lobe; Humans; Male; Mental Disorders; Middle Age | 1986 |
Hyponatremia associated with carbamazepine therapy.
Topics: Adult; Bipolar Disorder; Carbamazepine; Female; Humans; Hyponatremia; Male; Middle Aged; Psychotic D | 1986 |
Manic state with carbamazepine therapy of seizures.
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; H | 1986 |
[Carbamazepine in manic-depressive disorders].
Topics: Aged; Bipolar Disorder; Carbamazepine; Female; Humans; Middle Aged | 1986 |
[Problems associated with diagnosis and treatment of endogenous manias].
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Child; Dibenzothiepins; Female; Humans; Li | 1985 |
Effect of carbamazepine on neuroleptic plasma levels and efficacy.
Topics: Adult; Biological Availability; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; | 1986 |
A case of erythromycin-induced carbamazepine toxicity.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Erythromycin; | 1986 |
The side effects of carbamazepine.
Topics: Anemia, Aplastic; Bipolar Disorder; Carbamazepine; Chemical and Drug Induced Liver Injury; Humans; P | 1986 |
The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants.
Topics: Anemia; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination | 1985 |
A haloperidol-carbamazepine interaction in a patient with rapid-cycling bipolar disorder.
Topics: Bipolar Disorder; Carbamazepine; Delirium; Drug Therapy, Combination; Female; Haloperidol; Humans; M | 1985 |
Lack of pharmacokinetic interaction of carbamazepine with tranylcypromine.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Humans; Kineti | 1985 |
Carbamazepine in manic depressive psychosis.
Topics: Adolescent; Adult; Bipolar Disorder; Carbamazepine; Female; Humans; Male; Middle Aged | 1985 |
Hematological effects of carbamazepine in patients with affective illness.
Topics: Adult; Anemia; Anemia, Aplastic; Bipolar Disorder; Carbamazepine; Diagnosis, Differential; Erythrocy | 1985 |
Carbamazepine in bipolar-depressed disorder complicated by tricyclic antidepressant switching: case report.
Topics: Adult; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Depression; Female; Humans | 1985 |
Simultaneous determination of carbamazepine and its epoxide metabolite in plasma and urine by high-performance liquid chromatography.
Topics: Bipolar Disorder; Carbamazepine; Chromatography, High Pressure Liquid; Drug Stability; Humans; Spect | 1985 |
Methylphenidate infusion in euthymic bipolars: effect of carbamazepine pretreatment.
Topics: Adult; Arousal; Bipolar Disorder; Carbamazepine; Euphoria; Female; Humans; Infusions, Parenteral; Ma | 1985 |
Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Drug Evaluation; Female; Humans; Lithium; | 1973 |
[Lithium and diabetes insipidus].
Topics: Bipolar Disorder; Carbamazepine; Clofibrate; Diabetes Insipidus; Humans; Lithium; Male; Middle Aged; | 1972 |
[Depressive condition with electroencephalographic abnormalities--contribution to differential diagnosis of endogenous depression].
Topics: Adolescent; Adult; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Depression; Diagnosis, Di | 1969 |